data_2ent_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ent _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 349' ' ' LYS . . . . . 0.417 ' HB3' ' C ' ' A' ' 362' ' ' PHE . 37.7 mttt . . . . . 0 C--O 1.232 0.148 0 CA-C-O 121.599 0.714 . . . . 0.0 110.943 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -25.64 28.33 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.698 2.265 . . . . 0.0 112.323 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 351' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -79.88 96.46 6.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.898 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -106.63 131.58 53.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.074 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 42.5 t -48.38 150.7 1.23 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.87 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 47.9 p -95.85 -30.68 13.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.153 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.566 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 44.7 t-105 -47.45 140.82 7.25 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.518 0.675 . . . . 0.0 110.918 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 356' ' ' PRO . . . . . 0.532 ' O ' ' CD1' ' A' ' 355' ' ' TRP . 54.0 Cg_endo -69.73 141.18 44.64 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.682 2.255 . . . . 0.0 112.375 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 81.88 -36.05 2.51 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.467 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 49.4 t -65.97 150.77 48.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.866 0.365 . . . . 0.0 110.874 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -142.37 46.15 0.89 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.476 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 44.0 m95 -99.06 128.86 45.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.746 0.308 . . . . 0.0 110.959 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 361' ' ' ARG . . . . . . . . . . . . . 29.6 mtt180 -120.64 156.55 31.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.87 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 362' ' ' PHE . . . . . 0.528 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 23.2 m-85 -140.92 147.02 38.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.932 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 74.3 m -76.23 -22.11 55.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.864 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -118.27 161.62 19.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.846 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 85.8 p -70.95 -56.15 6.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.88 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -49.71 -40.61 41.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.903 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -59.62 -33.14 71.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.856 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . 0.528 ' HA ' ' CD1' ' A' ' 362' ' ' PHE . 8.4 tp -81.6 -42.56 19.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.927 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 42.8 t -60.1 -46.7 88.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.831 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -59.86 -30.88 69.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.883 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 371' ' ' HIS . . . . . 0.412 ' CB ' ' CZ ' ' A' ' 362' ' ' PHE . 20.0 t60 -73.94 -48.5 30.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.85 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 27.0 mmm-85 -41.44 -29.5 0.16 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.864 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 73.0 mtt180 -52.91 -45.69 67.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.883 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 61.9 m -44.36 -34.01 1.84 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.843 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 375' ' ' HIS . . . . . 0.566 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 57.3 m-70 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.873 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 349' ' ' LYS . . . . . 0.463 ' HB3' ' N ' ' A' ' 362' ' ' PHE . 53.3 mttm . . . . . 0 C--O 1.231 0.122 0 CA-C-O 121.527 0.68 . . . . 0.0 110.858 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -34.94 13.55 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.716 2.277 . . . . 0.0 112.349 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 351' ' ' PHE . . . . . 0.519 ' CE1' ' HB3' ' A' ' 365' ' ' SER . 97.7 m-85 -68.2 103.25 1.52 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.868 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -107.66 129.59 55.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.082 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 40.5 t -47.41 146.12 2.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.889 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 58.5 m -91.37 -32.14 15.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.16 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.513 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 46.7 t-105 -47.13 140.72 6.51 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.593 0.711 . . . . 0.0 110.915 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 356' ' ' PRO . . . . . 0.509 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 53.8 Cg_endo -69.77 139.46 40.26 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.636 2.224 . . . . 0.0 112.367 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 83.39 -41.13 2.89 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.552 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 36.1 t -61.39 150.14 36.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.928 0.394 . . . . 0.0 110.839 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -139.78 45.16 1.02 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.532 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 25.2 m95 -97.68 130.99 44.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.758 0.313 . . . . 0.0 110.896 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 361' ' ' ARG . . . . . 0.421 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 67.5 mtt180 -121.49 165.66 15.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.867 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 362' ' ' PHE . . . . . 0.465 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 14.5 m-85 -150.83 156.43 41.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.853 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 15.3 t -78.92 -37.46 39.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.872 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -106.91 161.25 14.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.894 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 365' ' ' SER . . . . . 0.519 ' HB3' ' CE1' ' A' ' 351' ' ' PHE . 54.4 p -71.3 -38.1 71.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.879 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -62.51 -45.62 92.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.89 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -55.51 -34.48 64.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.873 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . 0.465 ' HA ' ' CD1' ' A' ' 362' ' ' PHE . 9.0 tp -79.25 -42.96 24.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.902 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 18.3 t -58.13 -44.9 88.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.809 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 370' ' ' ARG . . . . . 0.408 ' HG3' ' N ' ' A' ' 371' ' ' HIS . 29.6 ptt85 -61.82 -30.46 70.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.848 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 371' ' ' HIS . . . . . 0.409 ' CB ' ' CZ ' ' A' ' 362' ' ' PHE . 22.5 t60 -74.4 -39.0 62.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.863 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 26.3 mmm-85 -51.31 -25.1 5.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.863 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 28.8 mtt85 -57.56 -40.87 79.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 58.0 m -50.35 -30.87 13.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.879 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 375' ' ' HIS . . . . . 0.513 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 68.5 m-70 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.848 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 349' ' ' LYS . . . . . 0.415 ' HB3' ' C ' ' A' ' 362' ' ' PHE . 79.4 mttt . . . . . 0 C--O 1.232 0.157 0 CA-C-O 121.6 0.714 . . . . 0.0 110.901 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -31.23 20.96 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.69 2.26 . . . . 0.0 112.355 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 351' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -73.53 97.12 2.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.896 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -108.39 143.85 36.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.043 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 51.5 t -59.94 147.95 36.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.868 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 57.7 m -90.64 -29.25 17.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.157 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.568 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 52.8 t-105 -48.23 140.36 9.56 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.547 0.689 . . . . 0.0 110.92 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 356' ' ' PRO . . . . . 0.515 ' HD2' ' CG ' ' A' ' 355' ' ' TRP . 54.2 Cg_endo -69.77 140.45 42.65 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.715 2.276 . . . . 0.0 112.342 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 83.05 -36.94 2.7 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.475 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 42.4 t -64.55 152.71 41.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.884 0.373 . . . . 0.0 110.857 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -141.92 38.9 1.44 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.477 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 30.4 m95 -91.46 127.89 37.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.713 0.292 . . . . 0.0 110.916 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 361' ' ' ARG . . . . . 0.441 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 33.2 mtt180 -123.19 161.36 24.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.861 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 362' ' ' PHE . . . . . 0.441 ' CD1' ' C ' ' A' ' 361' ' ' ARG . 4.7 m-85 -147.67 153.38 39.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 33.8 t -75.8 -34.94 60.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.837 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -108.74 168.37 9.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 74.0 p -75.24 -56.82 4.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.868 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -46.46 -41.47 13.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.856 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -60.33 -35.02 74.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.863 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . 0.421 ' HA ' ' CD1' ' A' ' 362' ' ' PHE . 11.7 tp -80.71 -44.17 19.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.922 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 14.7 t -57.87 -46.43 84.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.857 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -58.85 -27.96 65.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.884 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 19.8 t60 -76.99 -46.46 23.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.864 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 41.0 mmm-85 -43.55 -28.83 0.41 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.883 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 79.1 mtt180 -50.51 -45.36 56.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.848 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 1.3 t -44.73 -39.59 5.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.846 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 375' ' ' HIS . . . . . 0.568 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 42.8 m-70 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.871 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 349' ' ' LYS . . . . . 0.416 ' HB3' ' C ' ' A' ' 362' ' ' PHE . 79.3 mttt . . . . . 0 C--O 1.231 0.109 0 CA-C-O 121.539 0.685 . . . . 0.0 110.938 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.74 -30.55 22.18 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.701 2.267 . . . . 0.0 112.319 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 351' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -73.24 99.65 2.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -106.76 138.09 43.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.106 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 42.0 t -54.11 151.96 6.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.868 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 61.4 p -94.5 -31.83 13.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.151 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.554 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 52.8 t-105 -49.2 140.46 12.39 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.566 0.698 . . . . 0.0 110.909 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 356' ' ' PRO . . . . . 0.52 ' HD2' ' CG ' ' A' ' 355' ' ' TRP . 53.6 Cg_endo -69.78 140.27 42.19 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.682 2.255 . . . . 0.0 112.358 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 83.71 -42.5 3.05 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.497 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 49.6 t -59.34 151.12 24.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.87 0.367 . . . . 0.0 110.91 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -139.02 41.64 1.33 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.47 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 23.1 m95 -93.23 128.1 39.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.81 0.338 . . . . 0.0 110.92 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 361' ' ' ARG . . . . . 0.408 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 65.7 mtt180 -123.21 162.97 21.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.923 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 362' ' ' PHE . . . . . 0.487 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 11.0 m-85 -149.34 154.56 39.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.883 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 30.6 t -76.6 -35.43 58.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.917 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -108.36 170.99 7.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.877 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 12.6 t -76.06 -57.08 4.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.885 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -46.6 -46.18 19.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.879 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 367' ' ' GLU . . . . . 0.413 ' HA ' ' NE ' ' A' ' 370' ' ' ARG . 5.4 mm-40 -54.89 -34.01 62.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.928 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . 0.487 ' HA ' ' CD1' ' A' ' 362' ' ' PHE . 13.1 tp -82.42 -42.34 18.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.897 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 46.0 m -60.1 -43.65 95.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.845 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 370' ' ' ARG . . . . . 0.413 ' NE ' ' HA ' ' A' ' 367' ' ' GLU . 19.6 ptp180 -61.97 -28.6 69.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.855 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 19.9 t60 -76.9 -44.16 32.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.889 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 28.7 mmm-85 -45.8 -27.63 0.89 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.85 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 48.8 mtm180 -51.66 -45.89 63.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.874 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 14.4 t -45.73 -36.59 5.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.869 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 375' ' ' HIS . . . . . 0.554 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 39.1 m-70 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.829 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 349' ' ' LYS . . . . . 0.444 ' HB3' ' N ' ' A' ' 362' ' ' PHE . 40.1 mttm . . . . . 0 C--O 1.232 0.14 0 CA-C-O 121.572 0.701 . . . . 0.0 110.859 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 350' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 349' ' ' LYS . 53.6 Cg_endo -69.8 -36.36 10.86 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.693 2.262 . . . . 0.0 112.364 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 351' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -68.47 98.96 0.9 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.832 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -107.95 136.8 47.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.118 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 45.0 t -50.76 151.45 2.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.91 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 76.9 m -93.79 -33.76 13.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.151 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.556 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 50.8 t-105 -45.12 140.42 3.69 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.605 0.717 . . . . 0.0 110.916 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 356' ' ' PRO . . . . . 0.51 ' HD2' ' CG ' ' A' ' 355' ' ' TRP . 53.4 Cg_endo -69.81 140.48 42.61 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.666 2.244 . . . . 0.0 112.347 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 83.49 -39.62 2.81 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.51 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 45.9 t -61.48 152.35 30.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.886 0.374 . . . . 0.0 110.881 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -140.55 41.67 1.26 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.524 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 29.3 m95 -94.08 129.29 40.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.765 0.317 . . . . 0.0 110.888 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 361' ' ' ARG . . . . . 0.424 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 32.3 mtt180 -122.91 164.33 18.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.879 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 362' ' ' PHE . . . . . 0.508 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 10.7 m-85 -150.69 155.36 39.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.938 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 28.7 t -77.21 -36.58 54.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.912 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 69.9 mtt180 -108.73 161.53 15.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.91 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 82.7 p -67.74 -52.71 34.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.05 -40.22 57.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.867 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -60.68 -30.35 69.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.88 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . 0.508 ' HA ' ' CD1' ' A' ' 362' ' ' PHE . 10.4 tp -85.73 -44.47 12.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.91 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 23.2 t -57.61 -46.42 84.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.847 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -57.84 -34.42 69.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.873 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 27.0 t60 -69.58 -47.49 63.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.823 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 45.0 mmm-85 -41.21 -30.29 0.16 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 47.5 mtm180 -48.21 -46.98 35.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.844 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 93.0 p -44.83 -41.52 7.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.888 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 375' ' ' HIS . . . . . 0.556 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 49.1 m-70 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.906 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 349' ' ' LYS . . . . . 0.405 ' HA ' ' HD2' ' A' ' 350' ' ' PRO . 39.4 mttp . . . . . 0 C--O 1.231 0.101 0 CA-C-O 121.559 0.695 . . . . 0.0 110.896 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 350' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 349' ' ' LYS . 53.7 Cg_endo -69.76 -32.62 18.23 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.668 2.245 . . . . 0.0 112.349 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 351' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -70.1 98.09 1.27 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -105.56 132.84 51.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.11 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 40.6 t -51.25 144.81 8.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.903 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 86.8 m -86.85 -33.25 19.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.114 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.569 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 60.5 t-105 -43.91 139.81 2.84 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.57 0.7 . . . . 0.0 110.891 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 356' ' ' PRO . . . . . 0.52 ' HD2' ' CG ' ' A' ' 355' ' ' TRP . 53.9 Cg_endo -69.75 138.69 38.46 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.661 2.24 . . . . 0.0 112.372 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 83.6 -45.26 3.43 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.509 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 54.0 t -53.27 157.4 1.95 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.854 0.359 . . . . 0.0 110.89 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -145.49 44.8 0.85 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.451 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 21.8 m95 -97.6 128.96 44.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.766 0.317 . . . . 0.0 110.91 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 361' ' ' ARG . . . . . . . . . . . . . 47.2 mtt180 -122.47 160.35 25.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.887 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 362' ' ' PHE . . . . . 0.507 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 6.1 m-85 -147.31 155.77 42.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.883 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 46.7 t -83.9 -29.48 27.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.884 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 31.7 mtp180 -113.21 165.38 12.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.904 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 1.2 m -70.23 -62.43 1.39 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.819 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -45.38 -38.33 5.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.862 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -60.22 -37.51 80.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.903 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . 0.507 ' HA ' ' CD1' ' A' ' 362' ' ' PHE . 10.1 tp -80.79 -44.8 17.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.907 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 74.6 m -56.5 -48.02 78.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.887 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 370' ' ' ARG . . . . . 0.451 ' HG3' ' N ' ' A' ' 371' ' ' HIS . 6.8 ptm180 -56.38 -30.29 62.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.911 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 371' ' ' HIS . . . . . 0.451 ' N ' ' HG3' ' A' ' 370' ' ' ARG . 23.8 t60 -74.23 -45.91 45.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.843 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 42.3 mmm-85 -43.28 -29.26 0.39 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 60.6 mtt180 -49.64 -47.45 49.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.892 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 56.0 p -45.17 -38.79 5.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.833 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 375' ' ' HIS . . . . . 0.569 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 45.2 m-70 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.898 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 46.0 mttp . . . . . 0 C--O 1.231 0.118 0 CA-C-O 121.619 0.723 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -28.25 25.49 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.7 2.267 . . . . 0.0 112.308 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 351' ' ' PHE . . . . . 0.441 ' HB3' ' CD2' ' A' ' 368' ' ' LEU . 80.8 m-85 -74.39 102.04 4.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.864 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -109.58 131.75 54.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.097 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 51.1 t -48.63 147.4 2.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.905 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 88.7 m -92.06 -34.6 14.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.181 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.566 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 58.0 t-105 -44.29 139.99 3.1 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.542 0.687 . . . . 0.0 110.941 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 356' ' ' PRO . . . . . 0.517 ' HD2' ' CG ' ' A' ' 355' ' ' TRP . 54.0 Cg_endo -69.72 138.18 37.33 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.693 2.262 . . . . 0.0 112.381 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 84.28 -41.58 3.01 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.471 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 42.4 t -60.23 152.08 25.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.863 0.364 . . . . 0.0 110.903 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -140.51 45.96 0.95 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.446 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 25.0 m95 -98.03 129.81 44.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.786 0.327 . . . . 0.0 110.913 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 361' ' ' ARG . . . . . 0.49 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 72.3 mtt180 -121.0 167.46 12.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.868 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 362' ' ' PHE . . . . . 0.516 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 7.4 m-85 -153.13 147.77 26.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.854 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 68.1 m -73.16 -33.48 65.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.899 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -110.45 171.13 7.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.88 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 37.4 t -75.68 -55.09 5.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.858 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -49.87 -48.08 51.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.877 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -52.42 -32.8 40.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.875 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . 0.516 ' HA ' ' CD1' ' A' ' 362' ' ' PHE . 10.9 tp -84.13 -43.29 15.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.92 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 12.2 t -58.28 -45.06 88.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.853 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 370' ' ' ARG . . . . . 0.469 ' CZ ' ' HB2' ' A' ' 370' ' ' ARG . 3.8 ptm85 -58.81 -31.34 68.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.861 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 371' ' ' HIS . . . . . 0.415 ' CB ' ' CZ ' ' A' ' 362' ' ' PHE . 11.0 t60 -73.34 -47.44 42.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.838 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 24.8 mmm-85 -43.55 -28.24 0.36 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.867 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 81.2 mtt180 -51.87 -44.75 63.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.897 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 4.9 t -48.58 -32.16 7.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.836 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 375' ' ' HIS . . . . . 0.566 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 57.7 m-70 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.844 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 349' ' ' LYS . . . . . 0.45 ' HB3' ' N ' ' A' ' 362' ' ' PHE . 46.2 mttm . . . . . 0 C--O 1.231 0.112 0 CA-C-O 121.538 0.685 . . . . 0.0 110.912 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -31.69 20.04 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.696 2.264 . . . . 0.0 112.344 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 351' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -72.96 94.04 1.81 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.897 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -101.46 147.0 26.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.096 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 53.2 t -66.24 145.02 56.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 46.2 p -90.63 -27.38 19.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.126 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.569 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 61.7 t-105 -47.86 139.64 9.08 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.58 0.705 . . . . 0.0 110.886 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 356' ' ' PRO . . . . . 0.519 ' HD2' ' CG ' ' A' ' 355' ' ' TRP . 54.0 Cg_endo -69.77 136.97 34.33 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.703 2.269 . . . . 0.0 112.319 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 84.16 -36.13 2.92 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.493 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 48.3 t -65.93 156.64 32.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.87 0.366 . . . . 0.0 110.879 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -147.04 44.79 0.8 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.481 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 39.8 m95 -96.74 129.99 44.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.813 0.34 . . . . 0.0 110.884 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 361' ' ' ARG . . . . . 0.449 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 51.1 mtm-85 -121.71 163.67 18.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.853 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 362' ' ' PHE . . . . . 0.467 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 7.3 m-85 -149.35 151.83 34.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.865 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 29.6 t -75.02 -36.66 61.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.846 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 40.9 mtp85 -109.38 162.91 13.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 90.1 p -68.11 -57.47 6.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.847 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -47.65 -38.15 14.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.91 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -61.66 -32.25 72.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.856 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . 0.467 ' HA ' ' CD1' ' A' ' 362' ' ' PHE . 7.8 tp -84.53 -46.99 11.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.952 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 46.9 t -54.37 -44.33 72.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.822 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -59.18 -36.3 75.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.815 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 371' ' ' HIS . . . . . 0.413 ' CB ' ' CZ ' ' A' ' 362' ' ' PHE . 18.8 t60 -70.0 -43.46 71.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.877 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 9.3 mmt85 -45.29 -28.21 0.78 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.879 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 47.6 mtp180 -53.04 -43.72 66.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.891 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 49.1 m -47.67 -33.65 7.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.856 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 375' ' ' HIS . . . . . 0.569 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 70.6 m-70 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.859 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 349' ' ' LYS . . . . . 0.412 ' HB3' ' C ' ' A' ' 362' ' ' PHE . 65.8 mttt . . . . . 0 C--O 1.231 0.104 0 CA-C-O 121.598 0.714 . . . . 0.0 110.874 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -33.61 16.34 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.653 2.235 . . . . 0.0 112.357 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 351' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -69.03 104.81 2.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.869 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -109.53 145.44 36.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.114 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 40.4 t -62.84 150.4 41.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.858 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 71.6 p -94.34 -31.94 13.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.193 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.563 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 58.4 t-105 -46.87 140.03 6.39 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.536 0.684 . . . . 0.0 110.876 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 356' ' ' PRO . . . . . 0.519 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 53.5 Cg_endo -69.82 138.57 37.94 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.662 2.241 . . . . 0.0 112.317 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 83.94 -38.64 2.83 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.483 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 45.3 t -64.04 157.08 26.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.894 0.378 . . . . 0.0 110.87 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -146.36 42.34 0.95 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.476 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 35.8 m95 -92.53 128.45 38.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.761 0.315 . . . . 0.0 110.925 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 361' ' ' ARG . . . . . 0.527 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 50.2 mtm180 -119.88 167.48 12.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.934 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 362' ' ' PHE . . . . . 0.527 ' CD1' ' C ' ' A' ' 361' ' ' ARG . 13.9 m-85 -154.19 149.32 26.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.925 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 72.7 m -77.44 -26.53 51.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.849 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 70.8 mtt180 -116.85 162.16 18.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.854 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 93.8 p -69.42 -57.96 4.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.891 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -48.29 -40.96 26.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.877 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -60.68 -32.91 72.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.908 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . 0.511 ' HA ' ' CD1' ' A' ' 362' ' ' PHE . 7.1 tp -83.17 -44.78 14.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.929 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 42.7 m -58.09 -45.53 87.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -58.75 -29.03 66.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.87 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 12.0 t60 -75.21 -46.91 30.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.88 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 41.6 mmm-85 -42.4 -29.31 0.26 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.866 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 43.4 mtp180 -49.63 -47.36 49.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.888 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 9.4 t -44.77 -38.93 4.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.85 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 375' ' ' HIS . . . . . 0.563 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 56.2 m-70 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.88 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 76.6 mttt . . . . . 0 C--O 1.231 0.103 0 CA-C-O 121.566 0.698 . . . . 0.0 110.916 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.69 -31.32 21.06 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.648 2.232 . . . . 0.0 112.357 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 351' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -72.69 103.76 3.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.889 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -111.57 139.65 46.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.097 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 39.9 t -59.18 148.29 32.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.934 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 34.2 m -92.9 -31.39 14.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.12 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.56 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 56.3 t-105 -46.97 140.16 6.45 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.54 0.686 . . . . 0.0 110.938 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 356' ' ' PRO . . . . . 0.519 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 53.7 Cg_endo -69.72 141.85 46.54 Favored 'Trans proline' 0 C--N 1.34 0.13 0 C-N-CA 122.69 2.26 . . . . 0.0 112.341 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 81.4 -36.57 2.41 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.465 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 42.8 t -67.4 153.63 43.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.924 0.392 . . . . 0.0 110.86 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -144.36 42.06 1.06 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.5 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 33.4 m95 -93.17 128.54 39.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.781 0.324 . . . . 0.0 110.921 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 361' ' ' ARG . . . . . 0.465 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 40.9 mtm180 -120.71 166.05 14.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.888 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 362' ' ' PHE . . . . . 0.493 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 7.2 m-85 -151.94 151.59 31.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.927 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 24.1 m -80.6 -23.24 39.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.86 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 5.4 mtp-105 -120.0 154.11 35.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.857 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 365' ' ' SER . . . . . 0.401 ' O ' ' N ' ' A' ' 368' ' ' LEU . 89.8 p -62.41 -63.43 1.23 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.867 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -41.65 -42.01 2.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.872 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -59.26 -39.73 83.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.869 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . 0.493 ' HA ' ' CD1' ' A' ' 362' ' ' PHE . 8.0 tp -77.14 -42.43 37.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.933 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 24.5 t -58.84 -47.22 85.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.824 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -58.71 -28.31 65.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.916 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 24.7 t60 -75.36 -46.38 33.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 44.2 mmm-85 -43.12 -29.44 0.37 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.853 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 68.8 mtm180 -52.2 -44.31 64.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.889 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 58.8 m -46.36 -38.14 8.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.876 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 375' ' ' HIS . . . . . 0.56 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 55.0 m-70 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.852 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 349' ' ' LYS . . . . . 0.416 ' HB3' ' C ' ' A' ' 362' ' ' PHE . 30.5 mttm . . . . . 0 C--O 1.232 0.139 0 CA-C-O 121.546 0.689 . . . . 0.0 110.923 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -28.69 24.85 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.719 2.28 . . . . 0.0 112.321 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 351' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -75.61 98.65 4.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.844 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -106.51 145.55 31.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.117 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 35.8 t -62.08 148.2 44.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.917 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 41.8 m -92.89 -31.87 14.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.131 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.568 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 55.7 t-105 -49.54 140.23 14.22 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.574 0.702 . . . . 0.0 110.951 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 356' ' ' PRO . . . . . 0.521 ' HD2' ' CG ' ' A' ' 355' ' ' TRP . 53.9 Cg_endo -69.78 140.71 43.28 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.676 2.25 . . . . 0.0 112.349 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 84.03 -41.53 2.99 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.474 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 44.9 t -63.28 150.9 42.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.888 0.375 . . . . 0.0 110.92 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -140.19 44.03 1.09 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.476 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 39.3 m95 -93.91 129.56 40.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.728 0.299 . . . . 0.0 110.946 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 361' ' ' ARG . . . . . 0.426 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 56.7 mtm180 -122.73 164.61 17.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.902 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 362' ' ' PHE . . . . . 0.467 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 11.3 m-85 -151.37 151.01 31.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.857 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 50.4 m -78.15 -25.8 47.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.871 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 78.1 mtt-85 -115.36 163.27 15.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.915 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 88.2 p -72.39 -53.47 12.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.851 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -50.23 -44.61 53.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.87 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -57.24 -34.4 68.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.864 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . 0.467 ' HA ' ' CD1' ' A' ' 362' ' ' PHE . 6.5 tp -80.49 -44.38 19.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.915 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 14.9 m -57.87 -45.12 86.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.851 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -60.67 -28.27 68.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.839 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 16.8 t60 -76.7 -44.84 31.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.875 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 45.7 mmm-85 -45.43 -28.14 0.83 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.864 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -52.66 -44.57 66.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.878 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 39.2 m -46.69 -38.12 9.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.883 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 375' ' ' HIS . . . . . 0.568 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 38.3 m-70 . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.878 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 349' ' ' LYS . . . . . 0.405 ' HB3' ' C ' ' A' ' 362' ' ' PHE . 64.1 mttt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 121.592 0.711 . . . . 0.0 110.871 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 350' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 349' ' ' LYS . 53.4 Cg_endo -69.76 -31.57 20.27 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.685 2.256 . . . . 0.0 112.317 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 351' ' ' PHE . . . . . 0.416 ' HB3' ' CD2' ' A' ' 368' ' ' LEU . 97.0 m-85 -71.74 100.48 2.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.872 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -108.47 132.92 53.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.121 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 35.9 t -49.55 153.95 1.05 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.902 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 30.6 m -94.92 -34.55 12.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.191 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.547 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 46.9 t-105 -44.59 140.66 3.1 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.555 0.693 . . . . 0.0 110.932 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 356' ' ' PRO . . . . . 0.514 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 53.7 Cg_endo -69.72 140.07 41.91 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.671 2.247 . . . . 0.0 112.372 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 83.65 -41.97 3.0 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.463 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 34.9 t -58.81 149.69 25.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.936 0.398 . . . . 0.0 110.908 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -139.21 42.53 1.24 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.456 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 37.0 m95 -94.8 128.61 41.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.771 0.319 . . . . 0.0 110.874 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 361' ' ' ARG . . . . . 0.408 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 37.7 mtt180 -121.74 159.15 27.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.923 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 362' ' ' PHE . . . . . 0.519 ' CE1' HD11 ' A' ' 368' ' ' LEU . 4.8 m-85 -144.64 152.47 40.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.874 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 36.2 t -74.39 -34.57 63.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.874 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 36.3 mtt-85 -110.63 169.7 8.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.872 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 68.2 p -74.76 -57.4 3.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.893 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -47.34 -44.93 24.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.859 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -55.97 -32.67 64.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.906 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . 0.519 HD11 ' CE1' ' A' ' 362' ' ' PHE . 12.5 tp -83.78 -42.72 16.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.913 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 14.8 t -58.66 -46.88 86.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.836 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 48.6 ptt85 -58.01 -29.29 65.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.849 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -74.34 -45.62 46.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.843 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . 0.422 ' HB3' ' NH1' ' A' ' 372' ' ' ARG . 4.6 mmm180 -42.98 -29.46 0.34 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.853 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 77.4 mtt180 -50.85 -45.5 59.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.846 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 3.2 m -44.56 -39.48 4.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.879 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 375' ' ' HIS . . . . . 0.547 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 48.2 m-70 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.848 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 349' ' ' LYS . . . . . 0.421 ' HB3' ' C ' ' A' ' 362' ' ' PHE . 47.7 mttm . . . . . 0 C--O 1.231 0.128 0 CA-C-O 121.555 0.693 . . . . 0.0 110.877 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -26.29 27.88 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.705 2.27 . . . . 0.0 112.366 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 351' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -79.95 97.78 6.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.906 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 352' ' ' ALA . . . . . 0.444 ' CB ' ' HG2' ' A' ' 361' ' ' ARG . . . -110.17 144.0 39.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.12 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 43.5 t -60.13 144.68 49.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.881 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 62.3 p -93.94 -26.14 16.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.178 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.558 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 60.3 t-105 -49.87 139.82 16.4 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.571 0.7 . . . . 0.0 110.927 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 356' ' ' PRO . . . . . 0.522 ' HD2' ' CG ' ' A' ' 355' ' ' TRP . 54.1 Cg_endo -69.77 137.93 36.59 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.709 2.273 . . . . 0.0 112.321 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 84.53 -33.83 3.19 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.478 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 49.9 t -72.97 153.77 40.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.904 0.383 . . . . 0.0 110.881 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -143.71 48.55 0.74 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.456 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 39.2 m95 -97.93 128.66 44.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.8 0.333 . . . . 0.0 110.875 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 361' ' ' ARG . . . . . 0.507 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 58.1 mtm180 -121.72 164.21 17.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.905 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 362' ' ' PHE . . . . . 0.507 ' CD1' ' C ' ' A' ' 361' ' ' ARG . 4.5 m-85 -151.23 151.13 31.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.896 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 52.6 m -80.06 -19.43 47.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.896 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 5.5 mpt_? -122.94 162.14 22.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.851 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 9.8 t -70.17 -62.74 1.27 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.874 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -43.66 -41.21 4.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.851 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 367' ' ' GLU . . . . . 0.414 ' O ' ' CG ' ' A' ' 370' ' ' ARG . 24.2 mm-40 -59.29 -40.11 85.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.888 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . 0.452 ' HA ' ' CD1' ' A' ' 362' ' ' PHE . 12.5 tp -77.06 -44.96 28.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.895 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 30.4 t -55.73 -44.67 77.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.846 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 370' ' ' ARG . . . . . 0.439 ' HG3' ' N ' ' A' ' 371' ' ' HIS . 9.6 ptt180 -59.32 -33.86 71.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.899 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 371' ' ' HIS . . . . . 0.439 ' N ' ' HG3' ' A' ' 370' ' ' ARG . 17.3 t60 -71.31 -46.69 60.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.9 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . 0.42 ' HB3' ' NH1' ' A' ' 372' ' ' ARG . 4.9 mmm180 -41.42 -30.13 0.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.838 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -49.67 -44.36 47.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.864 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 1.4 t -46.51 -33.44 4.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.881 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 375' ' ' HIS . . . . . 0.558 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 53.2 m-70 . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.884 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 349' ' ' LYS . . . . . 0.466 ' HB3' ' N ' ' A' ' 362' ' ' PHE . 36.9 mttp . . . . . 0 N--CA 1.457 -0.099 0 CA-C-O 121.574 0.702 . . . . 0.0 110.915 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 350' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 349' ' ' LYS . 54.0 Cg_endo -69.77 -32.2 18.99 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.696 2.264 . . . . 0.0 112.319 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 351' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -72.16 99.2 2.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.847 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -106.72 141.68 37.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.059 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 39.6 t -58.8 149.18 27.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.881 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 27.0 m -90.75 -33.19 15.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.138 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.563 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 56.2 t-105 -45.21 140.16 3.91 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.587 0.708 . . . . 0.0 110.865 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 356' ' ' PRO . . . . . 0.518 ' HD2' ' CG ' ' A' ' 355' ' ' TRP . 53.9 Cg_endo -69.74 142.37 47.84 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.713 2.275 . . . . 0.0 112.329 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 80.95 -37.99 2.36 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.491 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 49.7 t -63.12 154.52 30.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.827 0.346 . . . . 0.0 110.88 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -143.8 39.04 1.3 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.5 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 48.0 m95 -92.61 128.03 38.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.72 0.295 . . . . 0.0 110.899 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 361' ' ' ARG . . . . . 0.515 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 43.7 mtm180 -121.2 169.47 10.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.818 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 362' ' ' PHE . . . . . 0.515 ' CD1' ' C ' ' A' ' 361' ' ' ARG . 9.4 m-85 -154.48 153.51 31.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.876 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 27.2 t -75.83 -35.43 59.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.884 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -108.16 167.6 9.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.891 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 54.6 p -73.83 -55.51 6.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.836 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -48.58 -45.46 37.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.869 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -55.25 -33.72 63.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.884 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . 0.496 ' HA ' ' CD1' ' A' ' 362' ' ' PHE . 6.8 tp -81.98 -45.41 15.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 27.0 t -56.35 -45.99 80.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.854 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 370' ' ' ARG . . . . . 0.437 ' HG3' ' N ' ' A' ' 371' ' ' HIS . 20.4 ptt180 -59.19 -31.96 69.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.88 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 371' ' ' HIS . . . . . 0.437 ' N ' ' HG3' ' A' ' 370' ' ' ARG . 17.7 t60 -73.75 -38.25 64.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.876 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 19.9 mmm-85 -52.0 -24.96 7.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 37.5 mtt85 -55.56 -43.35 75.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.902 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 32.7 t -48.51 -36.02 14.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.89 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 375' ' ' HIS . . . . . 0.563 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 58.6 m-70 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.871 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 349' ' ' LYS . . . . . 0.448 ' HB3' ' N ' ' A' ' 362' ' ' PHE . 46.2 mttm . . . . . 0 C--O 1.231 0.109 0 CA-C-O 121.564 0.697 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 350' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 349' ' ' LYS . 53.4 Cg_endo -69.79 -30.57 21.91 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.659 2.239 . . . . 0.0 112.298 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 351' ' ' PHE . . . . . 0.411 ' HB3' ' CD2' ' A' ' 368' ' ' LEU . 95.0 m-85 -74.25 95.68 2.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.883 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -103.97 135.58 45.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.089 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 43.5 t -51.77 150.88 3.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.92 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 70.2 p -95.55 -30.69 13.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.147 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.553 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 55.0 t-105 -46.08 140.21 5.14 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.574 0.702 . . . . 0.0 110.895 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 356' ' ' PRO . . . . . 0.512 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 53.9 Cg_endo -69.73 133.8 26.51 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.681 2.254 . . . . 0.0 112.345 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 88.88 -37.75 3.28 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.528 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 46.8 t -64.78 151.86 44.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.917 0.389 . . . . 0.0 110.846 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -141.5 43.1 1.11 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.482 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 37.9 m95 -95.92 129.16 43.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.778 0.323 . . . . 0.0 110.917 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 361' ' ' ARG . . . . . . . . . . . . . 25.7 mtt180 -121.51 161.01 23.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.828 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 362' ' ' PHE . . . . . 0.488 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 10.2 m-85 -145.91 153.18 40.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.845 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 45.2 t -78.3 -29.84 48.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.819 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.14 165.78 11.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.848 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 36.1 t -73.89 -47.61 36.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.852 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -56.36 -46.89 79.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.876 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -54.26 -31.43 53.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.844 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . 0.488 ' HA ' ' CD1' ' A' ' 362' ' ' PHE . 8.4 tp -83.8 -44.03 14.79 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.948 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 5.5 t -57.7 -47.04 83.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.836 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 25.8 ptt180 -57.93 -33.12 68.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.877 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 22.3 t60 -72.32 -43.92 63.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.875 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . 0.422 ' HB3' ' NH1' ' A' ' 372' ' ' ARG . 4.9 mmm180 -44.68 -28.54 0.63 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.906 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 373' ' ' ARG . . . . . 0.422 ' NH1' ' HB3' ' A' ' 373' ' ' ARG . 10.3 mtp-105 -55.39 -42.79 74.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 58.4 m -47.28 -31.43 3.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.863 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 375' ' ' HIS . . . . . 0.553 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 61.8 m-70 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.866 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 349' ' ' LYS . . . . . 0.41 ' NZ ' ' HB2' ' A' ' 361' ' ' ARG . 7.6 mtmp? . . . . . 0 C--O 1.231 0.09 0 CA-C-O 121.584 0.706 . . . . 0.0 110.899 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -28.18 25.6 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.705 2.27 . . . . 0.0 112.316 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 351' ' ' PHE . . . . . 0.565 ' CD1' ' HA ' ' A' ' 365' ' ' SER . 84.1 m-85 -76.52 102.26 5.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.871 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -115.8 137.59 51.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.088 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 43.2 t -55.59 146.5 20.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.85 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 93.5 m -93.14 -29.05 15.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.154 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.545 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 59.0 t-105 -47.79 139.91 8.71 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.566 0.698 . . . . 0.0 110.932 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 356' ' ' PRO . . . . . 0.521 ' HD2' ' CG ' ' A' ' 355' ' ' TRP . 53.8 Cg_endo -69.8 140.97 43.81 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.707 2.271 . . . . 0.0 112.283 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 81.94 -36.87 2.51 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.503 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 47.2 t -68.29 151.51 46.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.853 0.358 . . . . 0.0 110.922 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -140.61 45.33 0.99 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.513 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 39.3 m95 -94.24 128.65 40.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.794 0.33 . . . . 0.0 110.913 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 361' ' ' ARG . . . . . 0.455 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 18.2 mtt85 -122.61 165.33 16.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.843 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 362' ' ' PHE . . . . . 0.532 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 11.3 m-85 -152.72 151.2 30.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 49.9 m -77.04 -33.41 57.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.855 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -104.67 171.65 7.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.833 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 365' ' ' SER . . . . . 0.565 ' HA ' ' CD1' ' A' ' 351' ' ' PHE . 80.7 p -81.13 -55.64 4.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.865 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.62 -34.59 59.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.853 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -62.75 -34.58 77.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.881 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . 0.532 ' HA ' ' CD1' ' A' ' 362' ' ' PHE . 9.4 tp -81.01 -45.58 16.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.943 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 58.7 m -56.02 -43.7 78.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.877 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -60.17 -28.9 68.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.855 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -76.44 -43.55 39.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.852 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 22.0 mmm-85 -45.97 -27.14 0.84 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.895 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 25.8 mtp85 -51.13 -46.01 61.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.847 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 58.3 m -46.42 -35.29 5.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.841 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 375' ' ' HIS . . . . . 0.545 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 66.3 m-70 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.861 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 349' ' ' LYS . . . . . 0.413 ' HB3' ' C ' ' A' ' 362' ' ' PHE . 56.6 mttt . . . . . 0 C--O 1.232 0.14 0 CA-C-O 121.559 0.695 . . . . 0.0 110.892 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.82 -29.4 23.64 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.721 2.28 . . . . 0.0 112.342 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 351' ' ' PHE . . . . . 0.43 ' HB3' ' CD2' ' A' ' 368' ' ' LEU . 94.4 m-85 -74.98 100.45 4.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.878 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -107.33 150.49 26.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.067 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 41.0 t -68.06 144.12 55.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.891 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 89.4 m -89.09 -28.69 19.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.139 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.568 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 57.8 t-105 -49.87 140.03 16.12 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.51 0.672 . . . . 0.0 110.931 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 356' ' ' PRO . . . . . 0.52 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 53.8 Cg_endo -69.72 138.64 38.41 Favored 'Trans proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.716 2.278 . . . . 0.0 112.358 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 84.34 -39.87 2.92 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.527 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 44.8 t -63.9 155.18 31.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.868 0.366 . . . . 0.0 110.896 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -145.3 45.21 0.84 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.494 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 32.7 m95 -96.13 128.69 43.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.745 0.307 . . . . 0.0 110.957 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 361' ' ' ARG . . . . . 0.519 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 56.6 mtm-85 -120.77 167.14 12.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.848 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 362' ' ' PHE . . . . . 0.519 ' CD1' ' C ' ' A' ' 361' ' ' ARG . 8.2 m-85 -153.2 146.94 25.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.876 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 29.0 t -70.96 -34.01 71.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.868 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 364' ' ' ARG . . . . . 0.462 ' HD2' ' N ' ' A' ' 364' ' ' ARG . 0.0 OUTLIER -109.66 174.0 6.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.855 -179.913 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 7.1 m -79.6 -57.95 3.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -46.59 -39.44 11.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.859 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 -62.43 -31.64 72.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.864 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . 0.48 ' HA ' ' CD1' ' A' ' 362' ' ' PHE . 9.1 tp -84.92 -45.91 11.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.898 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 37.1 t -56.43 -46.66 80.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.858 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -58.56 -31.91 68.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.867 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 13.4 t60 -70.87 -46.35 62.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.855 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 54.6 mmm-85 -44.09 -29.08 0.56 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.851 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 62.3 mtt-85 -48.74 -45.92 40.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 36.8 t -47.65 -35.78 9.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.875 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 375' ' ' HIS . . . . . 0.568 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 46.4 m-70 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.869 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? . . . . . 0 C--O 1.231 0.084 0 CA-C-O 121.597 0.713 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -29.82 23.1 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.683 2.255 . . . . 0.0 112.334 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 351' ' ' PHE . . . . . 0.56 ' CD1' ' HA ' ' A' ' 365' ' ' SER . 94.8 m-85 -74.43 95.5 2.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -109.58 139.65 44.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.11 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 53.3 t -58.85 145.07 42.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.865 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 49.9 m -93.11 -27.94 16.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.138 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.522 ' CG ' ' HD2' ' A' ' 356' ' ' PRO . 61.3 t-105 -47.93 139.69 9.22 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.521 0.677 . . . . 0.0 110.918 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 356' ' ' PRO . . . . . 0.522 ' HD2' ' CG ' ' A' ' 355' ' ' TRP . 54.0 Cg_endo -69.76 137.62 35.87 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.69 2.26 . . . . 0.0 112.325 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 84.49 -39.94 2.94 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.476 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 41.8 t -62.77 154.64 29.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.884 0.373 . . . . 0.0 110.843 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -142.57 47.71 0.81 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.513 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 31.6 m95 -97.68 132.81 42.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.754 0.311 . . . . 0.0 110.919 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 361' ' ' ARG . . . . . 0.485 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 30.1 mtt180 -128.51 163.23 25.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.875 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 362' ' ' PHE . . . . . 0.549 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 5.6 m-85 -151.94 152.77 32.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 50.7 m -79.06 -27.36 43.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.866 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 364' ' ' ARG . . . . . 0.501 ' C ' ' CD2' ' A' ' 351' ' ' PHE . 66.6 mtt180 -113.27 168.44 9.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.822 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 365' ' ' SER . . . . . 0.56 ' HA ' ' CD1' ' A' ' 351' ' ' PHE . 31.2 t -74.65 -62.85 1.39 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.865 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -44.38 -38.59 4.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.911 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -58.97 -41.79 88.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.885 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . 0.549 ' HA ' ' CD1' ' A' ' 362' ' ' PHE . 6.5 tp -76.0 -45.19 35.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 27.4 t -55.86 -49.45 73.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.868 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 25.8 ptt85 -56.05 -28.24 56.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.887 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 20.0 t60 -79.11 -41.85 27.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.852 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 22.0 mmm-85 -48.99 -24.7 1.61 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.849 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 -55.9 -44.16 77.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.936 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 39.5 t -46.64 -34.75 5.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.855 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 375' ' ' HIS . . . . . 0.471 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 48.5 m-70 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.852 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 349' ' ' LYS . . . . . 0.456 ' HB3' ' N ' ' A' ' 362' ' ' PHE . 74.4 mttt . . . . . 0 C--O 1.231 0.104 0 CA-C-O 121.548 0.69 . . . . 0.0 110.873 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -36.61 10.62 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.677 2.251 . . . . 0.0 112.408 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 351' ' ' PHE . . . . . 0.446 ' CE2' ' HB2' ' A' ' 365' ' ' SER . 86.2 m-85 -67.57 98.28 0.67 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.907 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -107.45 138.83 42.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.07 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 45.3 t -55.35 132.65 48.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.885 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 28.0 m -79.93 -18.86 49.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.125 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.552 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 58.7 t-105 -55.8 139.9 68.92 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.588 0.709 . . . . 0.0 110.949 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 356' ' ' PRO . . . . . 0.519 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 54.1 Cg_endo -69.7 137.73 36.33 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.711 2.274 . . . . 0.0 112.367 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 83.77 -37.29 2.81 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.498 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 47.0 t -65.13 153.81 39.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.859 0.362 . . . . 0.0 110.923 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -142.45 44.73 0.96 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.485 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 43.3 m95 -97.98 130.67 44.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.791 0.329 . . . . 0.0 110.926 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 361' ' ' ARG . . . . . . . . . . . . . 30.7 mtt180 -122.23 163.34 19.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.861 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 362' ' ' PHE . . . . . 0.527 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 23.5 m-85 -148.81 148.93 30.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.896 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 34.4 p -72.13 -35.48 69.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.841 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 64.3 mtt180 -112.9 165.58 12.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.886 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 365' ' ' SER . . . . . 0.446 ' HB2' ' CE2' ' A' ' 351' ' ' PHE . 26.3 t -71.54 -52.7 16.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.909 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -51.02 -31.37 18.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.894 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -71.25 -29.2 64.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.874 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . 0.527 ' HA ' ' CD1' ' A' ' 362' ' ' PHE . 10.4 tp -86.71 -47.16 9.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.924 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 22.1 t -54.43 -43.5 71.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.836 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -59.69 -35.42 74.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.87 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 22.8 t60 -70.84 -41.77 71.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.883 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -45.96 -27.64 0.95 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.881 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 373' ' ' ARG . . . . . 0.417 ' NH1' ' HB3' ' A' ' 373' ' ' ARG . 10.1 mtp-105 -53.45 -43.86 68.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.892 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 28.5 t -49.91 -33.47 17.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.863 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 375' ' ' HIS . . . . . 0.552 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 78.3 m-70 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.87 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 349' ' ' LYS . . . . . 0.416 ' HB3' ' C ' ' A' ' 362' ' ' PHE . 53.0 mttp . . . . . 0 C--O 1.23 0.078 0 CA-C-O 121.565 0.697 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 -25.17 28.97 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.66 2.24 . . . . 0.0 112.335 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 351' ' ' PHE . . . . . 0.488 ' CD1' ' HA ' ' A' ' 365' ' ' SER . 84.5 m-85 -80.35 92.88 5.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.912 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -104.09 139.09 39.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.104 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 50.2 t -53.28 148.68 8.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.836 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 82.6 p -94.83 -26.55 16.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.111 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.553 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 49.8 t-105 -52.47 140.58 35.73 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.62 0.724 . . . . 0.0 110.924 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 356' ' ' PRO . . . . . 0.511 ' HD2' ' CG ' ' A' ' 355' ' ' TRP . 53.3 Cg_endo -69.78 138.94 38.95 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.652 2.235 . . . . 0.0 112.341 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 84.22 -37.82 2.87 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.52 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 49.1 t -63.49 155.64 28.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.927 0.394 . . . . 0.0 110.862 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -142.58 37.91 1.49 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.519 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 42.7 m95 -92.19 128.97 38.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.758 0.313 . . . . 0.0 110.899 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 361' ' ' ARG . . . . . 0.487 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 56.6 mtt180 -124.34 165.01 18.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.926 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 362' ' ' PHE . . . . . 0.487 ' CD1' ' C ' ' A' ' 361' ' ' ARG . 7.6 m-85 -149.98 152.11 34.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.86 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 49.9 m -77.9 -22.85 49.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.867 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -118.72 165.99 13.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.832 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 365' ' ' SER . . . . . 0.488 ' HA ' ' CD1' ' A' ' 351' ' ' PHE . 1.3 t -74.17 -55.76 5.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.836 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -49.36 -45.97 46.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.868 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -54.58 -35.91 63.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.861 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . 0.447 ' HA ' ' CD1' ' A' ' 362' ' ' PHE . 14.3 tp -79.64 -42.55 24.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 44.7 t -57.8 -49.16 77.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.848 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -56.15 -31.61 63.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.868 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 20.1 t60 -73.15 -46.29 51.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.862 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 372' ' ' ARG . . . . . 0.429 ' HB3' ' NH1' ' A' ' 372' ' ' ARG . 5.6 mmm180 -41.34 -29.98 0.16 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.905 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 84.5 mtt180 -51.08 -46.66 61.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.878 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 85.3 p -43.56 -38.18 2.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 375' ' ' HIS . . . . . 0.553 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 39.0 m-70 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.858 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 54.3 m -112.27 -53.52 2.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.838 0.351 . . . . 0.0 110.849 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 2.0 t -61.68 122.35 15.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.833 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . -89.24 -159.46 35.41 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.534 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 59.5 p -112.7 126.77 55.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.882 0.372 . . . . 0.0 110.868 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 15.4 t -128.59 -46.59 1.3 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.872 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -62.11 -63.44 4.74 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.488 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 73.9 p -107.57 158.47 17.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.823 0.344 . . . . 0.0 111.179 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 150.24 71.31 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.451 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -157.54 119.5 3.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.91 0.386 . . . . 0.0 110.896 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 349' ' ' LYS . . . . . 0.417 ' HB3' ' C ' ' A' ' 362' ' ' PHE . 37.7 mttt -134.81 92.93 18.44 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.599 0.714 . . . . 0.0 110.943 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -25.64 28.33 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.698 2.265 . . . . 0.0 112.323 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 351' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -79.88 96.46 6.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.898 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -106.63 131.58 53.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.074 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 42.5 t -48.38 150.7 1.23 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.87 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 47.9 p -95.85 -30.68 13.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.153 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.566 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 44.7 t-105 -47.45 140.82 7.25 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.518 0.675 . . . . 0.0 110.918 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . 0.532 ' O ' ' CD1' ' A' ' 355' ' ' TRP . 54.0 Cg_endo -69.73 141.18 44.64 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.682 2.255 . . . . 0.0 112.375 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 81.88 -36.05 2.51 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.467 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 49.4 t -65.97 150.77 48.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.866 0.365 . . . . 0.0 110.874 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -142.37 46.15 0.89 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.476 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 44.0 m95 -99.06 128.86 45.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.746 0.308 . . . . 0.0 110.959 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' ARG . . . . . . . . . . . . . 29.6 mtt180 -120.64 156.55 31.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.87 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' PHE . . . . . 0.528 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 23.2 m-85 -140.92 147.02 38.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.932 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 74.3 m -76.23 -22.11 55.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.864 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -118.27 161.62 19.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.846 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 85.8 p -70.95 -56.15 6.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.88 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -49.71 -40.61 41.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.903 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -59.62 -33.14 71.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.856 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.528 ' HA ' ' CD1' ' A' ' 362' ' ' PHE . 8.4 tp -81.6 -42.56 19.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.927 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 42.8 t -60.1 -46.7 88.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.831 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -59.86 -30.88 69.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.883 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 371' ' ' HIS . . . . . 0.412 ' CB ' ' CZ ' ' A' ' 362' ' ' PHE . 20.0 t60 -73.94 -48.5 30.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.85 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 27.0 mmm-85 -41.44 -29.5 0.16 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.864 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 73.0 mtt180 -52.91 -45.69 67.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.883 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 61.9 m -44.36 -34.01 1.84 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.843 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 375' ' ' HIS . . . . . 0.566 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 57.3 m-70 -94.75 165.39 12.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.873 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 59.2 p -97.11 109.32 22.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.876 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -152.93 156.72 26.88 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.505 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 95.5 t -50.81 119.97 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.923 0.392 . . . . 0.0 111.095 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 379' ' ' LYS . . . . . . . . . . . . . 10.5 pttm -95.26 146.44 31.31 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.554 0.692 . . . . 0.0 110.896 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -3.41 11.97 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.695 2.263 . . . . 0.0 112.382 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 84.7 p -112.39 172.35 6.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.845 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -153.6 -92.73 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.512 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -17.0 37.86 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.727 2.284 . . . . 0.0 112.307 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 28.3 m -156.55 153.49 28.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.9 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 8.7 t -158.78 151.17 21.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.875 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.472 -179.975 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.29 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 5.0 m -125.8 147.53 49.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.879 0.371 . . . . 0.0 110.868 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 23.5 m -116.37 114.73 24.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.887 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 97.33 88.05 1.85 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.48 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 18.7 m -80.58 146.23 31.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.88 0.371 . . . . 0.0 110.861 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 3.0 m -80.66 139.14 36.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.892 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -104.19 -94.33 2.32 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.521 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 4.1 t -67.73 -18.12 64.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.846 0.355 . . . . 0.0 111.184 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 112.97 -123.27 6.15 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.508 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 -128.83 157.67 40.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.884 0.373 . . . . 0.0 110.927 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 349' ' ' LYS . . . . . 0.463 ' HB3' ' N ' ' A' ' 362' ' ' PHE . 53.3 mttm -104.55 93.45 5.97 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.527 0.68 . . . . 0.0 110.858 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -34.94 13.55 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.716 2.277 . . . . 0.0 112.349 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 351' ' ' PHE . . . . . 0.519 ' CE1' ' HB3' ' A' ' 365' ' ' SER . 97.7 m-85 -68.2 103.25 1.52 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.868 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -107.66 129.59 55.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.082 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 40.5 t -47.41 146.12 2.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.889 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 58.5 m -91.37 -32.14 15.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.16 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.513 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 46.7 t-105 -47.13 140.72 6.51 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.593 0.711 . . . . 0.0 110.915 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . 0.509 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 53.8 Cg_endo -69.77 139.46 40.26 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.636 2.224 . . . . 0.0 112.367 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 83.39 -41.13 2.89 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.552 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 36.1 t -61.39 150.14 36.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.928 0.394 . . . . 0.0 110.839 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -139.78 45.16 1.02 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.532 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 25.2 m95 -97.68 130.99 44.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.758 0.313 . . . . 0.0 110.896 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 361' ' ' ARG . . . . . 0.421 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 67.5 mtt180 -121.49 165.66 15.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.867 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 362' ' ' PHE . . . . . 0.465 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 14.5 m-85 -150.83 156.43 41.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.853 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 15.3 t -78.92 -37.46 39.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.872 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -106.91 161.25 14.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.894 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 365' ' ' SER . . . . . 0.519 ' HB3' ' CE1' ' A' ' 351' ' ' PHE . 54.4 p -71.3 -38.1 71.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.879 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -62.51 -45.62 92.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.89 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -55.51 -34.48 64.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.873 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.465 ' HA ' ' CD1' ' A' ' 362' ' ' PHE . 9.0 tp -79.25 -42.96 24.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.902 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 18.3 t -58.13 -44.9 88.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.809 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 370' ' ' ARG . . . . . 0.408 ' HG3' ' N ' ' A' ' 371' ' ' HIS . 29.6 ptt85 -61.82 -30.46 70.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.848 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 371' ' ' HIS . . . . . 0.409 ' CB ' ' CZ ' ' A' ' 362' ' ' PHE . 22.5 t60 -74.4 -39.0 62.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.863 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 26.3 mmm-85 -51.31 -25.1 5.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.863 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 28.8 mtt85 -57.56 -40.87 79.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 58.0 m -50.35 -30.87 13.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.879 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 375' ' ' HIS . . . . . 0.513 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 68.5 m-70 -94.75 169.13 10.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.848 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 36.9 p -93.28 49.11 1.37 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.861 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -72.24 130.19 15.79 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.481 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 34.8 m -83.9 143.63 11.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.928 0.394 . . . . 0.0 111.064 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 379' ' ' LYS . . . . . . . . . . . . . 25.6 mmtp -116.68 153.14 49.08 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.542 0.686 . . . . 0.0 110.885 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 158.71 55.99 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.661 2.241 . . . . 0.0 112.338 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 49.1 m 47.34 38.87 7.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.853 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 168.29 83.19 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.536 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 383' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 174.77 9.04 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.636 2.224 . . . . 0.0 112.401 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 52.7 p -134.37 154.97 51.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.86 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 22.4 p -75.45 -56.15 4.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.853 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.477 -179.964 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.521 -0.232 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 67.7 m -74.63 97.35 3.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.89 0.376 . . . . 0.0 110.861 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 28.8 t -172.2 115.24 0.33 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.889 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . -143.8 89.61 0.17 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.488 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 1.9 m -127.26 160.19 32.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.917 0.389 . . . . 0.0 110.809 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 78.7 p -101.12 41.95 1.15 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.866 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -86.59 156.62 29.26 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.483 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 8.8 t -163.41 153.98 16.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.819 0.343 . . . . 0.0 111.165 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 131.9 -122.59 3.4 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.461 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -155.98 143.19 19.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.94 0.4 . . . . 0.0 110.867 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 349' ' ' LYS . . . . . 0.415 ' HB3' ' C ' ' A' ' 362' ' ' PHE . 79.4 mttt -104.39 93.37 5.72 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.6 0.714 . . . . 0.0 110.901 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -31.23 20.96 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.69 2.26 . . . . 0.0 112.355 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 351' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -73.53 97.12 2.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.896 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -108.39 143.85 36.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.043 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 51.5 t -59.94 147.95 36.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.868 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 57.7 m -90.64 -29.25 17.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.157 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.568 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 52.8 t-105 -48.23 140.36 9.56 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.547 0.689 . . . . 0.0 110.92 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . 0.515 ' HD2' ' CG ' ' A' ' 355' ' ' TRP . 54.2 Cg_endo -69.77 140.45 42.65 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.715 2.276 . . . . 0.0 112.342 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 83.05 -36.94 2.7 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.475 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 42.4 t -64.55 152.71 41.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.884 0.373 . . . . 0.0 110.857 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -141.92 38.9 1.44 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.477 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 30.4 m95 -91.46 127.89 37.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.713 0.292 . . . . 0.0 110.916 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 361' ' ' ARG . . . . . 0.441 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 33.2 mtt180 -123.19 161.36 24.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.861 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 362' ' ' PHE . . . . . 0.441 ' CD1' ' C ' ' A' ' 361' ' ' ARG . 4.7 m-85 -147.67 153.38 39.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 33.8 t -75.8 -34.94 60.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.837 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -108.74 168.37 9.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 74.0 p -75.24 -56.82 4.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.868 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -46.46 -41.47 13.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.856 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -60.33 -35.02 74.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.863 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.421 ' HA ' ' CD1' ' A' ' 362' ' ' PHE . 11.7 tp -80.71 -44.17 19.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.922 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 14.7 t -57.87 -46.43 84.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.857 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -58.85 -27.96 65.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.884 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 19.8 t60 -76.99 -46.46 23.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.864 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 41.0 mmm-85 -43.55 -28.83 0.41 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.883 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 79.1 mtt180 -50.51 -45.36 56.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.848 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 1.3 t -44.73 -39.59 5.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.846 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 375' ' ' HIS . . . . . 0.568 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 42.8 m-70 -92.27 154.89 18.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.871 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 2.3 m -82.25 -50.57 8.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.818 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 118.91 133.01 4.61 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.505 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . 0.401 ' O ' ' CG2' ' A' ' 378' ' ' VAL . 34.4 m -110.33 108.54 25.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.908 0.385 . . . . 0.0 111.115 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 379' ' ' LYS . . . . . . . . . . . . . 17.1 mmmt -139.34 153.67 71.13 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.587 0.708 . . . . 0.0 110.883 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -7.84 22.08 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.669 2.246 . . . . 0.0 112.336 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 94.4 p -52.15 -48.35 64.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.927 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 39.99 68.55 0.54 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.472 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 383' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 148.7 65.5 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.696 2.264 . . . . 0.0 112.35 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 21.9 p -67.67 -60.12 2.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.875 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 71.9 p -128.4 152.55 48.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.893 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.477 -179.991 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.489 -0.245 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 95.1 p -112.7 151.85 29.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.843 0.354 . . . . 0.0 110.848 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 73.9 p -138.45 162.7 33.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.844 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 99.36 44.96 2.25 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.473 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 4.5 m -142.58 147.26 35.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.848 0.356 . . . . 0.0 110.868 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 76.2 p -128.71 134.91 48.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.867 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 119.52 85.54 0.95 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.489 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 74.6 p -103.87 -42.78 5.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.848 0.356 . . . . 0.0 111.167 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 134.52 140.12 4.22 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.508 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -106.3 139.8 40.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.906 0.384 . . . . 0.0 110.883 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 349' ' ' LYS . . . . . 0.416 ' HB3' ' C ' ' A' ' 362' ' ' PHE . 79.3 mttt -104.73 93.44 6.13 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.539 0.685 . . . . 0.0 110.938 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.74 -30.55 22.18 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.701 2.267 . . . . 0.0 112.319 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 351' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -73.24 99.65 2.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -106.76 138.09 43.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.106 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 42.0 t -54.11 151.96 6.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.868 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 61.4 p -94.5 -31.83 13.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.151 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.554 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 52.8 t-105 -49.2 140.46 12.39 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.566 0.698 . . . . 0.0 110.909 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . 0.52 ' HD2' ' CG ' ' A' ' 355' ' ' TRP . 53.6 Cg_endo -69.78 140.27 42.19 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.682 2.255 . . . . 0.0 112.358 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 83.71 -42.5 3.05 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.497 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 49.6 t -59.34 151.12 24.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.87 0.367 . . . . 0.0 110.91 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -139.02 41.64 1.33 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.47 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 23.1 m95 -93.23 128.1 39.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.81 0.338 . . . . 0.0 110.92 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 361' ' ' ARG . . . . . 0.408 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 65.7 mtt180 -123.21 162.97 21.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.923 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 362' ' ' PHE . . . . . 0.487 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 11.0 m-85 -149.34 154.56 39.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.883 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 30.6 t -76.6 -35.43 58.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.917 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -108.36 170.99 7.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.877 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 12.6 t -76.06 -57.08 4.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.885 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -46.6 -46.18 19.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.879 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . 0.413 ' HA ' ' NE ' ' A' ' 370' ' ' ARG . 5.4 mm-40 -54.89 -34.01 62.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.928 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.487 ' HA ' ' CD1' ' A' ' 362' ' ' PHE . 13.1 tp -82.42 -42.34 18.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.897 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 46.0 m -60.1 -43.65 95.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.845 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 370' ' ' ARG . . . . . 0.413 ' NE ' ' HA ' ' A' ' 367' ' ' GLU . 19.6 ptp180 -61.97 -28.6 69.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.855 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 19.9 t60 -76.9 -44.16 32.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.889 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 28.7 mmm-85 -45.8 -27.63 0.89 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.85 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 48.8 mtm180 -51.66 -45.89 63.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.874 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 14.4 t -45.73 -36.59 5.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.869 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 375' ' ' HIS . . . . . 0.554 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 39.1 m-70 -93.69 157.71 16.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.829 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 7.5 t -93.82 95.23 8.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.898 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -93.14 -157.04 33.2 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.462 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 35.9 m -127.78 122.66 59.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.861 0.363 . . . . 0.0 111.144 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 379' ' ' LYS . . . . . . . . . . . . . 28.8 mmtm -106.78 144.33 28.84 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.538 0.685 . . . . 0.0 110.886 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 -11.89 31.87 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.67 2.247 . . . . 0.0 112.381 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 66.2 m -78.71 -51.49 9.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.83 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 144.96 149.55 5.05 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.503 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 383' ' ' PRO . . . . . 0.44 ' O ' ' C ' ' A' ' 384' ' ' SER . 53.6 Cg_endo -69.75 0.85 5.03 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.686 2.257 . . . . 0.0 112.329 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 384' ' ' SER . . . . . 0.44 ' C ' ' O ' ' A' ' 383' ' ' PRO . 74.1 p -34.58 113.95 0.2 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.875 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 4.1 m -164.46 161.13 21.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.844 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.263 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.465 -179.995 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.474 -0.25 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 49.6 m -146.3 156.91 43.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.889 0.376 . . . . 0.0 110.852 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 28.9 t -95.17 144.83 25.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.831 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . -125.93 -76.42 0.25 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.486 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 17.3 m -61.92 164.05 6.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.877 0.37 . . . . 0.0 110.826 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 39.2 t -132.81 121.7 23.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.887 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 37.07 58.7 1.22 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.507 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 62.1 p -55.52 -52.94 62.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.868 0.366 . . . . 0.0 111.153 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 171.14 119.4 0.51 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.486 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -59.06 159.61 7.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.889 0.376 . . . . 0.0 110.902 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 349' ' ' LYS . . . . . 0.444 ' HB3' ' N ' ' A' ' 362' ' ' PHE . 40.1 mttm -104.53 93.54 6.06 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.572 0.701 . . . . 0.0 110.859 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 349' ' ' LYS . 53.6 Cg_endo -69.8 -36.36 10.86 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.693 2.262 . . . . 0.0 112.364 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 351' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -68.47 98.96 0.9 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.832 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -107.95 136.8 47.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.118 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 45.0 t -50.76 151.45 2.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.91 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 76.9 m -93.79 -33.76 13.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.151 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.556 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 50.8 t-105 -45.12 140.42 3.69 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.605 0.717 . . . . 0.0 110.916 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . 0.51 ' HD2' ' CG ' ' A' ' 355' ' ' TRP . 53.4 Cg_endo -69.81 140.48 42.61 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.666 2.244 . . . . 0.0 112.347 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 83.49 -39.62 2.81 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.51 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 45.9 t -61.48 152.35 30.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.886 0.374 . . . . 0.0 110.881 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -140.55 41.67 1.26 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.524 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 29.3 m95 -94.08 129.29 40.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.765 0.317 . . . . 0.0 110.888 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 361' ' ' ARG . . . . . 0.424 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 32.3 mtt180 -122.91 164.33 18.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.879 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 362' ' ' PHE . . . . . 0.508 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 10.7 m-85 -150.69 155.36 39.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.938 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 28.7 t -77.21 -36.58 54.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.912 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 69.9 mtt180 -108.73 161.53 15.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.91 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 82.7 p -67.74 -52.71 34.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.05 -40.22 57.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.867 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -60.68 -30.35 69.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.88 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.508 ' HA ' ' CD1' ' A' ' 362' ' ' PHE . 10.4 tp -85.73 -44.47 12.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.91 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 23.2 t -57.61 -46.42 84.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.847 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -57.84 -34.42 69.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.873 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 27.0 t60 -69.58 -47.49 63.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.823 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 45.0 mmm-85 -41.21 -30.29 0.16 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 47.5 mtm180 -48.21 -46.98 35.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.844 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 93.0 p -44.83 -41.52 7.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.888 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 375' ' ' HIS . . . . . 0.556 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 49.1 m-70 -89.09 158.25 18.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.906 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 3.5 m -97.43 127.0 43.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.854 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -118.42 152.9 17.28 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.469 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 6.8 m -70.42 128.37 33.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.925 0.393 . . . . 0.0 111.149 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 379' ' ' LYS . . . . . . . . . . . . . 30.6 mtmm -134.78 143.94 48.47 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.568 0.699 . . . . 0.0 110.927 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.67 -16.31 37.87 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.723 2.282 . . . . 0.0 112.357 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 1.1 t -103.56 109.18 20.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.844 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -166.76 75.95 0.13 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.497 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 383' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 -49.86 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.707 2.271 . . . . 0.0 112.335 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 5.4 t -88.62 41.63 1.03 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.871 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 3.5 m -161.5 143.5 11.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.871 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.479 -179.947 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 339' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 3.4 m -124.7 96.17 4.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.896 0.379 . . . . 0.0 110.874 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 73.4 m -65.02 159.64 22.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.876 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . -117.97 137.25 12.97 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.499 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 17.2 m -72.84 96.83 2.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.868 0.366 . . . . 0.0 110.87 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 21.3 m -62.64 174.75 0.93 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.835 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 71.01 156.5 2.09 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.446 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 23.8 p -139.48 110.51 6.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.845 0.355 . . . . 0.0 111.156 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -138.56 168.58 24.65 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.487 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -139.8 154.38 47.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.935 0.398 . . . . 0.0 110.878 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 349' ' ' LYS . . . . . 0.405 ' HA ' ' HD2' ' A' ' 350' ' ' PRO . 39.4 mttp -133.88 93.26 20.83 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.559 0.695 . . . . 0.0 110.896 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 349' ' ' LYS . 53.7 Cg_endo -69.76 -32.62 18.23 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.668 2.245 . . . . 0.0 112.349 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 351' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -70.1 98.09 1.27 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -105.56 132.84 51.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.11 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 40.6 t -51.25 144.81 8.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.903 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 86.8 m -86.85 -33.25 19.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.114 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.569 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 60.5 t-105 -43.91 139.81 2.84 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.57 0.7 . . . . 0.0 110.891 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . 0.52 ' HD2' ' CG ' ' A' ' 355' ' ' TRP . 53.9 Cg_endo -69.75 138.69 38.46 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.661 2.24 . . . . 0.0 112.372 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 83.6 -45.26 3.43 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.509 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 54.0 t -53.27 157.4 1.95 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.854 0.359 . . . . 0.0 110.89 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -145.49 44.8 0.85 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.451 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 21.8 m95 -97.6 128.96 44.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.766 0.317 . . . . 0.0 110.91 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 361' ' ' ARG . . . . . . . . . . . . . 47.2 mtt180 -122.47 160.35 25.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.887 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 362' ' ' PHE . . . . . 0.507 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 6.1 m-85 -147.31 155.77 42.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.883 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 46.7 t -83.9 -29.48 27.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.884 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 31.7 mtp180 -113.21 165.38 12.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.904 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 1.2 m -70.23 -62.43 1.39 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.819 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -45.38 -38.33 5.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.862 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -60.22 -37.51 80.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.903 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.507 ' HA ' ' CD1' ' A' ' 362' ' ' PHE . 10.1 tp -80.79 -44.8 17.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.907 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 74.6 m -56.5 -48.02 78.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.887 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 370' ' ' ARG . . . . . 0.451 ' HG3' ' N ' ' A' ' 371' ' ' HIS . 6.8 ptm180 -56.38 -30.29 62.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.911 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 371' ' ' HIS . . . . . 0.451 ' N ' ' HG3' ' A' ' 370' ' ' ARG . 23.8 t60 -74.23 -45.91 45.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.843 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 42.3 mmm-85 -43.28 -29.26 0.39 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 60.6 mtt180 -49.64 -47.45 49.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.892 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 56.0 p -45.17 -38.79 5.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.833 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 375' ' ' HIS . . . . . 0.569 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 45.2 m-70 -92.29 155.83 17.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.898 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 6.0 m -84.56 102.98 13.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.861 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -107.68 114.36 4.21 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.481 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . 0.413 HG13 ' N ' ' A' ' 379' ' ' LYS . 86.1 t -50.64 134.5 10.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.909 0.385 . . . . 0.0 111.144 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 379' ' ' LYS . . . . . 0.413 ' N ' HG13 ' A' ' 378' ' ' VAL . 20.0 mtpp -104.32 160.43 26.07 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.614 0.721 . . . . 0.0 110.895 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -32.15 18.96 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.68 2.253 . . . . 0.0 112.318 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 77.0 p -55.56 155.91 5.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.875 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -111.99 177.12 18.55 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.48 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 383' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 112.08 2.98 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.682 2.255 . . . . 0.0 112.324 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 6.6 t -59.38 -44.4 92.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.81 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 5.6 t 68.07 42.09 1.88 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.828 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.513 179.955 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 339' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.507 -0.237 . . . . 0.0 112.507 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 5.6 m -54.27 111.92 0.87 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.849 0.356 . . . . 0.0 110.824 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 14.9 t -165.89 148.36 7.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . -119.02 120.49 4.68 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.494 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 343' ' ' SER . . . . . 0.43 ' O ' ' C ' ' A' ' 344' ' ' SER . 59.9 p -109.03 112.81 25.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.928 0.394 . . . . 0.0 110.815 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 344' ' ' SER . . . . . 0.43 ' C ' ' O ' ' A' ' 343' ' ' SER . 51.8 p -36.27 -53.39 0.82 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.911 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -170.76 141.19 6.37 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.505 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 14.6 t -67.64 144.17 55.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.837 0.351 . . . . 0.0 111.116 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -123.64 121.66 4.6 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.488 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -64.3 162.66 14.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.884 0.373 . . . . 0.0 110.892 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 46.0 mttp -104.8 93.4 6.16 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.619 0.723 . . . . 0.0 110.919 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -28.25 25.49 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.7 2.267 . . . . 0.0 112.308 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 351' ' ' PHE . . . . . 0.441 ' HB3' ' CD2' ' A' ' 368' ' ' LEU . 80.8 m-85 -74.39 102.04 4.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.864 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -109.58 131.75 54.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.097 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 51.1 t -48.63 147.4 2.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.905 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 88.7 m -92.06 -34.6 14.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.181 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.566 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 58.0 t-105 -44.29 139.99 3.1 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.542 0.687 . . . . 0.0 110.941 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . 0.517 ' HD2' ' CG ' ' A' ' 355' ' ' TRP . 54.0 Cg_endo -69.72 138.18 37.33 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.693 2.262 . . . . 0.0 112.381 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 84.28 -41.58 3.01 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.471 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 42.4 t -60.23 152.08 25.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.863 0.364 . . . . 0.0 110.903 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -140.51 45.96 0.95 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.446 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 25.0 m95 -98.03 129.81 44.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.786 0.327 . . . . 0.0 110.913 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 361' ' ' ARG . . . . . 0.49 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 72.3 mtt180 -121.0 167.46 12.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.868 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 362' ' ' PHE . . . . . 0.516 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 7.4 m-85 -153.13 147.77 26.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.854 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 68.1 m -73.16 -33.48 65.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.899 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -110.45 171.13 7.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.88 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 37.4 t -75.68 -55.09 5.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.858 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -49.87 -48.08 51.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.877 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -52.42 -32.8 40.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.875 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.516 ' HA ' ' CD1' ' A' ' 362' ' ' PHE . 10.9 tp -84.13 -43.29 15.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.92 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 12.2 t -58.28 -45.06 88.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.853 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 370' ' ' ARG . . . . . 0.469 ' CZ ' ' HB2' ' A' ' 370' ' ' ARG . 3.8 ptm85 -58.81 -31.34 68.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.861 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 371' ' ' HIS . . . . . 0.415 ' CB ' ' CZ ' ' A' ' 362' ' ' PHE . 11.0 t60 -73.34 -47.44 42.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.838 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 24.8 mmm-85 -43.55 -28.24 0.36 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.867 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 81.2 mtt180 -51.87 -44.75 63.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.897 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 4.9 t -48.58 -32.16 7.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.836 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 375' ' ' HIS . . . . . 0.566 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 57.7 m-70 -95.75 144.51 26.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.844 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 1.9 m -70.25 -57.73 4.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.858 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 128.33 66.2 0.13 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.489 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 2.8 t 56.54 50.86 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.889 0.376 . . . . 0.0 111.145 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 379' ' ' LYS . . . . . . . . . . . . . 25.6 mmtp -140.43 143.96 35.07 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.594 0.711 . . . . 0.0 110.887 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . 0.414 ' O ' ' C ' ' A' ' 381' ' ' SER . 53.8 Cg_endo -69.81 -5.64 16.73 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.631 2.221 . . . . 0.0 112.347 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 381' ' ' SER . . . . . 0.414 ' C ' ' O ' ' A' ' 380' ' ' PRO . 3.8 t -37.62 -61.35 0.62 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.86 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 65.07 -179.07 8.81 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.737 -0.745 . . . . 0.0 112.466 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 383' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 87.4 0.55 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.692 2.262 . . . . 0.0 112.338 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 13.5 t -41.05 -62.85 0.76 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.8 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 41.7 p -51.97 -53.66 38.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.839 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.474 -179.979 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 339' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 95.8 p 41.54 42.18 1.88 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.89 0.376 . . . . 0.0 110.893 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 3.6 m -77.98 97.0 5.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.883 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . -94.82 -151.81 28.71 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.453 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 91.3 p -125.57 104.77 8.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.851 0.358 . . . . 0.0 110.873 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 5.4 m -58.36 -44.29 88.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.89 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -172.53 -122.6 0.67 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.436 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 55.5 p -104.33 129.16 52.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.831 0.348 . . . . 0.0 111.155 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 147.38 99.06 0.22 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.507 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -128.8 166.04 19.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.913 0.387 . . . . 0.0 110.888 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 349' ' ' LYS . . . . . 0.45 ' HB3' ' N ' ' A' ' 362' ' ' PHE . 46.2 mttm -107.35 93.39 9.61 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.538 0.685 . . . . 0.0 110.912 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -31.69 20.04 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.696 2.264 . . . . 0.0 112.344 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 351' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -72.96 94.04 1.81 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.897 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -101.46 147.0 26.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.096 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 53.2 t -66.24 145.02 56.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 46.2 p -90.63 -27.38 19.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.126 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.569 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 61.7 t-105 -47.86 139.64 9.08 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.58 0.705 . . . . 0.0 110.886 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . 0.519 ' HD2' ' CG ' ' A' ' 355' ' ' TRP . 54.0 Cg_endo -69.77 136.97 34.33 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.703 2.269 . . . . 0.0 112.319 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 84.16 -36.13 2.92 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.493 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 48.3 t -65.93 156.64 32.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.87 0.366 . . . . 0.0 110.879 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -147.04 44.79 0.8 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.481 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 39.8 m95 -96.74 129.99 44.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.813 0.34 . . . . 0.0 110.884 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 361' ' ' ARG . . . . . 0.449 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 51.1 mtm-85 -121.71 163.67 18.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.853 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 362' ' ' PHE . . . . . 0.467 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 7.3 m-85 -149.35 151.83 34.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.865 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 29.6 t -75.02 -36.66 61.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.846 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 40.9 mtp85 -109.38 162.91 13.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 90.1 p -68.11 -57.47 6.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.847 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -47.65 -38.15 14.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.91 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -61.66 -32.25 72.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.856 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.467 ' HA ' ' CD1' ' A' ' 362' ' ' PHE . 7.8 tp -84.53 -46.99 11.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.952 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 46.9 t -54.37 -44.33 72.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.822 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -59.18 -36.3 75.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.815 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 371' ' ' HIS . . . . . 0.413 ' CB ' ' CZ ' ' A' ' 362' ' ' PHE . 18.8 t60 -70.0 -43.46 71.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.877 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 9.3 mmt85 -45.29 -28.21 0.78 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.879 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 47.6 mtp180 -53.04 -43.72 66.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.891 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 49.1 m -47.67 -33.65 7.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.856 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 375' ' ' HIS . . . . . 0.569 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 70.6 m-70 -93.93 169.9 9.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.859 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 88.8 p -89.14 48.79 1.67 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.871 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -57.49 -76.04 0.23 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.513 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 33.7 m -116.47 145.44 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.855 0.36 . . . . 0.0 111.113 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 379' ' ' LYS . . . . . . . . . . . . . 17.2 pttp -77.51 143.79 68.84 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.556 0.693 . . . . 0.0 110.915 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 99.8 0.78 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.66 2.24 . . . . 0.0 112.34 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 80.4 p -101.72 81.17 2.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.878 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 151.29 146.04 4.25 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.478 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 383' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 114.99 3.88 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.681 2.254 . . . . 0.0 112.349 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 91.0 p -171.2 169.69 6.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.9 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 4.2 t -148.19 142.94 26.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.905 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.47 -179.967 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 339' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 19.3 t -48.21 133.02 15.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.873 0.368 . . . . 0.0 110.851 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 85.0 p -126.19 -44.42 1.74 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.822 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 99.7 -95.05 1.45 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.476 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 97.2 p -59.51 96.06 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.889 0.376 . . . . 0.0 110.889 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 59.6 p -56.59 -46.55 80.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.878 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 66.03 42.47 94.62 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.444 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 57.5 p -47.71 133.17 13.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.882 0.373 . . . . 0.0 111.136 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 125.28 165.66 12.15 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.475 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -89.55 152.51 21.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.886 0.374 . . . . 0.0 110.881 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 349' ' ' LYS . . . . . 0.412 ' HB3' ' C ' ' A' ' 362' ' ' PHE . 65.8 mttt -125.96 93.7 43.33 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.598 0.714 . . . . 0.0 110.874 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -33.61 16.34 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.653 2.235 . . . . 0.0 112.357 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 351' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -69.03 104.81 2.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.869 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -109.53 145.44 36.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.114 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 40.4 t -62.84 150.4 41.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.858 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 71.6 p -94.34 -31.94 13.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.193 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.563 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 58.4 t-105 -46.87 140.03 6.39 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.536 0.684 . . . . 0.0 110.876 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . 0.519 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 53.5 Cg_endo -69.82 138.57 37.94 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.662 2.241 . . . . 0.0 112.317 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 83.94 -38.64 2.83 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.483 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 45.3 t -64.04 157.08 26.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.894 0.378 . . . . 0.0 110.87 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -146.36 42.34 0.95 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.476 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 35.8 m95 -92.53 128.45 38.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.761 0.315 . . . . 0.0 110.925 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 361' ' ' ARG . . . . . 0.527 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 50.2 mtm180 -119.88 167.48 12.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.934 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 362' ' ' PHE . . . . . 0.527 ' CD1' ' C ' ' A' ' 361' ' ' ARG . 13.9 m-85 -154.19 149.32 26.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.925 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 72.7 m -77.44 -26.53 51.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.849 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 70.8 mtt180 -116.85 162.16 18.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.854 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 93.8 p -69.42 -57.96 4.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.891 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -48.29 -40.96 26.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.877 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -60.68 -32.91 72.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.908 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.511 ' HA ' ' CD1' ' A' ' 362' ' ' PHE . 7.1 tp -83.17 -44.78 14.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.929 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 42.7 m -58.09 -45.53 87.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -58.75 -29.03 66.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.87 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 12.0 t60 -75.21 -46.91 30.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.88 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 41.6 mmm-85 -42.4 -29.31 0.26 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.866 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 43.4 mtp180 -49.63 -47.36 49.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.888 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 9.4 t -44.77 -38.93 4.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.85 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 375' ' ' HIS . . . . . 0.563 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 56.2 m-70 -88.91 141.58 28.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.88 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 3.3 m -70.99 -58.72 3.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.9 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 85.29 -112.61 3.69 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.526 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 34.9 m -112.71 145.41 18.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.883 0.373 . . . . 0.0 111.129 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 379' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -55.82 141.81 65.29 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.597 0.713 . . . . 0.0 110.885 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -51.07 0.41 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.636 2.224 . . . . 0.0 112.374 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 76.4 p -175.27 161.72 2.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.834 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 80.5 159.05 19.62 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.481 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 383' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 87.49 0.55 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.718 2.278 . . . . 0.0 112.356 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 4.8 t 43.44 43.45 4.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.852 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 31.8 t -98.04 136.48 38.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.873 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.511 -179.985 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 339' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 340' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 341' ' ' SER . 48.2 t -108.21 140.65 41.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.911 0.386 . . . . 0.0 110.867 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 341' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 340' ' ' SER . 59.5 p -37.83 149.76 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.848 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . -129.64 68.55 0.54 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.473 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 36.6 m -88.97 103.32 15.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.847 0.356 . . . . 0.0 110.845 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 1.8 t -63.27 125.16 23.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.865 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 154.08 -172.74 32.72 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.455 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 35.4 p -103.79 163.49 12.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.815 0.34 . . . . 0.0 111.118 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 122.47 58.54 0.21 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.485 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -59.71 153.6 19.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.909 0.385 . . . . 0.0 110.888 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 76.6 mttt -104.31 93.21 5.45 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.566 0.698 . . . . 0.0 110.916 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.69 -31.32 21.06 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.648 2.232 . . . . 0.0 112.357 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 351' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -72.69 103.76 3.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.889 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -111.57 139.65 46.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.097 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 39.9 t -59.18 148.29 32.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.934 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 34.2 m -92.9 -31.39 14.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.12 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.56 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 56.3 t-105 -46.97 140.16 6.45 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.54 0.686 . . . . 0.0 110.938 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . 0.519 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 53.7 Cg_endo -69.72 141.85 46.54 Favored 'Trans proline' 0 C--N 1.34 0.13 0 C-N-CA 122.69 2.26 . . . . 0.0 112.341 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 81.4 -36.57 2.41 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.465 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 42.8 t -67.4 153.63 43.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.924 0.392 . . . . 0.0 110.86 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -144.36 42.06 1.06 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.5 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 33.4 m95 -93.17 128.54 39.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.781 0.324 . . . . 0.0 110.921 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 361' ' ' ARG . . . . . 0.465 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 40.9 mtm180 -120.71 166.05 14.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.888 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 362' ' ' PHE . . . . . 0.493 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 7.2 m-85 -151.94 151.59 31.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.927 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 24.1 m -80.6 -23.24 39.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.86 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 5.4 mtp-105 -120.0 154.11 35.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.857 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 365' ' ' SER . . . . . 0.401 ' O ' ' N ' ' A' ' 368' ' ' LEU . 89.8 p -62.41 -63.43 1.23 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.867 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -41.65 -42.01 2.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.872 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -59.26 -39.73 83.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.869 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.493 ' HA ' ' CD1' ' A' ' 362' ' ' PHE . 8.0 tp -77.14 -42.43 37.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.933 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 24.5 t -58.84 -47.22 85.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.824 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -58.71 -28.31 65.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.916 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 24.7 t60 -75.36 -46.38 33.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 44.2 mmm-85 -43.12 -29.44 0.37 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.853 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 68.8 mtm180 -52.2 -44.31 64.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.889 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 58.8 m -46.36 -38.14 8.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.876 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 375' ' ' HIS . . . . . 0.56 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 55.0 m-70 -92.82 166.21 12.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.852 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 2.0 m -101.07 160.28 14.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.896 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -82.1 -125.78 0.87 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.468 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -52.76 137.21 13.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.94 0.4 . . . . 0.0 111.11 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 379' ' ' LYS . . . . . 0.463 ' CG ' ' HD2' ' A' ' 380' ' ' PRO . 32.5 tttm -97.51 140.52 22.05 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.539 0.685 . . . . 0.0 110.907 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . 0.463 ' HD2' ' CG ' ' A' ' 379' ' ' LYS . 54.1 Cg_endo -69.74 -10.4 28.47 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.704 2.269 . . . . 0.0 112.321 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 381' ' ' SER . . . . . 0.449 ' C ' ' O ' ' A' ' 380' ' ' PRO . 2.1 m -34.6 137.18 0.13 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.879 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . 0.449 ' N ' ' HD2' ' A' ' 383' ' ' PRO . . . -64.85 -60.48 6.85 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.522 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 383' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 382' ' ' GLY . 54.1 Cg_endo -69.77 2.6 3.39 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.649 2.233 . . . . 0.0 112.367 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 43.1 t -45.79 93.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.851 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 385' ' ' SER . . . . . 0.434 ' N ' ' O ' ' A' ' 383' ' ' PRO . 28.5 t -80.16 -56.52 4.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.868 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.499 -179.992 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 339' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 40.3 t -107.58 156.97 18.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.899 0.381 . . . . 0.0 110.841 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 4.0 t -110.25 -49.3 3.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.875 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . -58.19 -66.6 2.7 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.497 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 1.9 m -63.8 81.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.808 0.337 . . . . 0.0 110.879 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 1.8 m -115.07 147.79 39.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.835 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -130.52 -177.93 15.16 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.49 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 8.9 t -66.56 -43.59 84.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.816 0.341 . . . . 0.0 111.111 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 122.93 107.75 1.89 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.471 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -64.18 148.08 50.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.898 0.38 . . . . 0.0 110.889 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 349' ' ' LYS . . . . . 0.416 ' HB3' ' C ' ' A' ' 362' ' ' PHE . 30.5 mttm -120.83 93.25 48.65 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.546 0.689 . . . . 0.0 110.923 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -28.69 24.85 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.719 2.28 . . . . 0.0 112.321 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 351' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -75.61 98.65 4.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.844 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -106.51 145.55 31.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.117 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 35.8 t -62.08 148.2 44.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.917 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 41.8 m -92.89 -31.87 14.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.131 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.568 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 55.7 t-105 -49.54 140.23 14.22 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.574 0.702 . . . . 0.0 110.951 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . 0.521 ' HD2' ' CG ' ' A' ' 355' ' ' TRP . 53.9 Cg_endo -69.78 140.71 43.28 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.676 2.25 . . . . 0.0 112.349 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 84.03 -41.53 2.99 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.474 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 44.9 t -63.28 150.9 42.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.888 0.375 . . . . 0.0 110.92 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -140.19 44.03 1.09 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.476 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 39.3 m95 -93.91 129.56 40.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.728 0.299 . . . . 0.0 110.946 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 361' ' ' ARG . . . . . 0.426 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 56.7 mtm180 -122.73 164.61 17.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.902 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 362' ' ' PHE . . . . . 0.467 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 11.3 m-85 -151.37 151.01 31.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.857 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 50.4 m -78.15 -25.8 47.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.871 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 78.1 mtt-85 -115.36 163.27 15.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.915 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 88.2 p -72.39 -53.47 12.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.851 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -50.23 -44.61 53.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.87 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -57.24 -34.4 68.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.864 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.467 ' HA ' ' CD1' ' A' ' 362' ' ' PHE . 6.5 tp -80.49 -44.38 19.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.915 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 14.9 m -57.87 -45.12 86.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.851 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -60.67 -28.27 68.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.839 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 16.8 t60 -76.7 -44.84 31.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.875 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 45.7 mmm-85 -45.43 -28.14 0.83 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.864 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -52.66 -44.57 66.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.878 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 39.2 m -46.69 -38.12 9.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.883 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 375' ' ' HIS . . . . . 0.568 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 38.3 m-70 -93.71 158.47 15.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.878 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 6.1 m -94.08 106.11 18.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.845 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -119.72 -136.17 5.2 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.461 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 14.9 p -133.76 141.54 43.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.873 0.368 . . . . 0.0 111.13 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 379' ' ' LYS . . . . . 0.468 ' CG ' ' HD2' ' A' ' 380' ' ' PRO . 6.0 ttpm? -143.98 139.44 16.01 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.584 0.707 . . . . 0.0 110.902 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . 0.468 ' HD2' ' CG ' ' A' ' 379' ' ' LYS . 53.6 Cg_endo -69.81 -171.14 0.45 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.671 2.247 . . . . 0.0 112.285 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 51.1 m -63.64 -56.71 13.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.844 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 122.93 -78.73 0.35 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.452 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 383' ' ' PRO . . . . . 0.407 ' O ' ' C ' ' A' ' 384' ' ' SER . 53.8 Cg_endo -69.71 -6.77 19.38 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.71 2.273 . . . . 0.0 112.357 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 384' ' ' SER . . . . . 0.407 ' C ' ' O ' ' A' ' 383' ' ' PRO . 88.7 p 37.41 42.08 0.3 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.869 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 29.9 t -44.68 -47.31 10.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.843 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.483 -179.975 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 339' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 16.4 m -105.33 105.05 14.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.889 0.376 . . . . 0.0 110.871 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 1.7 t -95.64 120.48 35.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.882 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 162.77 -159.63 32.01 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.468 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 13.0 t -145.04 157.0 44.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.902 0.382 . . . . 0.0 110.847 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 2.8 t -103.9 96.66 6.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.86 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 114.15 100.26 2.36 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.459 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 7.3 t -142.64 135.88 28.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.875 0.369 . . . . 0.0 111.14 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 139.4 -94.87 0.2 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.502 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -164.2 158.54 19.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.929 0.395 . . . . 0.0 110.877 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 349' ' ' LYS . . . . . 0.405 ' HB3' ' C ' ' A' ' 362' ' ' PHE . 64.1 mttt -125.79 93.44 44.25 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.592 0.711 . . . . 0.0 110.871 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 349' ' ' LYS . 53.4 Cg_endo -69.76 -31.57 20.27 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.685 2.256 . . . . 0.0 112.317 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 351' ' ' PHE . . . . . 0.416 ' HB3' ' CD2' ' A' ' 368' ' ' LEU . 97.0 m-85 -71.74 100.48 2.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.872 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -108.47 132.92 53.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.121 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 35.9 t -49.55 153.95 1.05 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.902 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 30.6 m -94.92 -34.55 12.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.191 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.547 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 46.9 t-105 -44.59 140.66 3.1 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.555 0.693 . . . . 0.0 110.932 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . 0.514 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 53.7 Cg_endo -69.72 140.07 41.91 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.671 2.247 . . . . 0.0 112.372 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 83.65 -41.97 3.0 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.463 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 34.9 t -58.81 149.69 25.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.936 0.398 . . . . 0.0 110.908 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -139.21 42.53 1.24 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.456 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 37.0 m95 -94.8 128.61 41.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.771 0.319 . . . . 0.0 110.874 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 361' ' ' ARG . . . . . 0.408 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 37.7 mtt180 -121.74 159.15 27.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.923 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 362' ' ' PHE . . . . . 0.519 ' CE1' HD11 ' A' ' 368' ' ' LEU . 4.8 m-85 -144.64 152.47 40.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.874 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 36.2 t -74.39 -34.57 63.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.874 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 36.3 mtt-85 -110.63 169.7 8.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.872 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 68.2 p -74.76 -57.4 3.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.893 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -47.34 -44.93 24.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.859 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -55.97 -32.67 64.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.906 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.519 HD11 ' CE1' ' A' ' 362' ' ' PHE . 12.5 tp -83.78 -42.72 16.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.913 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 14.8 t -58.66 -46.88 86.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.836 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 48.6 ptt85 -58.01 -29.29 65.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.849 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -74.34 -45.62 46.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.843 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . 0.422 ' HB3' ' NH1' ' A' ' 372' ' ' ARG . 4.6 mmm180 -42.98 -29.46 0.34 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.853 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 77.4 mtt180 -50.85 -45.5 59.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.846 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 3.2 m -44.56 -39.48 4.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.879 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 375' ' ' HIS . . . . . 0.547 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 48.2 m-70 -89.86 151.14 21.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.848 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 4.2 t -88.64 56.43 3.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.852 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 56.68 163.78 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.478 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 2.3 t -98.06 52.57 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.935 0.397 . . . . 0.0 111.166 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 379' ' ' LYS . . . . . . . . . . . . . 7.1 ptmm? -158.51 143.98 12.14 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.576 0.703 . . . . 0.0 110.912 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -46.76 1.1 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.687 2.258 . . . . 0.0 112.345 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 29.2 t -78.31 161.71 27.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.851 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 179.53 70.54 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.48 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 383' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 153.53 68.61 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.704 2.27 . . . . 0.0 112.309 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 10.4 m -84.25 99.43 10.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.858 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 32.6 m -158.59 159.35 35.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.882 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.501 179.991 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 339' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 N-CA-C 112.454 -0.259 . . . . 0.0 112.454 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 1.8 m 52.82 42.02 31.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.856 0.36 . . . . 0.0 110.831 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 11.9 m -46.54 130.28 11.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.848 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . -132.41 -79.72 0.17 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.47 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 33.4 t -81.21 135.42 35.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.86 0.362 . . . . 0.0 110.901 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 3.2 m -124.43 41.86 3.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.869 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -166.57 -79.31 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.516 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 44.2 p -126.63 104.94 8.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.796 0.331 . . . . 0.0 111.167 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -174.56 83.99 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.489 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 348' ' ' GLU . . . . . 0.42 ' CG ' ' N ' ' A' ' 349' ' ' LYS . 27.3 tt0 -160.64 163.3 32.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.941 0.4 . . . . 0.0 110.878 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 349' ' ' LYS . . . . . 0.421 ' HB3' ' C ' ' A' ' 362' ' ' PHE . 47.7 mttm -113.04 93.46 25.32 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.555 0.693 . . . . 0.0 110.877 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -26.29 27.88 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.705 2.27 . . . . 0.0 112.366 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 351' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -79.95 97.78 6.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.906 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . 0.444 ' CB ' ' HG2' ' A' ' 361' ' ' ARG . . . -110.17 144.0 39.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.12 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 43.5 t -60.13 144.68 49.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.881 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 62.3 p -93.94 -26.14 16.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.178 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.558 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 60.3 t-105 -49.87 139.82 16.4 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.571 0.7 . . . . 0.0 110.927 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . 0.522 ' HD2' ' CG ' ' A' ' 355' ' ' TRP . 54.1 Cg_endo -69.77 137.93 36.59 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.709 2.273 . . . . 0.0 112.321 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 84.53 -33.83 3.19 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.478 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 49.9 t -72.97 153.77 40.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.904 0.383 . . . . 0.0 110.881 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -143.71 48.55 0.74 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.456 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 39.2 m95 -97.93 128.66 44.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.8 0.333 . . . . 0.0 110.875 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 361' ' ' ARG . . . . . 0.507 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 58.1 mtm180 -121.72 164.21 17.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.905 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 362' ' ' PHE . . . . . 0.507 ' CD1' ' C ' ' A' ' 361' ' ' ARG . 4.5 m-85 -151.23 151.13 31.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.896 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 52.6 m -80.06 -19.43 47.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.896 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 5.5 mpt_? -122.94 162.14 22.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.851 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 9.8 t -70.17 -62.74 1.27 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.874 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -43.66 -41.21 4.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.851 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . 0.414 ' O ' ' CG ' ' A' ' 370' ' ' ARG . 24.2 mm-40 -59.29 -40.11 85.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.888 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.452 ' HA ' ' CD1' ' A' ' 362' ' ' PHE . 12.5 tp -77.06 -44.96 28.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.895 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 30.4 t -55.73 -44.67 77.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.846 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 370' ' ' ARG . . . . . 0.439 ' HG3' ' N ' ' A' ' 371' ' ' HIS . 9.6 ptt180 -59.32 -33.86 71.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.899 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 371' ' ' HIS . . . . . 0.439 ' N ' ' HG3' ' A' ' 370' ' ' ARG . 17.3 t60 -71.31 -46.69 60.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.9 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . 0.42 ' HB3' ' NH1' ' A' ' 372' ' ' ARG . 4.9 mmm180 -41.42 -30.13 0.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.838 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -49.67 -44.36 47.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.864 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 1.4 t -46.51 -33.44 4.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.881 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 375' ' ' HIS . . . . . 0.558 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 53.2 m-70 -99.23 166.47 11.2 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.884 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 2.2 m -110.82 166.59 10.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.814 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 155.61 -40.11 0.6 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.494 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 9.2 p -160.32 125.18 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.851 0.357 . . . . 0.0 111.146 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 379' ' ' LYS . . . . . . . . . . . . . 18.4 pttp -96.47 143.82 26.77 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.603 0.716 . . . . 0.0 110.892 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -176.36 1.47 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.637 2.225 . . . . 0.0 112.308 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 29.3 p -121.86 93.36 3.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.824 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 154.09 83.57 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.434 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 383' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 107.53 1.88 Allowed 'Trans proline' 0 N--CA 1.465 -0.149 0 C-N-CA 122.707 2.271 . . . . 0.0 112.371 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 1.1 t -54.17 -60.22 3.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.847 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 54.6 p -156.65 164.49 38.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.875 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.477 -179.966 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 339' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 19.8 m 60.98 42.21 13.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.846 0.355 . . . . 0.0 110.827 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 5.1 t -68.05 127.5 33.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.84 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 166.24 55.36 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.469 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 19.6 m -159.71 117.46 2.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.912 0.387 . . . . 0.0 110.845 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 3.8 m -112.31 135.14 53.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.811 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 125.86 74.96 0.23 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.425 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 74.3 p -67.59 150.33 48.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.803 0.335 . . . . 0.0 111.173 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 133.08 107.73 1.04 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.44 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -83.19 157.81 22.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.96 0.41 . . . . 0.0 110.842 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 349' ' ' LYS . . . . . 0.466 ' HB3' ' N ' ' A' ' 362' ' ' PHE . 36.9 mttp -104.41 93.41 5.79 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.574 0.702 . . . . 0.0 110.915 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 349' ' ' LYS . 54.0 Cg_endo -69.77 -32.2 18.99 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.696 2.264 . . . . 0.0 112.319 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 351' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -72.16 99.2 2.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.847 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -106.72 141.68 37.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.059 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 39.6 t -58.8 149.18 27.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.881 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 27.0 m -90.75 -33.19 15.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.138 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.563 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 56.2 t-105 -45.21 140.16 3.91 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.587 0.708 . . . . 0.0 110.865 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . 0.518 ' HD2' ' CG ' ' A' ' 355' ' ' TRP . 53.9 Cg_endo -69.74 142.37 47.84 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.713 2.275 . . . . 0.0 112.329 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 80.95 -37.99 2.36 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.491 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 49.7 t -63.12 154.52 30.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.827 0.346 . . . . 0.0 110.88 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -143.8 39.04 1.3 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.5 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 48.0 m95 -92.61 128.03 38.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.72 0.295 . . . . 0.0 110.899 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 361' ' ' ARG . . . . . 0.515 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 43.7 mtm180 -121.2 169.47 10.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.818 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 362' ' ' PHE . . . . . 0.515 ' CD1' ' C ' ' A' ' 361' ' ' ARG . 9.4 m-85 -154.48 153.51 31.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.876 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 27.2 t -75.83 -35.43 59.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.884 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -108.16 167.6 9.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.891 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 54.6 p -73.83 -55.51 6.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.836 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -48.58 -45.46 37.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.869 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -55.25 -33.72 63.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.884 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.496 ' HA ' ' CD1' ' A' ' 362' ' ' PHE . 6.8 tp -81.98 -45.41 15.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 27.0 t -56.35 -45.99 80.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.854 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 370' ' ' ARG . . . . . 0.437 ' HG3' ' N ' ' A' ' 371' ' ' HIS . 20.4 ptt180 -59.19 -31.96 69.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.88 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 371' ' ' HIS . . . . . 0.437 ' N ' ' HG3' ' A' ' 370' ' ' ARG . 17.7 t60 -73.75 -38.25 64.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.876 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 19.9 mmm-85 -52.0 -24.96 7.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 37.5 mtt85 -55.56 -43.35 75.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.902 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 32.7 t -48.51 -36.02 14.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.89 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 375' ' ' HIS . . . . . 0.563 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 58.6 m-70 -93.68 144.15 25.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.871 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 3.2 m -88.19 165.63 14.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.816 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -119.14 -132.81 4.53 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.505 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 96.6 t -59.31 119.08 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.884 0.373 . . . . 0.0 111.102 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 379' ' ' LYS . . . . . 0.431 ' NZ ' ' O ' ' A' ' 382' ' ' GLY . 28.0 ttpp -47.84 134.83 11.1 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.601 0.715 . . . . 0.0 110.874 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -51.04 0.41 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.624 2.216 . . . . 0.0 112.367 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 1.8 m -175.11 176.83 2.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.855 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . 0.431 ' O ' ' NZ ' ' A' ' 379' ' ' LYS . . . 64.82 146.25 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.492 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 383' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -50.53 0.45 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.697 2.264 . . . . 0.0 112.316 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 3.6 m 41.56 38.54 0.91 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.854 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 3.7 t 44.14 47.06 7.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.848 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.373 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.498 -179.976 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 339' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.501 -0.239 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 13.9 t -84.32 145.99 27.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.902 0.382 . . . . 0.0 110.877 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 2.1 t -130.13 127.76 40.44 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.863 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 150.81 -57.68 0.45 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.534 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 7.8 t -49.21 -47.08 46.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.924 0.393 . . . . 0.0 110.903 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 51.1 m -143.56 150.06 38.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.876 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 158.98 -153.48 24.59 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.507 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 9.3 t -75.29 -18.65 60.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.853 0.359 . . . . 0.0 111.138 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 348' ' ' GLU . . . -80.54 -35.86 24.72 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.513 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 348' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 347' ' ' GLY . 22.1 tt0 -35.17 146.5 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.881 0.372 . . . . 0.0 110.951 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 349' ' ' LYS . . . . . 0.448 ' HB3' ' N ' ' A' ' 362' ' ' PHE . 46.2 mttm -133.93 93.35 20.51 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.564 0.697 . . . . 0.0 110.895 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 349' ' ' LYS . 53.4 Cg_endo -69.79 -30.57 21.91 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.659 2.239 . . . . 0.0 112.298 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 351' ' ' PHE . . . . . 0.411 ' HB3' ' CD2' ' A' ' 368' ' ' LEU . 95.0 m-85 -74.25 95.68 2.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.883 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -103.97 135.58 45.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.089 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 43.5 t -51.77 150.88 3.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.92 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 70.2 p -95.55 -30.69 13.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.147 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.553 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 55.0 t-105 -46.08 140.21 5.14 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.574 0.702 . . . . 0.0 110.895 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . 0.512 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 53.9 Cg_endo -69.73 133.8 26.51 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.681 2.254 . . . . 0.0 112.345 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 88.88 -37.75 3.28 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.528 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 46.8 t -64.78 151.86 44.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.917 0.389 . . . . 0.0 110.846 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -141.5 43.1 1.11 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.482 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 37.9 m95 -95.92 129.16 43.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.778 0.323 . . . . 0.0 110.917 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 361' ' ' ARG . . . . . . . . . . . . . 25.7 mtt180 -121.51 161.01 23.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.828 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 362' ' ' PHE . . . . . 0.488 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 10.2 m-85 -145.91 153.18 40.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.845 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 45.2 t -78.3 -29.84 48.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.819 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.14 165.78 11.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.848 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 36.1 t -73.89 -47.61 36.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.852 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -56.36 -46.89 79.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.876 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -54.26 -31.43 53.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.844 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.488 ' HA ' ' CD1' ' A' ' 362' ' ' PHE . 8.4 tp -83.8 -44.03 14.79 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.948 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 5.5 t -57.7 -47.04 83.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.836 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 25.8 ptt180 -57.93 -33.12 68.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.877 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 22.3 t60 -72.32 -43.92 63.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.875 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . 0.422 ' HB3' ' NH1' ' A' ' 372' ' ' ARG . 4.9 mmm180 -44.68 -28.54 0.63 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.906 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 373' ' ' ARG . . . . . 0.422 ' NH1' ' HB3' ' A' ' 373' ' ' ARG . 10.3 mtp-105 -55.39 -42.79 74.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 58.4 m -47.28 -31.43 3.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.863 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 375' ' ' HIS . . . . . 0.553 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 61.8 m-70 -99.03 165.98 11.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.866 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 2.8 m -97.72 133.69 41.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.83 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 156.42 63.55 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.483 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 10.8 p -171.47 149.05 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.879 0.371 . . . . 0.0 111.085 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 379' ' ' LYS . . . . . . . . . . . . . 21.3 mtmt -45.13 144.11 2.22 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.573 0.701 . . . . 0.0 110.893 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 154.19 67.86 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.643 2.229 . . . . 0.0 112.323 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 58.7 m -114.74 102.53 10.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.816 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 67.81 -158.15 51.74 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.53 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 383' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 150.84 68.95 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.714 2.276 . . . . 0.0 112.316 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 4.1 m -86.97 112.98 22.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.915 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 1.1 t -99.21 142.53 30.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.848 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.521 -179.987 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 339' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.494 -0.243 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 4.4 m -78.55 151.51 32.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.878 0.371 . . . . 0.0 110.874 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 3.2 t -75.19 133.4 41.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.853 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . -102.45 -151.89 23.93 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.484 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 2.7 t -69.03 113.34 6.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.855 0.36 . . . . 0.0 110.853 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 33.2 m -90.69 41.27 1.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.881 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -146.86 64.93 0.43 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.457 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 12.8 t -95.48 145.1 25.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.785 0.326 . . . . 0.0 111.185 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -128.69 -74.3 0.17 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.479 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -142.95 112.37 6.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.874 0.368 . . . . 0.0 110.883 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 349' ' ' LYS . . . . . 0.41 ' NZ ' ' HB2' ' A' ' 361' ' ' ARG . 7.6 mtmp? -134.49 93.04 19.3 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.584 0.706 . . . . 0.0 110.899 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -28.18 25.6 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.705 2.27 . . . . 0.0 112.316 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 351' ' ' PHE . . . . . 0.565 ' CD1' ' HA ' ' A' ' 365' ' ' SER . 84.1 m-85 -76.52 102.26 5.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.871 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -115.8 137.59 51.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.088 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 43.2 t -55.59 146.5 20.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.85 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 93.5 m -93.14 -29.05 15.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.154 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.545 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 59.0 t-105 -47.79 139.91 8.71 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.566 0.698 . . . . 0.0 110.932 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . 0.521 ' HD2' ' CG ' ' A' ' 355' ' ' TRP . 53.8 Cg_endo -69.8 140.97 43.81 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.707 2.271 . . . . 0.0 112.283 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 81.94 -36.87 2.51 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.503 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 47.2 t -68.29 151.51 46.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.853 0.358 . . . . 0.0 110.922 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -140.61 45.33 0.99 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.513 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 39.3 m95 -94.24 128.65 40.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.794 0.33 . . . . 0.0 110.913 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 361' ' ' ARG . . . . . 0.455 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 18.2 mtt85 -122.61 165.33 16.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.843 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 362' ' ' PHE . . . . . 0.532 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 11.3 m-85 -152.72 151.2 30.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 49.9 m -77.04 -33.41 57.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.855 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -104.67 171.65 7.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.833 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 365' ' ' SER . . . . . 0.565 ' HA ' ' CD1' ' A' ' 351' ' ' PHE . 80.7 p -81.13 -55.64 4.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.865 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.62 -34.59 59.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.853 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -62.75 -34.58 77.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.881 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.532 ' HA ' ' CD1' ' A' ' 362' ' ' PHE . 9.4 tp -81.01 -45.58 16.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.943 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 58.7 m -56.02 -43.7 78.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.877 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -60.17 -28.9 68.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.855 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -76.44 -43.55 39.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.852 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 22.0 mmm-85 -45.97 -27.14 0.84 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.895 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 25.8 mtp85 -51.13 -46.01 61.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.847 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 58.3 m -46.42 -35.29 5.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.841 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 375' ' ' HIS . . . . . 0.545 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 66.3 m-70 -92.41 159.72 15.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.861 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 24.8 p -108.28 174.67 5.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.836 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -103.97 -107.7 3.21 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.477 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . 0.406 HG22 ' N ' ' A' ' 379' ' ' LYS . 12.6 p -68.1 143.74 15.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.886 0.374 . . . . 0.0 111.146 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 379' ' ' LYS . . . . . 0.406 ' N ' HG22 ' A' ' 378' ' ' VAL . 24.7 pttt -52.05 144.22 21.57 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.612 0.72 . . . . 0.0 110.878 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 144.86 55.07 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.63 2.22 . . . . 0.0 112.355 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 381' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 382' ' ' GLY . 1.2 t -123.59 -62.01 1.34 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.85 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 381' ' ' SER . . . 35.92 82.86 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.46 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 383' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -39.85 6.05 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.671 2.247 . . . . 0.0 112.339 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 65.9 p -70.45 -48.04 57.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 2.3 m -125.66 113.63 17.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.884 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.467 -179.992 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 339' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 112.476 -0.25 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 2.7 m -132.52 141.31 48.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.872 0.368 . . . . 0.0 110.885 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 41.2 t -116.64 153.11 32.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.898 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 169.41 -82.94 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.514 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 30.4 t -123.08 136.59 54.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.863 0.363 . . . . 0.0 110.867 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 17.2 m -50.72 116.62 2.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.822 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -60.54 147.71 45.39 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.454 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 66.7 p -118.15 86.41 2.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.832 0.349 . . . . 0.0 111.138 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 131.54 127.79 2.89 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.475 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.66 166.23 0.49 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.959 0.409 . . . . 0.0 110.847 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 349' ' ' LYS . . . . . 0.413 ' HB3' ' C ' ' A' ' 362' ' ' PHE . 56.6 mttt -104.31 92.93 5.15 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.559 0.695 . . . . 0.0 110.892 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.82 -29.4 23.64 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.721 2.28 . . . . 0.0 112.342 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 351' ' ' PHE . . . . . 0.43 ' HB3' ' CD2' ' A' ' 368' ' ' LEU . 94.4 m-85 -74.98 100.45 4.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.878 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -107.33 150.49 26.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.067 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 41.0 t -68.06 144.12 55.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.891 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 89.4 m -89.09 -28.69 19.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.139 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.568 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 57.8 t-105 -49.87 140.03 16.12 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.51 0.672 . . . . 0.0 110.931 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . 0.52 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 53.8 Cg_endo -69.72 138.64 38.41 Favored 'Trans proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.716 2.278 . . . . 0.0 112.358 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 84.34 -39.87 2.92 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.527 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 44.8 t -63.9 155.18 31.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.868 0.366 . . . . 0.0 110.896 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -145.3 45.21 0.84 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.494 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 32.7 m95 -96.13 128.69 43.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.745 0.307 . . . . 0.0 110.957 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 361' ' ' ARG . . . . . 0.519 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 56.6 mtm-85 -120.77 167.14 12.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.848 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 362' ' ' PHE . . . . . 0.519 ' CD1' ' C ' ' A' ' 361' ' ' ARG . 8.2 m-85 -153.2 146.94 25.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.876 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 29.0 t -70.96 -34.01 71.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.868 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 364' ' ' ARG . . . . . 0.462 ' HD2' ' N ' ' A' ' 364' ' ' ARG . 0.0 OUTLIER -109.66 174.0 6.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.855 -179.913 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 7.1 m -79.6 -57.95 3.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -46.59 -39.44 11.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.859 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 -62.43 -31.64 72.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.864 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.48 ' HA ' ' CD1' ' A' ' 362' ' ' PHE . 9.1 tp -84.92 -45.91 11.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.898 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 37.1 t -56.43 -46.66 80.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.858 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -58.56 -31.91 68.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.867 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 13.4 t60 -70.87 -46.35 62.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.855 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 54.6 mmm-85 -44.09 -29.08 0.56 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.851 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 62.3 mtt-85 -48.74 -45.92 40.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 36.8 t -47.65 -35.78 9.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.875 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 375' ' ' HIS . . . . . 0.568 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 46.4 m-70 -94.98 170.96 9.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.869 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 45.6 t -75.37 -59.21 2.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.853 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 76.31 -75.81 1.54 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.478 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 7.7 p -119.05 144.74 26.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.863 0.363 . . . . 0.0 111.172 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 379' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -124.37 144.13 44.97 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.601 0.715 . . . . 0.0 110.915 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -174.95 1.01 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.686 2.257 . . . . 0.0 112.3 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 3.6 m -133.35 72.52 1.48 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.856 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 128.73 -91.8 0.33 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.539 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 383' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 172.13 13.21 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.666 2.244 . . . . 0.0 112.366 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 36.7 t -128.62 108.63 10.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.889 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 67.9 m -99.11 84.48 3.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.876 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.272 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.463 -179.956 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 339' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 72.5 m -39.65 121.05 1.18 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.859 0.362 . . . . 0.0 110.817 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 71.7 m -106.91 83.05 1.78 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.848 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . -140.03 167.91 25.25 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.473 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 35.3 p -108.87 93.27 4.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.905 0.383 . . . . 0.0 110.872 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 49.4 m -96.6 40.54 1.13 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.837 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 114.57 -40.57 2.43 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.513 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 6.6 t -94.37 163.04 13.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.896 0.379 . . . . 0.0 111.136 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 159.34 -42.95 0.46 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.482 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -51.72 170.13 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.94 0.4 . . . . 0.0 110.895 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -106.24 93.38 7.97 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.597 0.713 . . . . 0.0 110.904 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -29.82 23.1 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.683 2.255 . . . . 0.0 112.334 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 351' ' ' PHE . . . . . 0.56 ' CD1' ' HA ' ' A' ' 365' ' ' SER . 94.8 m-85 -74.43 95.5 2.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -109.58 139.65 44.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.11 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 53.3 t -58.85 145.07 42.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.865 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 49.9 m -93.11 -27.94 16.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.138 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.522 ' CG ' ' HD2' ' A' ' 356' ' ' PRO . 61.3 t-105 -47.93 139.69 9.22 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.521 0.677 . . . . 0.0 110.918 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . 0.522 ' HD2' ' CG ' ' A' ' 355' ' ' TRP . 54.0 Cg_endo -69.76 137.62 35.87 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.69 2.26 . . . . 0.0 112.325 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 84.49 -39.94 2.94 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.476 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 41.8 t -62.77 154.64 29.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.884 0.373 . . . . 0.0 110.843 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -142.57 47.71 0.81 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.513 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 31.6 m95 -97.68 132.81 42.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.754 0.311 . . . . 0.0 110.919 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 361' ' ' ARG . . . . . 0.485 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 30.1 mtt180 -128.51 163.23 25.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.875 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 362' ' ' PHE . . . . . 0.549 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 5.6 m-85 -151.94 152.77 32.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 50.7 m -79.06 -27.36 43.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.866 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 364' ' ' ARG . . . . . 0.501 ' C ' ' CD2' ' A' ' 351' ' ' PHE . 66.6 mtt180 -113.27 168.44 9.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.822 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 365' ' ' SER . . . . . 0.56 ' HA ' ' CD1' ' A' ' 351' ' ' PHE . 31.2 t -74.65 -62.85 1.39 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.865 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -44.38 -38.59 4.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.911 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -58.97 -41.79 88.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.885 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.549 ' HA ' ' CD1' ' A' ' 362' ' ' PHE . 6.5 tp -76.0 -45.19 35.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 27.4 t -55.86 -49.45 73.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.868 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 25.8 ptt85 -56.05 -28.24 56.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.887 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 20.0 t60 -79.11 -41.85 27.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.852 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 22.0 mmm-85 -48.99 -24.7 1.61 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.849 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 -55.9 -44.16 77.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.936 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 39.5 t -46.64 -34.75 5.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.855 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 375' ' ' HIS . . . . . 0.471 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 48.5 m-70 -94.11 156.85 16.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.852 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 55.5 p -84.09 51.67 2.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -93.29 -123.23 3.46 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.463 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 87.8 t -62.07 131.55 27.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.902 0.382 . . . . 0.0 111.16 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 379' ' ' LYS . . . . . 0.469 ' CG ' ' HD2' ' A' ' 380' ' ' PRO . 21.2 ttmt -132.06 140.24 37.5 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.568 0.699 . . . . 0.0 110.9 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . 0.469 ' HD2' ' CG ' ' A' ' 379' ' ' LYS . 54.1 Cg_endo -69.74 -31.98 19.53 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.665 2.243 . . . . 0.0 112.345 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 74.1 m 51.12 40.96 27.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.876 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -88.82 152.1 22.78 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.514 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 383' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 105.67 1.53 Allowed 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.726 2.284 . . . . 0.0 112.303 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 5.5 m -110.67 154.28 24.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.863 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 7.5 t -129.18 160.88 31.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.89 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.482 -179.994 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 339' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.464 -0.254 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 2.0 m -98.97 168.13 10.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.853 0.359 . . . . 0.0 110.886 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 90.2 p -106.74 145.04 32.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.884 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . -80.01 -138.29 1.86 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.467 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 24.8 p -79.87 129.35 34.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.872 0.368 . . . . 0.0 110.865 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 4.7 m -85.13 163.35 18.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.849 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 92.19 -88.79 1.35 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.465 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 72.1 p -129.32 133.6 47.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.81 0.338 . . . . 0.0 111.154 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 128.77 56.19 0.11 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.483 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -114.4 157.28 23.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.974 0.416 . . . . 0.0 110.842 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 349' ' ' LYS . . . . . 0.456 ' HB3' ' N ' ' A' ' 362' ' ' PHE . 74.4 mttt -104.2 93.95 6.21 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.548 0.69 . . . . 0.0 110.873 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -36.61 10.62 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.677 2.251 . . . . 0.0 112.408 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 351' ' ' PHE . . . . . 0.446 ' CE2' ' HB2' ' A' ' 365' ' ' SER . 86.2 m-85 -67.57 98.28 0.67 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.907 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -107.45 138.83 42.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.07 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 45.3 t -55.35 132.65 48.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.885 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 28.0 m -79.93 -18.86 49.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.125 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.552 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 58.7 t-105 -55.8 139.9 68.92 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.588 0.709 . . . . 0.0 110.949 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . 0.519 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 54.1 Cg_endo -69.7 137.73 36.33 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.711 2.274 . . . . 0.0 112.367 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 83.77 -37.29 2.81 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.498 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 47.0 t -65.13 153.81 39.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.859 0.362 . . . . 0.0 110.923 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -142.45 44.73 0.96 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.485 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 43.3 m95 -97.98 130.67 44.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.791 0.329 . . . . 0.0 110.926 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 361' ' ' ARG . . . . . . . . . . . . . 30.7 mtt180 -122.23 163.34 19.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.861 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 362' ' ' PHE . . . . . 0.527 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 23.5 m-85 -148.81 148.93 30.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.896 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 34.4 p -72.13 -35.48 69.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.841 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 64.3 mtt180 -112.9 165.58 12.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.886 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 365' ' ' SER . . . . . 0.446 ' HB2' ' CE2' ' A' ' 351' ' ' PHE . 26.3 t -71.54 -52.7 16.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.909 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -51.02 -31.37 18.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.894 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -71.25 -29.2 64.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.874 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.527 ' HA ' ' CD1' ' A' ' 362' ' ' PHE . 10.4 tp -86.71 -47.16 9.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.924 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 22.1 t -54.43 -43.5 71.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.836 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -59.69 -35.42 74.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.87 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 22.8 t60 -70.84 -41.77 71.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.883 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -45.96 -27.64 0.95 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.881 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 373' ' ' ARG . . . . . 0.417 ' NH1' ' HB3' ' A' ' 373' ' ' ARG . 10.1 mtp-105 -53.45 -43.86 68.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.892 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 28.5 t -49.91 -33.47 17.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.863 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 375' ' ' HIS . . . . . 0.552 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 78.3 m-70 -95.77 172.39 8.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.87 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 3.3 m -76.99 -65.03 1.0 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.895 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 135.53 -77.99 0.35 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.493 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 31.5 m -113.35 129.19 69.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.94 0.4 . . . . 0.0 111.17 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 379' ' ' LYS . . . . . 0.473 ' CG ' ' HD2' ' A' ' 380' ' ' PRO . 25.3 ttpt -51.45 139.37 27.77 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.59 0.71 . . . . 0.0 110.872 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . 0.473 ' HD2' ' CG ' ' A' ' 379' ' ' LYS . 53.7 Cg_endo -69.78 150.09 67.65 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.705 2.27 . . . . 0.0 112.328 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 27.7 t -167.74 120.28 0.9 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.843 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 177.6 138.46 3.04 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.479 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 383' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -15.92 37.52 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.662 2.241 . . . . 0.0 112.345 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 8.4 t -60.12 -62.68 1.69 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.882 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 79.2 p -84.48 136.11 33.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.86 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.512 179.994 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 339' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 28.4 t -84.73 -44.22 13.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.843 0.354 . . . . 0.0 110.834 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 50.1 p -149.26 171.79 15.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.855 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . -76.65 175.23 53.51 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.497 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 24.0 t -40.95 -54.64 2.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.883 0.373 . . . . 0.0 110.859 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 68.4 m -64.02 -59.11 4.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.872 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 70.64 104.18 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.542 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 28.7 p 38.36 40.64 0.37 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.805 0.336 . . . . 0.0 111.153 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -80.69 -135.1 1.53 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.534 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -161.29 130.99 4.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.919 0.39 . . . . 0.0 110.872 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 349' ' ' LYS . . . . . 0.416 ' HB3' ' C ' ' A' ' 362' ' ' PHE . 53.0 mttp -134.59 93.34 18.6 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.565 0.697 . . . . 0.0 110.903 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 -25.17 28.97 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.66 2.24 . . . . 0.0 112.335 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 351' ' ' PHE . . . . . 0.488 ' CD1' ' HA ' ' A' ' 365' ' ' SER . 84.5 m-85 -80.35 92.88 5.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.912 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -104.09 139.09 39.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.104 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 50.2 t -53.28 148.68 8.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.836 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 82.6 p -94.83 -26.55 16.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.111 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.553 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 49.8 t-105 -52.47 140.58 35.73 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.62 0.724 . . . . 0.0 110.924 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 356' ' ' PRO . . . . . 0.511 ' HD2' ' CG ' ' A' ' 355' ' ' TRP . 53.3 Cg_endo -69.78 138.94 38.95 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.652 2.235 . . . . 0.0 112.341 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 84.22 -37.82 2.87 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.52 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 49.1 t -63.49 155.64 28.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.927 0.394 . . . . 0.0 110.862 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -142.58 37.91 1.49 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.519 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 42.7 m95 -92.19 128.97 38.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.758 0.313 . . . . 0.0 110.899 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 361' ' ' ARG . . . . . 0.487 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 56.6 mtt180 -124.34 165.01 18.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.926 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 362' ' ' PHE . . . . . 0.487 ' CD1' ' C ' ' A' ' 361' ' ' ARG . 7.6 m-85 -149.98 152.11 34.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.86 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 49.9 m -77.9 -22.85 49.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.867 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -118.72 165.99 13.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.832 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 365' ' ' SER . . . . . 0.488 ' HA ' ' CD1' ' A' ' 351' ' ' PHE . 1.3 t -74.17 -55.76 5.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.836 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -49.36 -45.97 46.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.868 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -54.58 -35.91 63.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.861 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.447 ' HA ' ' CD1' ' A' ' 362' ' ' PHE . 14.3 tp -79.64 -42.55 24.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 44.7 t -57.8 -49.16 77.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.848 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -56.15 -31.61 63.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.868 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 20.1 t60 -73.15 -46.29 51.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.862 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 372' ' ' ARG . . . . . 0.429 ' HB3' ' NH1' ' A' ' 372' ' ' ARG . 5.6 mmm180 -41.34 -29.98 0.16 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.905 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 84.5 mtt180 -51.08 -46.66 61.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.878 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 85.3 p -43.56 -38.18 2.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 375' ' ' HIS . . . . . 0.553 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 39.0 m-70 -94.8 172.84 7.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.858 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 3.0 m -106.36 158.15 17.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.832 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -167.56 122.81 1.07 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.452 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 33.0 m -108.63 126.68 65.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.879 0.371 . . . . 0.0 111.092 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 379' ' ' LYS . . . . . 0.469 ' CD ' ' HD2' ' A' ' 380' ' ' PRO . 33.2 tptt -82.14 137.74 45.99 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.589 0.709 . . . . 0.0 110.894 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . 0.469 ' HD2' ' CD ' ' A' ' 379' ' ' LYS . 53.4 Cg_endo -69.75 165.95 29.23 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.664 2.242 . . . . 0.0 112.348 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 2.2 m 63.53 38.28 9.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.871 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 122.25 146.12 7.19 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.478 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 383' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 170.88 15.47 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.723 2.282 . . . . 0.0 112.33 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 83.8 p -127.24 168.83 14.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.851 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 14.8 t -60.42 128.25 35.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.868 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.501 -179.996 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 349' ' ' LYS . . . . . 0.412 ' HB3' ' C ' ' A' ' 362' ' ' PHE . 37.7 mttt . . . . . 0 C--O 1.232 0.148 0 CA-C-O 121.599 0.714 . . . . 0.0 110.943 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 350' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 349' ' ' LYS . 54.0 Cg_endo -69.77 -25.64 28.33 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.698 2.265 . . . . 0.0 112.323 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 351' ' ' PHE . . . . . 0.688 ' HB3' HD22 ' A' ' 368' ' ' LEU . 90.0 m-85 -79.88 96.46 6.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.898 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -106.63 131.58 53.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.074 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 42.5 t -48.38 150.7 1.23 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.87 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 47.9 p -95.85 -30.68 13.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.153 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.577 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 44.7 t-105 -47.45 140.82 7.25 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.518 0.675 . . . . 0.0 110.918 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 356' ' ' PRO . . . . . 0.532 ' O ' ' CD1' ' A' ' 355' ' ' TRP . 54.0 Cg_endo -69.73 141.18 44.64 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.682 2.255 . . . . 0.0 112.375 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 81.88 -36.05 2.51 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.467 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 49.4 t -65.97 150.77 48.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.866 0.365 . . . . 0.0 110.874 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -142.37 46.15 0.89 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.476 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 44.0 m95 -99.06 128.86 45.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.746 0.308 . . . . 0.0 110.959 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 361' ' ' ARG . . . . . . . . . . . . . 29.6 mtt180 -120.64 156.55 31.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.87 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 362' ' ' PHE . . . . . 0.529 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 23.2 m-85 -140.92 147.02 38.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.932 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 74.3 m -76.23 -22.11 55.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.864 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -118.27 161.62 19.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.846 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 85.8 p -70.95 -56.15 6.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.88 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -49.71 -40.61 41.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.903 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -59.62 -33.14 71.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.856 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.688 HD22 ' HB3' ' A' ' 351' ' ' PHE . 8.4 tp -81.6 -42.56 19.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.927 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 42.8 t -60.1 -46.7 88.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.831 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -59.86 -30.88 69.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.883 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 371' ' ' HIS . . . . . 0.412 ' CB ' ' CZ ' ' A' ' 362' ' ' PHE . 20.0 t60 -73.94 -48.5 30.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.85 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 27.0 mmm-85 -41.44 -29.5 0.16 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.864 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 73.0 mtt180 -52.91 -45.69 67.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.883 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 61.9 m -44.36 -34.01 1.84 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.843 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 375' ' ' HIS . . . . . 0.577 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 57.3 m-70 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.873 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 349' ' ' LYS . . . . . 0.475 ' HB3' ' N ' ' A' ' 362' ' ' PHE . 53.3 mttm . . . . . 0 C--O 1.231 0.122 0 CA-C-O 121.527 0.68 . . . . 0.0 110.858 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 350' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 349' ' ' LYS . 53.6 Cg_endo -69.76 -34.94 13.55 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.716 2.277 . . . . 0.0 112.349 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 351' ' ' PHE . . . . . 0.717 ' HB3' HD22 ' A' ' 368' ' ' LEU . 97.7 m-85 -68.2 103.25 1.52 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.868 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -107.66 129.59 55.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.082 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 353' ' ' CYS . . . . . 0.455 ' HA ' HD11 ' A' ' 368' ' ' LEU . 40.5 t -47.41 146.12 2.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.889 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 58.5 m -91.37 -32.14 15.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.16 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.522 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 46.7 t-105 -47.13 140.72 6.51 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.593 0.711 . . . . 0.0 110.915 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 356' ' ' PRO . . . . . 0.517 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 53.8 Cg_endo -69.77 139.46 40.26 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.636 2.224 . . . . 0.0 112.367 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 83.39 -41.13 2.89 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.552 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 36.1 t -61.39 150.14 36.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.928 0.394 . . . . 0.0 110.839 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -139.78 45.16 1.02 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.532 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 25.2 m95 -97.68 130.99 44.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.758 0.313 . . . . 0.0 110.896 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 361' ' ' ARG . . . . . 0.421 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 67.5 mtt180 -121.49 165.66 15.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.867 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 362' ' ' PHE . . . . . 0.475 ' N ' ' HB3' ' A' ' 349' ' ' LYS . 14.5 m-85 -150.83 156.43 41.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.853 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 15.3 t -78.92 -37.46 39.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.872 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -106.91 161.25 14.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.894 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 365' ' ' SER . . . . . 0.538 ' HB3' ' CE1' ' A' ' 351' ' ' PHE . 54.4 p -71.3 -38.1 71.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.879 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -62.51 -45.62 92.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.89 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -55.51 -34.48 64.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.873 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.717 HD22 ' HB3' ' A' ' 351' ' ' PHE . 9.0 tp -79.25 -42.96 24.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.902 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 18.3 t -58.13 -44.9 88.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.809 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 370' ' ' ARG . . . . . 0.411 ' HG3' ' N ' ' A' ' 371' ' ' HIS . 29.6 ptt85 -61.82 -30.46 70.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.848 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 371' ' ' HIS . . . . . 0.411 ' N ' ' HG3' ' A' ' 370' ' ' ARG . 22.5 t60 -74.4 -39.0 62.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.863 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 26.3 mmm-85 -51.31 -25.1 5.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.863 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 28.8 mtt85 -57.56 -40.87 79.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 58.0 m -50.35 -30.87 13.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.879 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 375' ' ' HIS . . . . . 0.522 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 68.5 m-70 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.848 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 349' ' ' LYS . . . . . 0.424 ' HA ' ' HD2' ' A' ' 350' ' ' PRO . 79.4 mttt . . . . . 0 C--O 1.232 0.157 0 CA-C-O 121.6 0.714 . . . . 0.0 110.901 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 350' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 349' ' ' LYS . 53.8 Cg_endo -69.75 -31.23 20.96 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.69 2.26 . . . . 0.0 112.355 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 351' ' ' PHE . . . . . 0.594 ' HB3' HD22 ' A' ' 368' ' ' LEU . 95.4 m-85 -73.53 97.12 2.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.896 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -108.39 143.85 36.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.043 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 51.5 t -59.94 147.95 36.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.868 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 57.7 m -90.64 -29.25 17.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.157 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.575 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 52.8 t-105 -48.23 140.36 9.56 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.547 0.689 . . . . 0.0 110.92 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 356' ' ' PRO . . . . . 0.509 ' HD2' ' CG ' ' A' ' 355' ' ' TRP . 54.2 Cg_endo -69.77 140.45 42.65 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.715 2.276 . . . . 0.0 112.342 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 83.05 -36.94 2.7 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.475 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 42.4 t -64.55 152.71 41.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.884 0.373 . . . . 0.0 110.857 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -141.92 38.9 1.44 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.477 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 30.4 m95 -91.46 127.89 37.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.713 0.292 . . . . 0.0 110.916 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 361' ' ' ARG . . . . . 0.441 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 33.2 mtt180 -123.19 161.36 24.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.861 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 362' ' ' PHE . . . . . 0.441 ' CD1' ' C ' ' A' ' 361' ' ' ARG . 4.7 m-85 -147.67 153.38 39.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 33.8 t -75.8 -34.94 60.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.837 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -108.74 168.37 9.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 74.0 p -75.24 -56.82 4.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.868 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -46.46 -41.47 13.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.856 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -60.33 -35.02 74.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.863 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.594 HD22 ' HB3' ' A' ' 351' ' ' PHE . 11.7 tp -80.71 -44.17 19.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.922 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 14.7 t -57.87 -46.43 84.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.857 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -58.85 -27.96 65.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.884 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 19.8 t60 -76.99 -46.46 23.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.864 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 41.0 mmm-85 -43.55 -28.83 0.41 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.883 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 79.1 mtt180 -50.51 -45.36 56.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.848 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 1.3 t -44.73 -39.59 5.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.846 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 375' ' ' HIS . . . . . 0.575 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 42.8 m-70 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.871 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 349' ' ' LYS . . . . . 0.424 ' HA ' ' HD2' ' A' ' 350' ' ' PRO . 79.3 mttt . . . . . 0 C--O 1.231 0.109 0 CA-C-O 121.539 0.685 . . . . 0.0 110.938 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 350' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 349' ' ' LYS . 53.3 Cg_endo -69.74 -30.55 22.18 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.701 2.267 . . . . 0.0 112.319 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 351' ' ' PHE . . . . . 0.669 ' HB3' HD22 ' A' ' 368' ' ' LEU . 99.0 m-85 -73.24 99.65 2.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -106.76 138.09 43.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.106 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 353' ' ' CYS . . . . . 0.419 ' HA ' HD11 ' A' ' 368' ' ' LEU . 42.0 t -54.11 151.96 6.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.868 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 61.4 p -94.5 -31.83 13.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.151 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.562 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 52.8 t-105 -49.2 140.46 12.39 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.566 0.698 . . . . 0.0 110.909 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 356' ' ' PRO . . . . . 0.514 ' HD2' ' CG ' ' A' ' 355' ' ' TRP . 53.6 Cg_endo -69.78 140.27 42.19 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.682 2.255 . . . . 0.0 112.358 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 83.71 -42.5 3.05 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.497 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 49.6 t -59.34 151.12 24.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.87 0.367 . . . . 0.0 110.91 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -139.02 41.64 1.33 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.47 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 23.1 m95 -93.23 128.1 39.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.81 0.338 . . . . 0.0 110.92 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 361' ' ' ARG . . . . . 0.408 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 65.7 mtt180 -123.21 162.97 21.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.923 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 362' ' ' PHE . . . . . 0.489 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 11.0 m-85 -149.34 154.56 39.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.883 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 30.6 t -76.6 -35.43 58.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.917 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -108.36 170.99 7.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.877 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 12.6 t -76.06 -57.08 4.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.885 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -46.6 -46.18 19.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.879 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 367' ' ' GLU . . . . . 0.422 ' HA ' ' NE ' ' A' ' 370' ' ' ARG . 5.4 mm-40 -54.89 -34.01 62.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.928 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.669 HD22 ' HB3' ' A' ' 351' ' ' PHE . 13.1 tp -82.42 -42.34 18.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.897 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 46.0 m -60.1 -43.65 95.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.845 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 370' ' ' ARG . . . . . 0.422 ' NE ' ' HA ' ' A' ' 367' ' ' GLU . 19.6 ptp180 -61.97 -28.6 69.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.855 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 19.9 t60 -76.9 -44.16 32.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.889 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 28.7 mmm-85 -45.8 -27.63 0.89 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.85 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 48.8 mtm180 -51.66 -45.89 63.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.874 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 14.4 t -45.73 -36.59 5.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.869 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 375' ' ' HIS . . . . . 0.562 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 39.1 m-70 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.829 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 349' ' ' LYS . . . . . 0.455 ' HB3' ' N ' ' A' ' 362' ' ' PHE . 40.1 mttm . . . . . 0 C--O 1.232 0.14 0 CA-C-O 121.572 0.701 . . . . 0.0 110.859 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 350' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 349' ' ' LYS . 53.6 Cg_endo -69.8 -36.36 10.86 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.693 2.262 . . . . 0.0 112.364 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 351' ' ' PHE . . . . . 0.552 ' HB3' HD22 ' A' ' 368' ' ' LEU . 97.0 m-85 -68.47 98.96 0.9 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.832 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -107.95 136.8 47.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.118 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 353' ' ' CYS . . . . . 0.607 ' HA ' HD11 ' A' ' 368' ' ' LEU . 45.0 t -50.76 151.45 2.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.91 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 76.9 m -93.79 -33.76 13.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.151 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.566 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 50.8 t-105 -45.12 140.42 3.69 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.605 0.717 . . . . 0.0 110.916 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 356' ' ' PRO . . . . . 0.505 ' HD2' ' CG ' ' A' ' 355' ' ' TRP . 53.4 Cg_endo -69.81 140.48 42.61 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.666 2.244 . . . . 0.0 112.347 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 83.49 -39.62 2.81 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.51 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 45.9 t -61.48 152.35 30.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.886 0.374 . . . . 0.0 110.881 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -140.55 41.67 1.26 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.524 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 29.3 m95 -94.08 129.29 40.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.765 0.317 . . . . 0.0 110.888 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 361' ' ' ARG . . . . . 0.424 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 32.3 mtt180 -122.91 164.33 18.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.879 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 362' ' ' PHE . . . . . 0.509 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 10.7 m-85 -150.69 155.36 39.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.938 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 28.7 t -77.21 -36.58 54.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.912 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 69.9 mtt180 -108.73 161.53 15.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.91 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 82.7 p -67.74 -52.71 34.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.05 -40.22 57.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.867 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -60.68 -30.35 69.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.88 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.607 HD11 ' HA ' ' A' ' 353' ' ' CYS . 10.4 tp -85.73 -44.47 12.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.91 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 23.2 t -57.61 -46.42 84.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.847 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -57.84 -34.42 69.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.873 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 27.0 t60 -69.58 -47.49 63.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.823 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 45.0 mmm-85 -41.21 -30.29 0.16 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 47.5 mtm180 -48.21 -46.98 35.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.844 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 93.0 p -44.83 -41.52 7.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.888 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 375' ' ' HIS . . . . . 0.566 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 49.1 m-70 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.906 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 349' ' ' LYS . . . . . 0.417 ' HB3' ' N ' ' A' ' 362' ' ' PHE . 39.4 mttp . . . . . 0 C--O 1.231 0.101 0 CA-C-O 121.559 0.695 . . . . 0.0 110.896 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -32.62 18.23 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.668 2.245 . . . . 0.0 112.349 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 351' ' ' PHE . . . . . 0.671 ' HB3' HD22 ' A' ' 368' ' ' LEU . 79.6 m-85 -70.1 98.09 1.27 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -105.56 132.84 51.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.11 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 40.6 t -51.25 144.81 8.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.903 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 86.8 m -86.85 -33.25 19.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.114 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.578 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 60.5 t-105 -43.91 139.81 2.84 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.57 0.7 . . . . 0.0 110.891 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 356' ' ' PRO . . . . . 0.524 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 53.9 Cg_endo -69.75 138.69 38.46 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.661 2.24 . . . . 0.0 112.372 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 83.6 -45.26 3.43 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.509 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 54.0 t -53.27 157.4 1.95 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.854 0.359 . . . . 0.0 110.89 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -145.49 44.8 0.85 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.451 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 21.8 m95 -97.6 128.96 44.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.766 0.317 . . . . 0.0 110.91 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 361' ' ' ARG . . . . . . . . . . . . . 47.2 mtt180 -122.47 160.35 25.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.887 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 362' ' ' PHE . . . . . 0.509 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 6.1 m-85 -147.31 155.77 42.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.883 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 46.7 t -83.9 -29.48 27.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.884 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 31.7 mtp180 -113.21 165.38 12.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.904 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 1.2 m -70.23 -62.43 1.39 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.819 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -45.38 -38.33 5.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.862 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -60.22 -37.51 80.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.903 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.671 HD22 ' HB3' ' A' ' 351' ' ' PHE . 10.1 tp -80.79 -44.8 17.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.907 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 74.6 m -56.5 -48.02 78.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.887 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 370' ' ' ARG . . . . . 0.456 ' HG3' ' N ' ' A' ' 371' ' ' HIS . 6.8 ptm180 -56.38 -30.29 62.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.911 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 371' ' ' HIS . . . . . 0.456 ' N ' ' HG3' ' A' ' 370' ' ' ARG . 23.8 t60 -74.23 -45.91 45.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.843 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 42.3 mmm-85 -43.28 -29.26 0.39 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 60.6 mtt180 -49.64 -47.45 49.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.892 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 56.0 p -45.17 -38.79 5.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.833 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 375' ' ' HIS . . . . . 0.578 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 45.2 m-70 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.898 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 349' ' ' LYS . . . . . 0.424 ' HA ' ' HD2' ' A' ' 350' ' ' PRO . 46.0 mttp . . . . . 0 C--O 1.231 0.118 0 CA-C-O 121.619 0.723 . . . . 0.0 110.919 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 350' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 349' ' ' LYS . 53.5 Cg_endo -69.76 -28.25 25.49 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.7 2.267 . . . . 0.0 112.308 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 351' ' ' PHE . . . . . 0.808 ' HB3' HD22 ' A' ' 368' ' ' LEU . 80.8 m-85 -74.39 102.04 4.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.864 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -109.58 131.75 54.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.097 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 51.1 t -48.63 147.4 2.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.905 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 88.7 m -92.06 -34.6 14.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.181 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.574 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 58.0 t-105 -44.29 139.99 3.1 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.542 0.687 . . . . 0.0 110.941 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 356' ' ' PRO . . . . . 0.516 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 54.0 Cg_endo -69.72 138.18 37.33 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.693 2.262 . . . . 0.0 112.381 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 84.28 -41.58 3.01 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.471 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 42.4 t -60.23 152.08 25.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.863 0.364 . . . . 0.0 110.903 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -140.51 45.96 0.95 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.446 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 25.0 m95 -98.03 129.81 44.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.786 0.327 . . . . 0.0 110.913 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 361' ' ' ARG . . . . . 0.49 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 72.3 mtt180 -121.0 167.46 12.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.868 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 362' ' ' PHE . . . . . 0.518 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 7.4 m-85 -153.13 147.77 26.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.854 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 68.1 m -73.16 -33.48 65.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.899 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -110.45 171.13 7.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.88 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 37.4 t -75.68 -55.09 5.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.858 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -49.87 -48.08 51.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.877 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -52.42 -32.8 40.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.875 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.808 HD22 ' HB3' ' A' ' 351' ' ' PHE . 10.9 tp -84.13 -43.29 15.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.92 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 12.2 t -58.28 -45.06 88.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.853 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 370' ' ' ARG . . . . . 0.476 ' CZ ' ' HB2' ' A' ' 370' ' ' ARG . 3.8 ptm85 -58.81 -31.34 68.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.861 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 371' ' ' HIS . . . . . 0.415 ' CB ' ' CZ ' ' A' ' 362' ' ' PHE . 11.0 t60 -73.34 -47.44 42.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.838 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 24.8 mmm-85 -43.55 -28.24 0.36 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.867 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 81.2 mtt180 -51.87 -44.75 63.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.897 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 4.9 t -48.58 -32.16 7.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.836 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 375' ' ' HIS . . . . . 0.574 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 57.7 m-70 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.844 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 349' ' ' LYS . . . . . 0.462 ' HB3' ' N ' ' A' ' 362' ' ' PHE . 46.2 mttm . . . . . 0 C--O 1.231 0.112 0 CA-C-O 121.538 0.685 . . . . 0.0 110.912 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 350' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 349' ' ' LYS . 53.7 Cg_endo -69.76 -31.69 20.04 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.696 2.264 . . . . 0.0 112.344 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 351' ' ' PHE . . . . . 0.544 ' HB3' HD22 ' A' ' 368' ' ' LEU . 93.6 m-85 -72.96 94.04 1.81 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.897 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -101.46 147.0 26.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.096 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 53.2 t -66.24 145.02 56.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 46.2 p -90.63 -27.38 19.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.126 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.575 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 61.7 t-105 -47.86 139.64 9.08 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.58 0.705 . . . . 0.0 110.886 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 356' ' ' PRO . . . . . 0.527 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 54.0 Cg_endo -69.77 136.97 34.33 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.703 2.269 . . . . 0.0 112.319 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 84.16 -36.13 2.92 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.493 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 48.3 t -65.93 156.64 32.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.87 0.366 . . . . 0.0 110.879 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -147.04 44.79 0.8 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.481 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 39.8 m95 -96.74 129.99 44.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.813 0.34 . . . . 0.0 110.884 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 361' ' ' ARG . . . . . 0.449 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 51.1 mtm-85 -121.71 163.67 18.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.853 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 362' ' ' PHE . . . . . 0.47 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 7.3 m-85 -149.35 151.83 34.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.865 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 29.6 t -75.02 -36.66 61.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.846 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 40.9 mtp85 -109.38 162.91 13.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 90.1 p -68.11 -57.47 6.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.847 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -47.65 -38.15 14.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.91 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -61.66 -32.25 72.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.856 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.544 HD22 ' HB3' ' A' ' 351' ' ' PHE . 7.8 tp -84.53 -46.99 11.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.952 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 46.9 t -54.37 -44.33 72.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.822 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -59.18 -36.3 75.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.815 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 371' ' ' HIS . . . . . 0.413 ' CB ' ' CZ ' ' A' ' 362' ' ' PHE . 18.8 t60 -70.0 -43.46 71.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.877 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 9.3 mmt85 -45.29 -28.21 0.78 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.879 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 47.6 mtp180 -53.04 -43.72 66.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.891 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 49.1 m -47.67 -33.65 7.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.856 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 375' ' ' HIS . . . . . 0.575 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 70.6 m-70 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.859 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 349' ' ' LYS . . . . . 0.405 ' HB3' ' C ' ' A' ' 362' ' ' PHE . 65.8 mttt . . . . . 0 C--O 1.231 0.104 0 CA-C-O 121.598 0.714 . . . . 0.0 110.874 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -33.61 16.34 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.653 2.235 . . . . 0.0 112.357 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 351' ' ' PHE . . . . . 0.729 ' HB3' HD22 ' A' ' 368' ' ' LEU . 90.6 m-85 -69.03 104.81 2.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.869 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -109.53 145.44 36.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.114 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 40.4 t -62.84 150.4 41.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.858 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 71.6 p -94.34 -31.94 13.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.193 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.573 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 58.4 t-105 -46.87 140.03 6.39 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.536 0.684 . . . . 0.0 110.876 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 356' ' ' PRO . . . . . 0.523 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 53.5 Cg_endo -69.82 138.57 37.94 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.662 2.241 . . . . 0.0 112.317 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 83.94 -38.64 2.83 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.483 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 45.3 t -64.04 157.08 26.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.894 0.378 . . . . 0.0 110.87 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -146.36 42.34 0.95 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.476 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 35.8 m95 -92.53 128.45 38.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.761 0.315 . . . . 0.0 110.925 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 361' ' ' ARG . . . . . 0.527 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 50.2 mtm180 -119.88 167.48 12.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.934 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 362' ' ' PHE . . . . . 0.527 ' CD1' ' C ' ' A' ' 361' ' ' ARG . 13.9 m-85 -154.19 149.32 26.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.925 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 72.7 m -77.44 -26.53 51.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.849 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 70.8 mtt180 -116.85 162.16 18.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.854 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 93.8 p -69.42 -57.96 4.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.891 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -48.29 -40.96 26.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.877 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -60.68 -32.91 72.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.908 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.729 HD22 ' HB3' ' A' ' 351' ' ' PHE . 7.1 tp -83.17 -44.78 14.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.929 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 42.7 m -58.09 -45.53 87.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -58.75 -29.03 66.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.87 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 12.0 t60 -75.21 -46.91 30.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.88 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 41.6 mmm-85 -42.4 -29.31 0.26 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.866 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 43.4 mtp180 -49.63 -47.36 49.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.888 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 9.4 t -44.77 -38.93 4.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.85 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 375' ' ' HIS . . . . . 0.573 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 56.2 m-70 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.88 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 349' ' ' LYS . . . . . 0.413 ' HA ' ' HD2' ' A' ' 350' ' ' PRO . 76.6 mttt . . . . . 0 C--O 1.231 0.103 0 CA-C-O 121.566 0.698 . . . . 0.0 110.916 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 350' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 349' ' ' LYS . 54.6 Cg_endo -69.69 -31.32 21.06 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.648 2.232 . . . . 0.0 112.357 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 351' ' ' PHE . . . . . 0.683 ' HB3' HD22 ' A' ' 368' ' ' LEU . 96.1 m-85 -72.69 103.76 3.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.889 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -111.57 139.65 46.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.097 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 39.9 t -59.18 148.29 32.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.934 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 34.2 m -92.9 -31.39 14.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.12 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.572 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 56.3 t-105 -46.97 140.16 6.45 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.54 0.686 . . . . 0.0 110.938 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 356' ' ' PRO . . . . . 0.522 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 53.7 Cg_endo -69.72 141.85 46.54 Favored 'Trans proline' 0 C--N 1.34 0.13 0 C-N-CA 122.69 2.26 . . . . 0.0 112.341 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 81.4 -36.57 2.41 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.465 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 42.8 t -67.4 153.63 43.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.924 0.392 . . . . 0.0 110.86 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -144.36 42.06 1.06 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.5 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 33.4 m95 -93.17 128.54 39.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.781 0.324 . . . . 0.0 110.921 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 361' ' ' ARG . . . . . 0.465 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 40.9 mtm180 -120.71 166.05 14.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.888 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 362' ' ' PHE . . . . . 0.494 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 7.2 m-85 -151.94 151.59 31.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.927 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 24.1 m -80.6 -23.24 39.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.86 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 5.4 mtp-105 -120.0 154.11 35.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.857 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 365' ' ' SER . . . . . 0.401 ' O ' ' N ' ' A' ' 368' ' ' LEU . 89.8 p -62.41 -63.43 1.23 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.867 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -41.65 -42.01 2.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.872 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -59.26 -39.73 83.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.869 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.683 HD22 ' HB3' ' A' ' 351' ' ' PHE . 8.0 tp -77.14 -42.43 37.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.933 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 24.5 t -58.84 -47.22 85.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.824 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -58.71 -28.31 65.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.916 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 24.7 t60 -75.36 -46.38 33.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 44.2 mmm-85 -43.12 -29.44 0.37 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.853 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 68.8 mtm180 -52.2 -44.31 64.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.889 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 58.8 m -46.36 -38.14 8.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.876 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 375' ' ' HIS . . . . . 0.572 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 55.0 m-70 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.852 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 349' ' ' LYS . . . . . 0.411 ' HA ' ' HD2' ' A' ' 350' ' ' PRO . 30.5 mttm . . . . . 0 C--O 1.232 0.139 0 CA-C-O 121.546 0.689 . . . . 0.0 110.923 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 350' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 349' ' ' LYS . 53.6 Cg_endo -69.78 -28.69 24.85 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.719 2.28 . . . . 0.0 112.321 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 351' ' ' PHE . . . . . 0.677 ' HB3' HD22 ' A' ' 368' ' ' LEU . 94.6 m-85 -75.61 98.65 4.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.844 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -106.51 145.55 31.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.117 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 35.8 t -62.08 148.2 44.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.917 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 41.8 m -92.89 -31.87 14.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.131 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.577 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 55.7 t-105 -49.54 140.23 14.22 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.574 0.702 . . . . 0.0 110.951 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 356' ' ' PRO . . . . . 0.517 ' HD2' ' CG ' ' A' ' 355' ' ' TRP . 53.9 Cg_endo -69.78 140.71 43.28 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.676 2.25 . . . . 0.0 112.349 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 84.03 -41.53 2.99 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.474 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 44.9 t -63.28 150.9 42.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.888 0.375 . . . . 0.0 110.92 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -140.19 44.03 1.09 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.476 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 39.3 m95 -93.91 129.56 40.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.728 0.299 . . . . 0.0 110.946 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 361' ' ' ARG . . . . . 0.426 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 56.7 mtm180 -122.73 164.61 17.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.902 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 362' ' ' PHE . . . . . 0.469 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 11.3 m-85 -151.37 151.01 31.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.857 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 50.4 m -78.15 -25.8 47.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.871 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 78.1 mtt-85 -115.36 163.27 15.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.915 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 88.2 p -72.39 -53.47 12.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.851 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -50.23 -44.61 53.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.87 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -57.24 -34.4 68.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.864 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.677 HD22 ' HB3' ' A' ' 351' ' ' PHE . 6.5 tp -80.49 -44.38 19.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.915 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 14.9 m -57.87 -45.12 86.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.851 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -60.67 -28.27 68.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.839 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 16.8 t60 -76.7 -44.84 31.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.875 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 45.7 mmm-85 -45.43 -28.14 0.83 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.864 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -52.66 -44.57 66.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.878 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 39.2 m -46.69 -38.12 9.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.883 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 375' ' ' HIS . . . . . 0.577 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 38.3 m-70 . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.878 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 349' ' ' LYS . . . . . 0.43 ' HA ' ' HD2' ' A' ' 350' ' ' PRO . 64.1 mttt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 121.592 0.711 . . . . 0.0 110.871 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 350' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 349' ' ' LYS . 53.4 Cg_endo -69.76 -31.57 20.27 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.685 2.256 . . . . 0.0 112.317 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 351' ' ' PHE . . . . . 0.687 ' HB3' HD22 ' A' ' 368' ' ' LEU . 97.0 m-85 -71.74 100.48 2.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.872 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -108.47 132.92 53.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.121 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 353' ' ' CYS . . . . . 0.553 ' HA ' HD11 ' A' ' 368' ' ' LEU . 35.9 t -49.55 153.95 1.05 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.902 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 30.6 m -94.92 -34.55 12.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.191 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.555 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 46.9 t-105 -44.59 140.66 3.1 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.555 0.693 . . . . 0.0 110.932 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 356' ' ' PRO . . . . . 0.521 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 53.7 Cg_endo -69.72 140.07 41.91 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.671 2.247 . . . . 0.0 112.372 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 83.65 -41.97 3.0 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.463 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 34.9 t -58.81 149.69 25.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.936 0.398 . . . . 0.0 110.908 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -139.21 42.53 1.24 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.456 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 37.0 m95 -94.8 128.61 41.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.771 0.319 . . . . 0.0 110.874 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 361' ' ' ARG . . . . . 0.408 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 37.7 mtt180 -121.74 159.15 27.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.923 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 362' ' ' PHE . . . . . 0.434 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 4.8 m-85 -144.64 152.47 40.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.874 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 36.2 t -74.39 -34.57 63.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.874 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 36.3 mtt-85 -110.63 169.7 8.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.872 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 68.2 p -74.76 -57.4 3.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.893 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -47.34 -44.93 24.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.859 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -55.97 -32.67 64.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.906 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.687 HD22 ' HB3' ' A' ' 351' ' ' PHE . 12.5 tp -83.78 -42.72 16.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.913 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 14.8 t -58.66 -46.88 86.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.836 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 48.6 ptt85 -58.01 -29.29 65.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.849 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -74.34 -45.62 46.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.843 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 372' ' ' ARG . . . . . 0.416 ' NH1' ' HB3' ' A' ' 372' ' ' ARG . 4.6 mmm180 -42.98 -29.46 0.34 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.853 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 77.4 mtt180 -50.85 -45.5 59.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.846 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 3.2 m -44.56 -39.48 4.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.879 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 375' ' ' HIS . . . . . 0.555 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 48.2 m-70 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.848 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 349' ' ' LYS . . . . . 0.414 ' HB3' ' C ' ' A' ' 362' ' ' PHE . 47.7 mttm . . . . . 0 C--O 1.231 0.128 0 CA-C-O 121.555 0.693 . . . . 0.0 110.877 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 350' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 349' ' ' LYS . 53.7 Cg_endo -69.73 -26.29 27.88 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.705 2.27 . . . . 0.0 112.366 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 351' ' ' PHE . . . . . 0.651 ' HB3' HD22 ' A' ' 368' ' ' LEU . 89.4 m-85 -79.95 97.78 6.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.906 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 352' ' ' ALA . . . . . 0.457 ' CB ' ' HG2' ' A' ' 361' ' ' ARG . . . -110.17 144.0 39.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.12 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 43.5 t -60.13 144.68 49.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.881 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 62.3 p -93.94 -26.14 16.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.178 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.569 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 60.3 t-105 -49.87 139.82 16.4 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.571 0.7 . . . . 0.0 110.927 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 356' ' ' PRO . . . . . 0.525 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 54.1 Cg_endo -69.77 137.93 36.59 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.709 2.273 . . . . 0.0 112.321 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 84.53 -33.83 3.19 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.478 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 49.9 t -72.97 153.77 40.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.904 0.383 . . . . 0.0 110.881 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -143.71 48.55 0.74 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.456 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 39.2 m95 -97.93 128.66 44.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.8 0.333 . . . . 0.0 110.875 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 361' ' ' ARG . . . . . 0.507 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 58.1 mtm180 -121.72 164.21 17.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.905 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 362' ' ' PHE . . . . . 0.507 ' CD1' ' C ' ' A' ' 361' ' ' ARG . 4.5 m-85 -151.23 151.13 31.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.896 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 52.6 m -80.06 -19.43 47.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.896 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 5.5 mpt_? -122.94 162.14 22.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.851 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 9.8 t -70.17 -62.74 1.27 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.874 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -43.66 -41.21 4.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.851 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 367' ' ' GLU . . . . . 0.414 ' O ' ' CG ' ' A' ' 370' ' ' ARG . 24.2 mm-40 -59.29 -40.11 85.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.888 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.651 HD22 ' HB3' ' A' ' 351' ' ' PHE . 12.5 tp -77.06 -44.96 28.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.895 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 30.4 t -55.73 -44.67 77.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.846 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 370' ' ' ARG . . . . . 0.442 ' HG3' ' N ' ' A' ' 371' ' ' HIS . 9.6 ptt180 -59.32 -33.86 71.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.899 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 371' ' ' HIS . . . . . 0.442 ' N ' ' HG3' ' A' ' 370' ' ' ARG . 17.3 t60 -71.31 -46.69 60.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.9 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 372' ' ' ARG . . . . . 0.41 ' NH1' ' HB3' ' A' ' 372' ' ' ARG . 4.9 mmm180 -41.42 -30.13 0.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.838 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -49.67 -44.36 47.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.864 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 1.4 t -46.51 -33.44 4.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.881 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 375' ' ' HIS . . . . . 0.569 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 53.2 m-70 . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.884 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 349' ' ' LYS . . . . . 0.477 ' HB3' ' N ' ' A' ' 362' ' ' PHE . 36.9 mttp . . . . . 0 N--CA 1.457 -0.099 0 CA-C-O 121.574 0.702 . . . . 0.0 110.915 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 350' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 349' ' ' LYS . 54.0 Cg_endo -69.77 -32.2 18.99 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.696 2.264 . . . . 0.0 112.319 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 351' ' ' PHE . . . . . 0.636 ' HB3' HD22 ' A' ' 368' ' ' LEU . 98.3 m-85 -72.16 99.2 2.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.847 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -106.72 141.68 37.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.059 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 39.6 t -58.8 149.18 27.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.881 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 27.0 m -90.75 -33.19 15.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.138 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.573 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 56.2 t-105 -45.21 140.16 3.91 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.587 0.708 . . . . 0.0 110.865 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 356' ' ' PRO . . . . . 0.514 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 53.9 Cg_endo -69.74 142.37 47.84 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.713 2.275 . . . . 0.0 112.329 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 80.95 -37.99 2.36 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.491 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 49.7 t -63.12 154.52 30.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.827 0.346 . . . . 0.0 110.88 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -143.8 39.04 1.3 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.5 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 48.0 m95 -92.61 128.03 38.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.72 0.295 . . . . 0.0 110.899 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 361' ' ' ARG . . . . . 0.515 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 43.7 mtm180 -121.2 169.47 10.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.818 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 362' ' ' PHE . . . . . 0.515 ' CD1' ' C ' ' A' ' 361' ' ' ARG . 9.4 m-85 -154.48 153.51 31.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.876 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 27.2 t -75.83 -35.43 59.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.884 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -108.16 167.6 9.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.891 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 54.6 p -73.83 -55.51 6.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.836 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -48.58 -45.46 37.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.869 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -55.25 -33.72 63.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.884 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.636 HD22 ' HB3' ' A' ' 351' ' ' PHE . 6.8 tp -81.98 -45.41 15.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 27.0 t -56.35 -45.99 80.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.854 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 370' ' ' ARG . . . . . 0.44 ' HG3' ' N ' ' A' ' 371' ' ' HIS . 20.4 ptt180 -59.19 -31.96 69.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.88 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 371' ' ' HIS . . . . . 0.44 ' N ' ' HG3' ' A' ' 370' ' ' ARG . 17.7 t60 -73.75 -38.25 64.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.876 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 19.9 mmm-85 -52.0 -24.96 7.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 37.5 mtt85 -55.56 -43.35 75.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.902 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 32.7 t -48.51 -36.02 14.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.89 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 375' ' ' HIS . . . . . 0.573 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 58.6 m-70 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.871 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 349' ' ' LYS . . . . . 0.46 ' HB3' ' N ' ' A' ' 362' ' ' PHE . 46.2 mttm . . . . . 0 C--O 1.231 0.109 0 CA-C-O 121.564 0.697 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 350' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 349' ' ' LYS . 53.4 Cg_endo -69.79 -30.57 21.91 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.659 2.239 . . . . 0.0 112.298 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 351' ' ' PHE . . . . . 0.745 ' HB3' HD22 ' A' ' 368' ' ' LEU . 95.0 m-85 -74.25 95.68 2.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.883 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 352' ' ' ALA . . . . . 0.522 ' HB2' ' HD3' ' A' ' 361' ' ' ARG . . . -103.97 135.58 45.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.089 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 43.5 t -51.77 150.88 3.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.92 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 70.2 p -95.55 -30.69 13.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.147 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.566 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 55.0 t-105 -46.08 140.21 5.14 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.574 0.702 . . . . 0.0 110.895 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 356' ' ' PRO . . . . . 0.513 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 53.9 Cg_endo -69.73 133.8 26.51 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.681 2.254 . . . . 0.0 112.345 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 88.88 -37.75 3.28 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.528 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 46.8 t -64.78 151.86 44.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.917 0.389 . . . . 0.0 110.846 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -141.5 43.1 1.11 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.482 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 37.9 m95 -95.92 129.16 43.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.778 0.323 . . . . 0.0 110.917 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 361' ' ' ARG . . . . . 0.522 ' HD3' ' HB2' ' A' ' 352' ' ' ALA . 25.7 mtt180 -121.51 161.01 23.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.828 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 362' ' ' PHE . . . . . 0.49 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 10.2 m-85 -145.91 153.18 40.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.845 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 45.2 t -78.3 -29.84 48.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.819 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.14 165.78 11.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.848 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 36.1 t -73.89 -47.61 36.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.852 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -56.36 -46.89 79.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.876 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -54.26 -31.43 53.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.844 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.745 HD22 ' HB3' ' A' ' 351' ' ' PHE . 8.4 tp -83.8 -44.03 14.79 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.948 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 5.5 t -57.7 -47.04 83.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.836 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 25.8 ptt180 -57.93 -33.12 68.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.877 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 22.3 t60 -72.32 -43.92 63.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.875 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 372' ' ' ARG . . . . . 0.412 ' NH1' ' HB3' ' A' ' 372' ' ' ARG . 4.9 mmm180 -44.68 -28.54 0.63 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.906 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 373' ' ' ARG . . . . . 0.432 ' NH1' ' HB3' ' A' ' 373' ' ' ARG . 10.3 mtp-105 -55.39 -42.79 74.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 58.4 m -47.28 -31.43 3.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.863 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 375' ' ' HIS . . . . . 0.566 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 61.8 m-70 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.866 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 349' ' ' LYS . . . . . 0.432 ' NZ ' ' HB2' ' A' ' 361' ' ' ARG . 7.6 mtmp? . . . . . 0 C--O 1.231 0.09 0 CA-C-O 121.584 0.706 . . . . 0.0 110.899 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -28.18 25.6 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.705 2.27 . . . . 0.0 112.316 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 351' ' ' PHE . . . . . 0.601 ' HB3' HD22 ' A' ' 368' ' ' LEU . 84.1 m-85 -76.52 102.26 5.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.871 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -115.8 137.59 51.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.088 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 43.2 t -55.59 146.5 20.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.85 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 93.5 m -93.14 -29.05 15.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.154 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.552 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 59.0 t-105 -47.79 139.91 8.71 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.566 0.698 . . . . 0.0 110.932 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 356' ' ' PRO . . . . . 0.523 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 53.8 Cg_endo -69.8 140.97 43.81 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.707 2.271 . . . . 0.0 112.283 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 81.94 -36.87 2.51 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.503 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 47.2 t -68.29 151.51 46.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.853 0.358 . . . . 0.0 110.922 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -140.61 45.33 0.99 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.513 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 39.3 m95 -94.24 128.65 40.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.794 0.33 . . . . 0.0 110.913 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 361' ' ' ARG . . . . . 0.455 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 18.2 mtt85 -122.61 165.33 16.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.843 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 362' ' ' PHE . . . . . 0.534 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 11.3 m-85 -152.72 151.2 30.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 49.9 m -77.04 -33.41 57.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.855 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -104.67 171.65 7.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.833 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 365' ' ' SER . . . . . 0.57 ' HA ' ' CD1' ' A' ' 351' ' ' PHE . 80.7 p -81.13 -55.64 4.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.865 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.62 -34.59 59.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.853 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -62.75 -34.58 77.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.881 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.601 HD22 ' HB3' ' A' ' 351' ' ' PHE . 9.4 tp -81.01 -45.58 16.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.943 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 58.7 m -56.02 -43.7 78.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.877 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -60.17 -28.9 68.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.855 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -76.44 -43.55 39.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.852 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 22.0 mmm-85 -45.97 -27.14 0.84 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.895 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 25.8 mtp85 -51.13 -46.01 61.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.847 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 58.3 m -46.42 -35.29 5.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.841 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 375' ' ' HIS . . . . . 0.552 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 66.3 m-70 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.861 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 349' ' ' LYS . . . . . 0.421 ' HA ' ' HD2' ' A' ' 350' ' ' PRO . 56.6 mttt . . . . . 0 C--O 1.232 0.14 0 CA-C-O 121.559 0.695 . . . . 0.0 110.892 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 350' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 349' ' ' LYS . 54.3 Cg_endo -69.82 -29.4 23.64 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.721 2.28 . . . . 0.0 112.342 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 351' ' ' PHE . . . . . 0.732 ' HB3' HD22 ' A' ' 368' ' ' LEU . 94.4 m-85 -74.98 100.45 4.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.878 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -107.33 150.49 26.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.067 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 41.0 t -68.06 144.12 55.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.891 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 89.4 m -89.09 -28.69 19.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.139 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.578 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 57.8 t-105 -49.87 140.03 16.12 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.51 0.672 . . . . 0.0 110.931 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 356' ' ' PRO . . . . . 0.524 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 53.8 Cg_endo -69.72 138.64 38.41 Favored 'Trans proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.716 2.278 . . . . 0.0 112.358 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 84.34 -39.87 2.92 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.527 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 44.8 t -63.9 155.18 31.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.868 0.366 . . . . 0.0 110.896 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -145.3 45.21 0.84 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.494 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 32.7 m95 -96.13 128.69 43.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.745 0.307 . . . . 0.0 110.957 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 361' ' ' ARG . . . . . 0.519 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 56.6 mtm-85 -120.77 167.14 12.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.848 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 362' ' ' PHE . . . . . 0.519 ' CD1' ' C ' ' A' ' 361' ' ' ARG . 8.2 m-85 -153.2 146.94 25.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.876 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 29.0 t -70.96 -34.01 71.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.868 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 364' ' ' ARG . . . . . 0.456 ' N ' ' HD2' ' A' ' 364' ' ' ARG . 0.0 OUTLIER -109.66 174.0 6.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.855 -179.913 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 7.1 m -79.6 -57.95 3.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -46.59 -39.44 11.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.859 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 -62.43 -31.64 72.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.864 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.732 HD22 ' HB3' ' A' ' 351' ' ' PHE . 9.1 tp -84.92 -45.91 11.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.898 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 37.1 t -56.43 -46.66 80.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.858 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -58.56 -31.91 68.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.867 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 13.4 t60 -70.87 -46.35 62.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.855 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 54.6 mmm-85 -44.09 -29.08 0.56 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.851 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 62.3 mtt-85 -48.74 -45.92 40.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 36.8 t -47.65 -35.78 9.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.875 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 375' ' ' HIS . . . . . 0.578 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 46.4 m-70 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.869 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? . . . . . 0 C--O 1.231 0.084 0 CA-C-O 121.597 0.713 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -29.82 23.1 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.683 2.255 . . . . 0.0 112.334 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 351' ' ' PHE . . . . . 0.564 ' CD1' ' HA ' ' A' ' 365' ' ' SER . 94.8 m-85 -74.43 95.5 2.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -109.58 139.65 44.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.11 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 53.3 t -58.85 145.07 42.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.865 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 49.9 m -93.11 -27.94 16.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.138 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.526 ' CD2' ' HD2' ' A' ' 356' ' ' PRO . 61.3 t-105 -47.93 139.69 9.22 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.521 0.677 . . . . 0.0 110.918 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 356' ' ' PRO . . . . . 0.526 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 54.0 Cg_endo -69.76 137.62 35.87 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.69 2.26 . . . . 0.0 112.325 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 84.49 -39.94 2.94 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.476 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 41.8 t -62.77 154.64 29.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.884 0.373 . . . . 0.0 110.843 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -142.57 47.71 0.81 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.513 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 31.6 m95 -97.68 132.81 42.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.754 0.311 . . . . 0.0 110.919 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 361' ' ' ARG . . . . . 0.485 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 30.1 mtt180 -128.51 163.23 25.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.875 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 362' ' ' PHE . . . . . 0.551 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 5.6 m-85 -151.94 152.77 32.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 50.7 m -79.06 -27.36 43.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.866 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 364' ' ' ARG . . . . . 0.501 ' C ' ' CD2' ' A' ' 351' ' ' PHE . 66.6 mtt180 -113.27 168.44 9.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.822 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 365' ' ' SER . . . . . 0.564 ' HA ' ' CD1' ' A' ' 351' ' ' PHE . 31.2 t -74.65 -62.85 1.39 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.865 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -44.38 -38.59 4.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.911 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -58.97 -41.79 88.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.885 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.551 ' HA ' ' CD1' ' A' ' 362' ' ' PHE . 6.5 tp -76.0 -45.19 35.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 27.4 t -55.86 -49.45 73.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.868 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 25.8 ptt85 -56.05 -28.24 56.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.887 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 20.0 t60 -79.11 -41.85 27.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.852 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 22.0 mmm-85 -48.99 -24.7 1.61 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.849 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 -55.9 -44.16 77.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.936 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 39.5 t -46.64 -34.75 5.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.855 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 375' ' ' HIS . . . . . 0.479 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 48.5 m-70 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.852 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 349' ' ' LYS . . . . . 0.468 ' HB3' ' N ' ' A' ' 362' ' ' PHE . 74.4 mttt . . . . . 0 C--O 1.231 0.104 0 CA-C-O 121.548 0.69 . . . . 0.0 110.873 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -36.61 10.62 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.677 2.251 . . . . 0.0 112.408 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 351' ' ' PHE . . . . . 0.622 ' HB3' HD22 ' A' ' 368' ' ' LEU . 86.2 m-85 -67.57 98.28 0.67 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.907 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -107.45 138.83 42.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.07 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 45.3 t -55.35 132.65 48.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.885 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 28.0 m -79.93 -18.86 49.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.125 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.56 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 58.7 t-105 -55.8 139.9 68.92 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.588 0.709 . . . . 0.0 110.949 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 356' ' ' PRO . . . . . 0.525 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 54.1 Cg_endo -69.7 137.73 36.33 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.711 2.274 . . . . 0.0 112.367 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 83.77 -37.29 2.81 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.498 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 47.0 t -65.13 153.81 39.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.859 0.362 . . . . 0.0 110.923 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -142.45 44.73 0.96 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.485 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 43.3 m95 -97.98 130.67 44.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.791 0.329 . . . . 0.0 110.926 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 361' ' ' ARG . . . . . . . . . . . . . 30.7 mtt180 -122.23 163.34 19.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.861 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 362' ' ' PHE . . . . . 0.529 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 23.5 m-85 -148.81 148.93 30.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.896 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 34.4 p -72.13 -35.48 69.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.841 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 64.3 mtt180 -112.9 165.58 12.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.886 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 365' ' ' SER . . . . . 0.446 ' HB2' ' CE2' ' A' ' 351' ' ' PHE . 26.3 t -71.54 -52.7 16.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.909 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -51.02 -31.37 18.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.894 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -71.25 -29.2 64.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.874 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.622 HD22 ' HB3' ' A' ' 351' ' ' PHE . 10.4 tp -86.71 -47.16 9.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.924 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 22.1 t -54.43 -43.5 71.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.836 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -59.69 -35.42 74.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.87 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 22.8 t60 -70.84 -41.77 71.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.883 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -45.96 -27.64 0.95 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.881 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 373' ' ' ARG . . . . . 0.428 ' NH1' ' HB3' ' A' ' 373' ' ' ARG . 10.1 mtp-105 -53.45 -43.86 68.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.892 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 28.5 t -49.91 -33.47 17.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.863 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 375' ' ' HIS . . . . . 0.56 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 78.3 m-70 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.87 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 349' ' ' LYS . . . . . 0.41 ' HA ' ' HD2' ' A' ' 350' ' ' PRO . 53.0 mttp . . . . . 0 C--O 1.23 0.078 0 CA-C-O 121.565 0.697 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 350' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 349' ' ' LYS . 53.4 Cg_endo -69.74 -25.17 28.97 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.66 2.24 . . . . 0.0 112.335 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 351' ' ' PHE . . . . . 0.558 ' HB3' HD22 ' A' ' 368' ' ' LEU . 84.5 m-85 -80.35 92.88 5.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.912 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -104.09 139.09 39.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.104 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 353' ' ' CYS . . . . . 0.44 ' HA ' HD11 ' A' ' 368' ' ' LEU . 50.2 t -53.28 148.68 8.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.836 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 82.6 p -94.83 -26.55 16.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.111 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.566 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 49.8 t-105 -52.47 140.58 35.73 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.62 0.724 . . . . 0.0 110.924 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 356' ' ' PRO . . . . . 0.512 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 53.3 Cg_endo -69.78 138.94 38.95 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.652 2.235 . . . . 0.0 112.341 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 84.22 -37.82 2.87 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.52 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 49.1 t -63.49 155.64 28.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.927 0.394 . . . . 0.0 110.862 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -142.58 37.91 1.49 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.519 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 42.7 m95 -92.19 128.97 38.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.758 0.313 . . . . 0.0 110.899 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 361' ' ' ARG . . . . . 0.487 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 56.6 mtt180 -124.34 165.01 18.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.926 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 362' ' ' PHE . . . . . 0.487 ' CD1' ' C ' ' A' ' 361' ' ' ARG . 7.6 m-85 -149.98 152.11 34.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.86 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 49.9 m -77.9 -22.85 49.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.867 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -118.72 165.99 13.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.832 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 365' ' ' SER . . . . . 0.492 ' HA ' ' CD1' ' A' ' 351' ' ' PHE . 1.3 t -74.17 -55.76 5.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.836 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -49.36 -45.97 46.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.868 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -54.58 -35.91 63.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.861 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.558 HD22 ' HB3' ' A' ' 351' ' ' PHE . 14.3 tp -79.64 -42.55 24.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 44.7 t -57.8 -49.16 77.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.848 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -56.15 -31.61 63.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.868 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 20.1 t60 -73.15 -46.29 51.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.862 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 372' ' ' ARG . . . . . 0.421 ' NH1' ' HB3' ' A' ' 372' ' ' ARG . 5.6 mmm180 -41.34 -29.98 0.16 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.905 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 84.5 mtt180 -51.08 -46.66 61.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.878 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 85.3 p -43.56 -38.18 2.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 375' ' ' HIS . . . . . 0.566 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 39.0 m-70 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.858 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 339' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 54.3 m -112.27 -53.52 2.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.838 0.351 . . . . 0.0 110.849 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 2.0 t -61.68 122.35 15.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.833 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . -89.24 -159.46 35.41 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.534 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 59.5 p -112.7 126.77 55.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.882 0.372 . . . . 0.0 110.868 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 15.4 t -128.59 -46.59 1.3 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.872 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -62.11 -63.44 4.74 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.488 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 73.9 p -107.57 158.47 17.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.823 0.344 . . . . 0.0 111.179 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 150.24 71.31 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.451 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -157.54 119.5 3.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.91 0.386 . . . . 0.0 110.896 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 349' ' ' LYS . . . . . 0.412 ' HB3' ' C ' ' A' ' 362' ' ' PHE . 37.7 mttt -134.81 92.93 18.44 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.599 0.714 . . . . 0.0 110.943 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 350' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 349' ' ' LYS . 54.0 Cg_endo -69.77 -25.64 28.33 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.698 2.265 . . . . 0.0 112.323 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 351' ' ' PHE . . . . . 0.688 ' HB3' HD22 ' A' ' 368' ' ' LEU . 90.0 m-85 -79.88 96.46 6.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.898 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -106.63 131.58 53.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.074 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 42.5 t -48.38 150.7 1.23 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.87 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 47.9 p -95.85 -30.68 13.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.153 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.577 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 44.7 t-105 -47.45 140.82 7.25 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.518 0.675 . . . . 0.0 110.918 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 356' ' ' PRO . . . . . 0.532 ' O ' ' CD1' ' A' ' 355' ' ' TRP . 54.0 Cg_endo -69.73 141.18 44.64 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.682 2.255 . . . . 0.0 112.375 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 81.88 -36.05 2.51 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.467 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 49.4 t -65.97 150.77 48.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.866 0.365 . . . . 0.0 110.874 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -142.37 46.15 0.89 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.476 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 44.0 m95 -99.06 128.86 45.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.746 0.308 . . . . 0.0 110.959 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 361' ' ' ARG . . . . . . . . . . . . . 29.6 mtt180 -120.64 156.55 31.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.87 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 362' ' ' PHE . . . . . 0.529 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 23.2 m-85 -140.92 147.02 38.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.932 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 74.3 m -76.23 -22.11 55.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.864 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -118.27 161.62 19.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.846 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 85.8 p -70.95 -56.15 6.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.88 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -49.71 -40.61 41.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.903 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -59.62 -33.14 71.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.856 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.688 HD22 ' HB3' ' A' ' 351' ' ' PHE . 8.4 tp -81.6 -42.56 19.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.927 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 42.8 t -60.1 -46.7 88.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.831 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -59.86 -30.88 69.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.883 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 371' ' ' HIS . . . . . 0.412 ' CB ' ' CZ ' ' A' ' 362' ' ' PHE . 20.0 t60 -73.94 -48.5 30.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.85 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 27.0 mmm-85 -41.44 -29.5 0.16 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.864 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 73.0 mtt180 -52.91 -45.69 67.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.883 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 61.9 m -44.36 -34.01 1.84 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.843 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 375' ' ' HIS . . . . . 0.577 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 57.3 m-70 -94.75 165.39 12.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.873 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 59.2 p -97.11 109.32 22.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.876 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -152.93 156.72 26.88 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.505 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 95.5 t -50.81 119.97 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.923 0.392 . . . . 0.0 111.095 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 379' ' ' LYS . . . . . . . . . . . . . 10.5 pttm -95.26 146.44 31.31 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.554 0.692 . . . . 0.0 110.896 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -3.41 11.97 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.695 2.263 . . . . 0.0 112.382 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 84.7 p -112.39 172.35 6.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.845 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -153.6 -92.73 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.512 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 383' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -17.0 37.86 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.727 2.284 . . . . 0.0 112.307 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 28.3 m -156.55 153.49 28.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.9 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 8.7 t -158.78 151.17 21.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.875 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.472 -179.975 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 339' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.29 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 5.0 m -125.8 147.53 49.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.879 0.371 . . . . 0.0 110.868 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 23.5 m -116.37 114.73 24.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.887 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 97.33 88.05 1.85 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.48 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 18.7 m -80.58 146.23 31.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.88 0.371 . . . . 0.0 110.861 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 3.0 m -80.66 139.14 36.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.892 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -104.19 -94.33 2.32 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.521 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 4.1 t -67.73 -18.12 64.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.846 0.355 . . . . 0.0 111.184 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 112.97 -123.27 6.15 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.508 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 -128.83 157.67 40.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.884 0.373 . . . . 0.0 110.927 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 349' ' ' LYS . . . . . 0.475 ' HB3' ' N ' ' A' ' 362' ' ' PHE . 53.3 mttm -104.55 93.45 5.97 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.527 0.68 . . . . 0.0 110.858 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 350' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 349' ' ' LYS . 53.6 Cg_endo -69.76 -34.94 13.55 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.716 2.277 . . . . 0.0 112.349 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 351' ' ' PHE . . . . . 0.717 ' HB3' HD22 ' A' ' 368' ' ' LEU . 97.7 m-85 -68.2 103.25 1.52 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.868 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -107.66 129.59 55.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.082 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 353' ' ' CYS . . . . . 0.455 ' HA ' HD11 ' A' ' 368' ' ' LEU . 40.5 t -47.41 146.12 2.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.889 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 58.5 m -91.37 -32.14 15.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.16 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.522 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 46.7 t-105 -47.13 140.72 6.51 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.593 0.711 . . . . 0.0 110.915 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 356' ' ' PRO . . . . . 0.517 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 53.8 Cg_endo -69.77 139.46 40.26 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.636 2.224 . . . . 0.0 112.367 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 83.39 -41.13 2.89 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.552 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 36.1 t -61.39 150.14 36.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.928 0.394 . . . . 0.0 110.839 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -139.78 45.16 1.02 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.532 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 25.2 m95 -97.68 130.99 44.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.758 0.313 . . . . 0.0 110.896 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 361' ' ' ARG . . . . . 0.421 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 67.5 mtt180 -121.49 165.66 15.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.867 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 362' ' ' PHE . . . . . 0.475 ' N ' ' HB3' ' A' ' 349' ' ' LYS . 14.5 m-85 -150.83 156.43 41.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.853 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 15.3 t -78.92 -37.46 39.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.872 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -106.91 161.25 14.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.894 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 365' ' ' SER . . . . . 0.538 ' HB3' ' CE1' ' A' ' 351' ' ' PHE . 54.4 p -71.3 -38.1 71.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.879 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -62.51 -45.62 92.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.89 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -55.51 -34.48 64.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.873 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.717 HD22 ' HB3' ' A' ' 351' ' ' PHE . 9.0 tp -79.25 -42.96 24.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.902 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 18.3 t -58.13 -44.9 88.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.809 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 370' ' ' ARG . . . . . 0.411 ' HG3' ' N ' ' A' ' 371' ' ' HIS . 29.6 ptt85 -61.82 -30.46 70.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.848 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 371' ' ' HIS . . . . . 0.411 ' N ' ' HG3' ' A' ' 370' ' ' ARG . 22.5 t60 -74.4 -39.0 62.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.863 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 26.3 mmm-85 -51.31 -25.1 5.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.863 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 28.8 mtt85 -57.56 -40.87 79.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 58.0 m -50.35 -30.87 13.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.879 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 375' ' ' HIS . . . . . 0.522 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 68.5 m-70 -94.75 169.13 10.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.848 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 36.9 p -93.28 49.11 1.37 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.861 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -72.24 130.19 15.79 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.481 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 34.8 m -83.9 143.63 11.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.928 0.394 . . . . 0.0 111.064 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 379' ' ' LYS . . . . . . . . . . . . . 25.6 mmtp -116.68 153.14 49.08 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.542 0.686 . . . . 0.0 110.885 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 158.71 55.99 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.661 2.241 . . . . 0.0 112.338 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 49.1 m 47.34 38.87 7.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.853 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 168.29 83.19 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.536 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 383' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 174.77 9.04 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.636 2.224 . . . . 0.0 112.401 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 52.7 p -134.37 154.97 51.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.86 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 22.4 p -75.45 -56.15 4.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.853 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.477 -179.964 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 339' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.521 -0.232 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 67.7 m -74.63 97.35 3.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.89 0.376 . . . . 0.0 110.861 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 28.8 t -172.2 115.24 0.33 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.889 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . -143.8 89.61 0.17 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.488 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 1.9 m -127.26 160.19 32.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.917 0.389 . . . . 0.0 110.809 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 78.7 p -101.12 41.95 1.15 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.866 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -86.59 156.62 29.26 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.483 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 8.8 t -163.41 153.98 16.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.819 0.343 . . . . 0.0 111.165 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 131.9 -122.59 3.4 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.461 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -155.98 143.19 19.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.94 0.4 . . . . 0.0 110.867 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 349' ' ' LYS . . . . . 0.424 ' HA ' ' HD2' ' A' ' 350' ' ' PRO . 79.4 mttt -104.39 93.37 5.72 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.6 0.714 . . . . 0.0 110.901 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 350' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 349' ' ' LYS . 53.8 Cg_endo -69.75 -31.23 20.96 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.69 2.26 . . . . 0.0 112.355 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 351' ' ' PHE . . . . . 0.594 ' HB3' HD22 ' A' ' 368' ' ' LEU . 95.4 m-85 -73.53 97.12 2.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.896 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -108.39 143.85 36.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.043 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 51.5 t -59.94 147.95 36.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.868 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 57.7 m -90.64 -29.25 17.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.157 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.575 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 52.8 t-105 -48.23 140.36 9.56 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.547 0.689 . . . . 0.0 110.92 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 356' ' ' PRO . . . . . 0.509 ' HD2' ' CG ' ' A' ' 355' ' ' TRP . 54.2 Cg_endo -69.77 140.45 42.65 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.715 2.276 . . . . 0.0 112.342 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 83.05 -36.94 2.7 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.475 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 42.4 t -64.55 152.71 41.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.884 0.373 . . . . 0.0 110.857 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -141.92 38.9 1.44 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.477 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 30.4 m95 -91.46 127.89 37.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.713 0.292 . . . . 0.0 110.916 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 361' ' ' ARG . . . . . 0.441 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 33.2 mtt180 -123.19 161.36 24.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.861 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 362' ' ' PHE . . . . . 0.441 ' CD1' ' C ' ' A' ' 361' ' ' ARG . 4.7 m-85 -147.67 153.38 39.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 33.8 t -75.8 -34.94 60.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.837 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -108.74 168.37 9.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 74.0 p -75.24 -56.82 4.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.868 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -46.46 -41.47 13.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.856 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -60.33 -35.02 74.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.863 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.594 HD22 ' HB3' ' A' ' 351' ' ' PHE . 11.7 tp -80.71 -44.17 19.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.922 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 14.7 t -57.87 -46.43 84.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.857 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -58.85 -27.96 65.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.884 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 19.8 t60 -76.99 -46.46 23.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.864 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 41.0 mmm-85 -43.55 -28.83 0.41 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.883 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 79.1 mtt180 -50.51 -45.36 56.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.848 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 1.3 t -44.73 -39.59 5.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.846 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 375' ' ' HIS . . . . . 0.575 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 42.8 m-70 -92.27 154.89 18.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.871 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 2.3 m -82.25 -50.57 8.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.818 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 118.91 133.01 4.61 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.505 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 378' ' ' VAL . . . . . 0.631 ' O ' HG23 ' A' ' 378' ' ' VAL . 34.4 m -110.33 108.54 25.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.908 0.385 . . . . 0.0 111.115 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 379' ' ' LYS . . . . . . . . . . . . . 17.1 mmmt -139.34 153.67 71.13 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.587 0.708 . . . . 0.0 110.883 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -7.84 22.08 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.669 2.246 . . . . 0.0 112.336 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 94.4 p -52.15 -48.35 64.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.927 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 39.99 68.55 0.54 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.472 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 383' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 148.7 65.5 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.696 2.264 . . . . 0.0 112.35 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 21.9 p -67.67 -60.12 2.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.875 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 71.9 p -128.4 152.55 48.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.893 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.477 -179.991 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 339' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.489 -0.245 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 95.1 p -112.7 151.85 29.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.843 0.354 . . . . 0.0 110.848 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 73.9 p -138.45 162.7 33.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.844 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 99.36 44.96 2.25 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.473 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 4.5 m -142.58 147.26 35.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.848 0.356 . . . . 0.0 110.868 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 76.2 p -128.71 134.91 48.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.867 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 119.52 85.54 0.95 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.489 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 74.6 p -103.87 -42.78 5.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.848 0.356 . . . . 0.0 111.167 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 134.52 140.12 4.22 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.508 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -106.3 139.8 40.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.906 0.384 . . . . 0.0 110.883 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 349' ' ' LYS . . . . . 0.424 ' HA ' ' HD2' ' A' ' 350' ' ' PRO . 79.3 mttt -104.73 93.44 6.13 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.539 0.685 . . . . 0.0 110.938 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 350' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 349' ' ' LYS . 53.3 Cg_endo -69.74 -30.55 22.18 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.701 2.267 . . . . 0.0 112.319 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 351' ' ' PHE . . . . . 0.669 ' HB3' HD22 ' A' ' 368' ' ' LEU . 99.0 m-85 -73.24 99.65 2.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -106.76 138.09 43.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.106 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 353' ' ' CYS . . . . . 0.419 ' HA ' HD11 ' A' ' 368' ' ' LEU . 42.0 t -54.11 151.96 6.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.868 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 61.4 p -94.5 -31.83 13.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.151 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.562 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 52.8 t-105 -49.2 140.46 12.39 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.566 0.698 . . . . 0.0 110.909 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 356' ' ' PRO . . . . . 0.514 ' HD2' ' CG ' ' A' ' 355' ' ' TRP . 53.6 Cg_endo -69.78 140.27 42.19 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.682 2.255 . . . . 0.0 112.358 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 83.71 -42.5 3.05 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.497 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 49.6 t -59.34 151.12 24.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.87 0.367 . . . . 0.0 110.91 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -139.02 41.64 1.33 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.47 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 23.1 m95 -93.23 128.1 39.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.81 0.338 . . . . 0.0 110.92 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 361' ' ' ARG . . . . . 0.408 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 65.7 mtt180 -123.21 162.97 21.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.923 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 362' ' ' PHE . . . . . 0.489 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 11.0 m-85 -149.34 154.56 39.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.883 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 30.6 t -76.6 -35.43 58.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.917 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -108.36 170.99 7.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.877 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 12.6 t -76.06 -57.08 4.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.885 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -46.6 -46.18 19.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.879 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 367' ' ' GLU . . . . . 0.422 ' HA ' ' NE ' ' A' ' 370' ' ' ARG . 5.4 mm-40 -54.89 -34.01 62.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.928 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.669 HD22 ' HB3' ' A' ' 351' ' ' PHE . 13.1 tp -82.42 -42.34 18.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.897 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 46.0 m -60.1 -43.65 95.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.845 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 370' ' ' ARG . . . . . 0.422 ' NE ' ' HA ' ' A' ' 367' ' ' GLU . 19.6 ptp180 -61.97 -28.6 69.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.855 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 19.9 t60 -76.9 -44.16 32.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.889 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 28.7 mmm-85 -45.8 -27.63 0.89 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.85 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 48.8 mtm180 -51.66 -45.89 63.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.874 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 14.4 t -45.73 -36.59 5.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.869 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 375' ' ' HIS . . . . . 0.562 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 39.1 m-70 -93.69 157.71 16.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.829 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 7.5 t -93.82 95.23 8.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.898 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -93.14 -157.04 33.2 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.462 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 378' ' ' VAL . . . . . 0.462 ' O ' HG23 ' A' ' 378' ' ' VAL . 35.9 m -127.78 122.66 59.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.861 0.363 . . . . 0.0 111.144 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 379' ' ' LYS . . . . . . . . . . . . . 28.8 mmtm -106.78 144.33 28.84 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.538 0.685 . . . . 0.0 110.886 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 -11.89 31.87 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.67 2.247 . . . . 0.0 112.381 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 66.2 m -78.71 -51.49 9.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.83 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 144.96 149.55 5.05 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.503 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 383' ' ' PRO . . . . . 0.44 ' O ' ' C ' ' A' ' 384' ' ' SER . 53.6 Cg_endo -69.75 0.85 5.03 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.686 2.257 . . . . 0.0 112.329 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 384' ' ' SER . . . . . 0.44 ' C ' ' O ' ' A' ' 383' ' ' PRO . 74.1 p -34.58 113.95 0.2 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.875 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 4.1 m -164.46 161.13 21.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.844 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.263 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.465 -179.995 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 339' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.474 -0.25 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 49.6 m -146.3 156.91 43.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.889 0.376 . . . . 0.0 110.852 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 28.9 t -95.17 144.83 25.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.831 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . -125.93 -76.42 0.25 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.486 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 17.3 m -61.92 164.05 6.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.877 0.37 . . . . 0.0 110.826 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 39.2 t -132.81 121.7 23.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.887 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 37.07 58.7 1.22 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.507 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 62.1 p -55.52 -52.94 62.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.868 0.366 . . . . 0.0 111.153 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 171.14 119.4 0.51 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.486 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -59.06 159.61 7.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.889 0.376 . . . . 0.0 110.902 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 349' ' ' LYS . . . . . 0.455 ' HB3' ' N ' ' A' ' 362' ' ' PHE . 40.1 mttm -104.53 93.54 6.06 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.572 0.701 . . . . 0.0 110.859 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 350' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 349' ' ' LYS . 53.6 Cg_endo -69.8 -36.36 10.86 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.693 2.262 . . . . 0.0 112.364 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 351' ' ' PHE . . . . . 0.552 ' HB3' HD22 ' A' ' 368' ' ' LEU . 97.0 m-85 -68.47 98.96 0.9 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.832 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -107.95 136.8 47.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.118 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 353' ' ' CYS . . . . . 0.607 ' HA ' HD11 ' A' ' 368' ' ' LEU . 45.0 t -50.76 151.45 2.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.91 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 76.9 m -93.79 -33.76 13.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.151 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.566 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 50.8 t-105 -45.12 140.42 3.69 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.605 0.717 . . . . 0.0 110.916 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 356' ' ' PRO . . . . . 0.505 ' HD2' ' CG ' ' A' ' 355' ' ' TRP . 53.4 Cg_endo -69.81 140.48 42.61 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.666 2.244 . . . . 0.0 112.347 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 83.49 -39.62 2.81 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.51 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 45.9 t -61.48 152.35 30.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.886 0.374 . . . . 0.0 110.881 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -140.55 41.67 1.26 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.524 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 29.3 m95 -94.08 129.29 40.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.765 0.317 . . . . 0.0 110.888 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 361' ' ' ARG . . . . . 0.424 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 32.3 mtt180 -122.91 164.33 18.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.879 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 362' ' ' PHE . . . . . 0.509 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 10.7 m-85 -150.69 155.36 39.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.938 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 28.7 t -77.21 -36.58 54.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.912 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 69.9 mtt180 -108.73 161.53 15.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.91 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 82.7 p -67.74 -52.71 34.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.05 -40.22 57.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.867 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -60.68 -30.35 69.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.88 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.607 HD11 ' HA ' ' A' ' 353' ' ' CYS . 10.4 tp -85.73 -44.47 12.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.91 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 23.2 t -57.61 -46.42 84.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.847 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -57.84 -34.42 69.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.873 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 27.0 t60 -69.58 -47.49 63.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.823 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 45.0 mmm-85 -41.21 -30.29 0.16 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 47.5 mtm180 -48.21 -46.98 35.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.844 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 93.0 p -44.83 -41.52 7.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.888 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 375' ' ' HIS . . . . . 0.566 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 49.1 m-70 -89.09 158.25 18.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.906 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 3.5 m -97.43 127.0 43.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.854 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -118.42 152.9 17.28 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.469 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 6.8 m -70.42 128.37 33.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.925 0.393 . . . . 0.0 111.149 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 379' ' ' LYS . . . . . . . . . . . . . 30.6 mtmm -134.78 143.94 48.47 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.568 0.699 . . . . 0.0 110.927 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.67 -16.31 37.87 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.723 2.282 . . . . 0.0 112.357 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 1.1 t -103.56 109.18 20.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.844 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -166.76 75.95 0.13 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.497 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 383' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 -49.86 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.707 2.271 . . . . 0.0 112.335 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 5.4 t -88.62 41.63 1.03 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.871 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 3.5 m -161.5 143.5 11.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.871 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.479 -179.947 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 339' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 3.4 m -124.7 96.17 4.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.896 0.379 . . . . 0.0 110.874 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 73.4 m -65.02 159.64 22.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.876 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . -117.97 137.25 12.97 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.499 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 17.2 m -72.84 96.83 2.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.868 0.366 . . . . 0.0 110.87 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 21.3 m -62.64 174.75 0.93 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.835 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 71.01 156.5 2.09 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.446 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 23.8 p -139.48 110.51 6.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.845 0.355 . . . . 0.0 111.156 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -138.56 168.58 24.65 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.487 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -139.8 154.38 47.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.935 0.398 . . . . 0.0 110.878 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 349' ' ' LYS . . . . . 0.417 ' HB3' ' N ' ' A' ' 362' ' ' PHE . 39.4 mttp -133.88 93.26 20.83 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.559 0.695 . . . . 0.0 110.896 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -32.62 18.23 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.668 2.245 . . . . 0.0 112.349 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 351' ' ' PHE . . . . . 0.671 ' HB3' HD22 ' A' ' 368' ' ' LEU . 79.6 m-85 -70.1 98.09 1.27 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -105.56 132.84 51.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.11 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 40.6 t -51.25 144.81 8.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.903 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 86.8 m -86.85 -33.25 19.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.114 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.578 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 60.5 t-105 -43.91 139.81 2.84 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.57 0.7 . . . . 0.0 110.891 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 356' ' ' PRO . . . . . 0.524 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 53.9 Cg_endo -69.75 138.69 38.46 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.661 2.24 . . . . 0.0 112.372 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 83.6 -45.26 3.43 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.509 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 54.0 t -53.27 157.4 1.95 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.854 0.359 . . . . 0.0 110.89 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -145.49 44.8 0.85 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.451 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 21.8 m95 -97.6 128.96 44.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.766 0.317 . . . . 0.0 110.91 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 361' ' ' ARG . . . . . . . . . . . . . 47.2 mtt180 -122.47 160.35 25.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.887 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 362' ' ' PHE . . . . . 0.509 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 6.1 m-85 -147.31 155.77 42.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.883 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 46.7 t -83.9 -29.48 27.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.884 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 31.7 mtp180 -113.21 165.38 12.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.904 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 1.2 m -70.23 -62.43 1.39 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.819 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -45.38 -38.33 5.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.862 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -60.22 -37.51 80.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.903 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.671 HD22 ' HB3' ' A' ' 351' ' ' PHE . 10.1 tp -80.79 -44.8 17.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.907 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 74.6 m -56.5 -48.02 78.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.887 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 370' ' ' ARG . . . . . 0.456 ' HG3' ' N ' ' A' ' 371' ' ' HIS . 6.8 ptm180 -56.38 -30.29 62.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.911 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 371' ' ' HIS . . . . . 0.456 ' N ' ' HG3' ' A' ' 370' ' ' ARG . 23.8 t60 -74.23 -45.91 45.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.843 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 42.3 mmm-85 -43.28 -29.26 0.39 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 60.6 mtt180 -49.64 -47.45 49.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.892 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 56.0 p -45.17 -38.79 5.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.833 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 375' ' ' HIS . . . . . 0.578 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 45.2 m-70 -92.29 155.83 17.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.898 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 6.0 m -84.56 102.98 13.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.861 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -107.68 114.36 4.21 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.481 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 86.1 t -50.64 134.5 10.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.909 0.385 . . . . 0.0 111.144 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 379' ' ' LYS . . . . . . . . . . . . . 20.0 mtpp -104.32 160.43 26.07 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.614 0.721 . . . . 0.0 110.895 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -32.15 18.96 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.68 2.253 . . . . 0.0 112.318 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 77.0 p -55.56 155.91 5.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.875 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -111.99 177.12 18.55 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.48 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 383' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 112.08 2.98 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.682 2.255 . . . . 0.0 112.324 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 6.6 t -59.38 -44.4 92.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.81 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 5.6 t 68.07 42.09 1.88 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.828 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.513 179.955 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 339' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.507 -0.237 . . . . 0.0 112.507 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 5.6 m -54.27 111.92 0.87 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.849 0.356 . . . . 0.0 110.824 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 14.9 t -165.89 148.36 7.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . -119.02 120.49 4.68 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.494 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 343' ' ' SER . . . . . 0.43 ' O ' ' C ' ' A' ' 344' ' ' SER . 59.9 p -109.03 112.81 25.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.928 0.394 . . . . 0.0 110.815 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 344' ' ' SER . . . . . 0.43 ' C ' ' O ' ' A' ' 343' ' ' SER . 51.8 p -36.27 -53.39 0.82 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.911 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -170.76 141.19 6.37 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.505 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 14.6 t -67.64 144.17 55.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.837 0.351 . . . . 0.0 111.116 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -123.64 121.66 4.6 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.488 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -64.3 162.66 14.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.884 0.373 . . . . 0.0 110.892 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 349' ' ' LYS . . . . . 0.424 ' HA ' ' HD2' ' A' ' 350' ' ' PRO . 46.0 mttp -104.8 93.4 6.16 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.619 0.723 . . . . 0.0 110.919 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 350' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 349' ' ' LYS . 53.5 Cg_endo -69.76 -28.25 25.49 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.7 2.267 . . . . 0.0 112.308 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 351' ' ' PHE . . . . . 0.808 ' HB3' HD22 ' A' ' 368' ' ' LEU . 80.8 m-85 -74.39 102.04 4.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.864 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -109.58 131.75 54.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.097 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 51.1 t -48.63 147.4 2.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.905 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 88.7 m -92.06 -34.6 14.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.181 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.574 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 58.0 t-105 -44.29 139.99 3.1 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.542 0.687 . . . . 0.0 110.941 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 356' ' ' PRO . . . . . 0.516 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 54.0 Cg_endo -69.72 138.18 37.33 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.693 2.262 . . . . 0.0 112.381 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 84.28 -41.58 3.01 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.471 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 42.4 t -60.23 152.08 25.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.863 0.364 . . . . 0.0 110.903 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -140.51 45.96 0.95 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.446 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 25.0 m95 -98.03 129.81 44.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.786 0.327 . . . . 0.0 110.913 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 361' ' ' ARG . . . . . 0.49 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 72.3 mtt180 -121.0 167.46 12.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.868 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 362' ' ' PHE . . . . . 0.518 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 7.4 m-85 -153.13 147.77 26.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.854 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 68.1 m -73.16 -33.48 65.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.899 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -110.45 171.13 7.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.88 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 37.4 t -75.68 -55.09 5.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.858 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -49.87 -48.08 51.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.877 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -52.42 -32.8 40.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.875 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.808 HD22 ' HB3' ' A' ' 351' ' ' PHE . 10.9 tp -84.13 -43.29 15.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.92 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 12.2 t -58.28 -45.06 88.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.853 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 370' ' ' ARG . . . . . 0.476 ' CZ ' ' HB2' ' A' ' 370' ' ' ARG . 3.8 ptm85 -58.81 -31.34 68.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.861 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 371' ' ' HIS . . . . . 0.415 ' CB ' ' CZ ' ' A' ' 362' ' ' PHE . 11.0 t60 -73.34 -47.44 42.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.838 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 24.8 mmm-85 -43.55 -28.24 0.36 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.867 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 81.2 mtt180 -51.87 -44.75 63.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.897 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 4.9 t -48.58 -32.16 7.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.836 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 375' ' ' HIS . . . . . 0.574 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 57.7 m-70 -95.75 144.51 26.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.844 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 1.9 m -70.25 -57.73 4.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.858 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 128.33 66.2 0.13 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.489 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 2.8 t 56.54 50.86 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.889 0.376 . . . . 0.0 111.145 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 379' ' ' LYS . . . . . . . . . . . . . 25.6 mmtp -140.43 143.96 35.07 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.594 0.711 . . . . 0.0 110.887 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 380' ' ' PRO . . . . . 0.414 ' O ' ' C ' ' A' ' 381' ' ' SER . 53.8 Cg_endo -69.81 -5.64 16.73 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.631 2.221 . . . . 0.0 112.347 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 381' ' ' SER . . . . . 0.414 ' C ' ' O ' ' A' ' 380' ' ' PRO . 3.8 t -37.62 -61.35 0.62 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.86 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 65.07 -179.07 8.81 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.737 -0.745 . . . . 0.0 112.466 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 383' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 87.4 0.55 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.692 2.262 . . . . 0.0 112.338 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 13.5 t -41.05 -62.85 0.76 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.8 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 41.7 p -51.97 -53.66 38.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.839 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.474 -179.979 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 339' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 95.8 p 41.54 42.18 1.88 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.89 0.376 . . . . 0.0 110.893 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 3.6 m -77.98 97.0 5.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.883 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . -94.82 -151.81 28.71 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.453 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 91.3 p -125.57 104.77 8.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.851 0.358 . . . . 0.0 110.873 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 5.4 m -58.36 -44.29 88.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.89 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -172.53 -122.6 0.67 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.436 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 55.5 p -104.33 129.16 52.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.831 0.348 . . . . 0.0 111.155 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 147.38 99.06 0.22 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.507 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -128.8 166.04 19.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.913 0.387 . . . . 0.0 110.888 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 349' ' ' LYS . . . . . 0.462 ' HB3' ' N ' ' A' ' 362' ' ' PHE . 46.2 mttm -107.35 93.39 9.61 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.538 0.685 . . . . 0.0 110.912 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 350' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 349' ' ' LYS . 53.7 Cg_endo -69.76 -31.69 20.04 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.696 2.264 . . . . 0.0 112.344 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 351' ' ' PHE . . . . . 0.544 ' HB3' HD22 ' A' ' 368' ' ' LEU . 93.6 m-85 -72.96 94.04 1.81 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.897 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -101.46 147.0 26.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.096 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 53.2 t -66.24 145.02 56.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 46.2 p -90.63 -27.38 19.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.126 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.575 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 61.7 t-105 -47.86 139.64 9.08 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.58 0.705 . . . . 0.0 110.886 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 356' ' ' PRO . . . . . 0.527 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 54.0 Cg_endo -69.77 136.97 34.33 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.703 2.269 . . . . 0.0 112.319 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 84.16 -36.13 2.92 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.493 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 48.3 t -65.93 156.64 32.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.87 0.366 . . . . 0.0 110.879 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -147.04 44.79 0.8 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.481 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 39.8 m95 -96.74 129.99 44.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.813 0.34 . . . . 0.0 110.884 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 361' ' ' ARG . . . . . 0.449 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 51.1 mtm-85 -121.71 163.67 18.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.853 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 362' ' ' PHE . . . . . 0.47 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 7.3 m-85 -149.35 151.83 34.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.865 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 29.6 t -75.02 -36.66 61.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.846 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 40.9 mtp85 -109.38 162.91 13.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 90.1 p -68.11 -57.47 6.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.847 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -47.65 -38.15 14.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.91 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -61.66 -32.25 72.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.856 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.544 HD22 ' HB3' ' A' ' 351' ' ' PHE . 7.8 tp -84.53 -46.99 11.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.952 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 46.9 t -54.37 -44.33 72.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.822 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -59.18 -36.3 75.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.815 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 371' ' ' HIS . . . . . 0.413 ' CB ' ' CZ ' ' A' ' 362' ' ' PHE . 18.8 t60 -70.0 -43.46 71.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.877 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 9.3 mmt85 -45.29 -28.21 0.78 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.879 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 47.6 mtp180 -53.04 -43.72 66.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.891 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 49.1 m -47.67 -33.65 7.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.856 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 375' ' ' HIS . . . . . 0.575 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 70.6 m-70 -93.93 169.9 9.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.859 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 88.8 p -89.14 48.79 1.67 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.871 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -57.49 -76.04 0.23 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.513 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 33.7 m -116.47 145.44 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.855 0.36 . . . . 0.0 111.113 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 379' ' ' LYS . . . . . . . . . . . . . 17.2 pttp -77.51 143.79 68.84 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.556 0.693 . . . . 0.0 110.915 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 99.8 0.78 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.66 2.24 . . . . 0.0 112.34 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 80.4 p -101.72 81.17 2.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.878 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 151.29 146.04 4.25 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.478 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 383' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 114.99 3.88 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.681 2.254 . . . . 0.0 112.349 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 91.0 p -171.2 169.69 6.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.9 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 4.2 t -148.19 142.94 26.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.905 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.47 -179.967 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 339' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 19.3 t -48.21 133.02 15.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.873 0.368 . . . . 0.0 110.851 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 85.0 p -126.19 -44.42 1.74 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.822 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 99.7 -95.05 1.45 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.476 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 97.2 p -59.51 96.06 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.889 0.376 . . . . 0.0 110.889 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 59.6 p -56.59 -46.55 80.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.878 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 66.03 42.47 94.62 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.444 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 57.5 p -47.71 133.17 13.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.882 0.373 . . . . 0.0 111.136 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 125.28 165.66 12.15 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.475 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -89.55 152.51 21.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.886 0.374 . . . . 0.0 110.881 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 349' ' ' LYS . . . . . 0.405 ' HB3' ' C ' ' A' ' 362' ' ' PHE . 65.8 mttt -125.96 93.7 43.33 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.598 0.714 . . . . 0.0 110.874 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -33.61 16.34 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.653 2.235 . . . . 0.0 112.357 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 351' ' ' PHE . . . . . 0.729 ' HB3' HD22 ' A' ' 368' ' ' LEU . 90.6 m-85 -69.03 104.81 2.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.869 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -109.53 145.44 36.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.114 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 40.4 t -62.84 150.4 41.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.858 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 71.6 p -94.34 -31.94 13.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.193 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.573 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 58.4 t-105 -46.87 140.03 6.39 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.536 0.684 . . . . 0.0 110.876 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 356' ' ' PRO . . . . . 0.523 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 53.5 Cg_endo -69.82 138.57 37.94 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.662 2.241 . . . . 0.0 112.317 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 83.94 -38.64 2.83 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.483 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 45.3 t -64.04 157.08 26.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.894 0.378 . . . . 0.0 110.87 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -146.36 42.34 0.95 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.476 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 35.8 m95 -92.53 128.45 38.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.761 0.315 . . . . 0.0 110.925 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 361' ' ' ARG . . . . . 0.527 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 50.2 mtm180 -119.88 167.48 12.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.934 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 362' ' ' PHE . . . . . 0.527 ' CD1' ' C ' ' A' ' 361' ' ' ARG . 13.9 m-85 -154.19 149.32 26.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.925 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 72.7 m -77.44 -26.53 51.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.849 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 70.8 mtt180 -116.85 162.16 18.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.854 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 93.8 p -69.42 -57.96 4.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.891 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -48.29 -40.96 26.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.877 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -60.68 -32.91 72.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.908 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.729 HD22 ' HB3' ' A' ' 351' ' ' PHE . 7.1 tp -83.17 -44.78 14.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.929 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 42.7 m -58.09 -45.53 87.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -58.75 -29.03 66.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.87 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 12.0 t60 -75.21 -46.91 30.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.88 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 41.6 mmm-85 -42.4 -29.31 0.26 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.866 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 43.4 mtp180 -49.63 -47.36 49.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.888 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 9.4 t -44.77 -38.93 4.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.85 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 375' ' ' HIS . . . . . 0.573 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 56.2 m-70 -88.91 141.58 28.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.88 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 3.3 m -70.99 -58.72 3.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.9 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 85.29 -112.61 3.69 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.526 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 34.9 m -112.71 145.41 18.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.883 0.373 . . . . 0.0 111.129 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 379' ' ' LYS . . . . . 0.401 ' HZ2' ' H ' ' A' ' 384' ' ' SER . 17.0 ptmt -55.82 141.81 65.29 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.597 0.713 . . . . 0.0 110.885 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -51.07 0.41 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.636 2.224 . . . . 0.0 112.374 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 76.4 p -175.27 161.72 2.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.834 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 80.5 159.05 19.62 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.481 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 383' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 87.49 0.55 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.718 2.278 . . . . 0.0 112.356 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 384' ' ' SER . . . . . 0.401 ' H ' ' HZ2' ' A' ' 379' ' ' LYS . 4.8 t 43.44 43.45 4.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.852 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 31.8 t -98.04 136.48 38.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.873 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.511 -179.985 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 339' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 340' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 341' ' ' SER . 48.2 t -108.21 140.65 41.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.911 0.386 . . . . 0.0 110.867 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 341' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 340' ' ' SER . 59.5 p -37.83 149.76 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.848 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . -129.64 68.55 0.54 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.473 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 36.6 m -88.97 103.32 15.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.847 0.356 . . . . 0.0 110.845 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 1.8 t -63.27 125.16 23.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.865 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 154.08 -172.74 32.72 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.455 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 35.4 p -103.79 163.49 12.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.815 0.34 . . . . 0.0 111.118 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 122.47 58.54 0.21 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.485 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -59.71 153.6 19.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.909 0.385 . . . . 0.0 110.888 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 349' ' ' LYS . . . . . 0.413 ' HA ' ' HD2' ' A' ' 350' ' ' PRO . 76.6 mttt -104.31 93.21 5.45 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.566 0.698 . . . . 0.0 110.916 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 350' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 349' ' ' LYS . 54.6 Cg_endo -69.69 -31.32 21.06 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.648 2.232 . . . . 0.0 112.357 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 351' ' ' PHE . . . . . 0.683 ' HB3' HD22 ' A' ' 368' ' ' LEU . 96.1 m-85 -72.69 103.76 3.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.889 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -111.57 139.65 46.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.097 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 39.9 t -59.18 148.29 32.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.934 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 34.2 m -92.9 -31.39 14.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.12 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.572 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 56.3 t-105 -46.97 140.16 6.45 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.54 0.686 . . . . 0.0 110.938 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 356' ' ' PRO . . . . . 0.522 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 53.7 Cg_endo -69.72 141.85 46.54 Favored 'Trans proline' 0 C--N 1.34 0.13 0 C-N-CA 122.69 2.26 . . . . 0.0 112.341 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 81.4 -36.57 2.41 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.465 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 42.8 t -67.4 153.63 43.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.924 0.392 . . . . 0.0 110.86 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -144.36 42.06 1.06 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.5 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 33.4 m95 -93.17 128.54 39.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.781 0.324 . . . . 0.0 110.921 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 361' ' ' ARG . . . . . 0.465 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 40.9 mtm180 -120.71 166.05 14.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.888 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 362' ' ' PHE . . . . . 0.494 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 7.2 m-85 -151.94 151.59 31.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.927 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 24.1 m -80.6 -23.24 39.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.86 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 5.4 mtp-105 -120.0 154.11 35.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.857 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 365' ' ' SER . . . . . 0.401 ' O ' ' N ' ' A' ' 368' ' ' LEU . 89.8 p -62.41 -63.43 1.23 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.867 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -41.65 -42.01 2.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.872 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -59.26 -39.73 83.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.869 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.683 HD22 ' HB3' ' A' ' 351' ' ' PHE . 8.0 tp -77.14 -42.43 37.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.933 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 24.5 t -58.84 -47.22 85.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.824 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -58.71 -28.31 65.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.916 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 24.7 t60 -75.36 -46.38 33.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 44.2 mmm-85 -43.12 -29.44 0.37 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.853 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 68.8 mtm180 -52.2 -44.31 64.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.889 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 58.8 m -46.36 -38.14 8.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.876 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 375' ' ' HIS . . . . . 0.572 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 55.0 m-70 -92.82 166.21 12.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.852 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 2.0 m -101.07 160.28 14.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.896 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -82.1 -125.78 0.87 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.468 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 378' ' ' VAL . . . . . 0.427 HG22 ' H ' ' A' ' 378' ' ' VAL . 0.1 OUTLIER -52.76 137.21 13.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.94 0.4 . . . . 0.0 111.11 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 379' ' ' LYS . . . . . 0.472 ' CG ' ' HD2' ' A' ' 380' ' ' PRO . 32.5 tttm -97.51 140.52 22.05 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.539 0.685 . . . . 0.0 110.907 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 380' ' ' PRO . . . . . 0.472 ' HD2' ' CG ' ' A' ' 379' ' ' LYS . 54.1 Cg_endo -69.74 -10.4 28.47 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.704 2.269 . . . . 0.0 112.321 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 381' ' ' SER . . . . . 0.449 ' C ' ' O ' ' A' ' 380' ' ' PRO . 2.1 m -34.6 137.18 0.13 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.879 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 382' ' ' GLY . . . . . 0.463 ' N ' ' HD2' ' A' ' 383' ' ' PRO . . . -64.85 -60.48 6.85 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.522 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 383' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 382' ' ' GLY . 54.1 Cg_endo -69.77 2.6 3.39 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.649 2.233 . . . . 0.0 112.367 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 43.1 t -45.79 93.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.851 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 385' ' ' SER . . . . . 0.434 ' N ' ' O ' ' A' ' 383' ' ' PRO . 28.5 t -80.16 -56.52 4.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.868 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.499 -179.992 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 339' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 40.3 t -107.58 156.97 18.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.899 0.381 . . . . 0.0 110.841 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 4.0 t -110.25 -49.3 3.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.875 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . -58.19 -66.6 2.7 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.497 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 1.9 m -63.8 81.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.808 0.337 . . . . 0.0 110.879 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 1.8 m -115.07 147.79 39.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.835 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -130.52 -177.93 15.16 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.49 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 346' ' ' THR . . . . . 0.466 HG23 ' N ' ' A' ' 347' ' ' GLY . 8.9 t -66.56 -43.59 84.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.816 0.341 . . . . 0.0 111.111 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 347' ' ' GLY . . . . . 0.466 ' N ' HG23 ' A' ' 346' ' ' THR . . . 122.93 107.75 1.89 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.471 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -64.18 148.08 50.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.898 0.38 . . . . 0.0 110.889 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 349' ' ' LYS . . . . . 0.411 ' HA ' ' HD2' ' A' ' 350' ' ' PRO . 30.5 mttm -120.83 93.25 48.65 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.546 0.689 . . . . 0.0 110.923 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 350' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 349' ' ' LYS . 53.6 Cg_endo -69.78 -28.69 24.85 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.719 2.28 . . . . 0.0 112.321 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 351' ' ' PHE . . . . . 0.677 ' HB3' HD22 ' A' ' 368' ' ' LEU . 94.6 m-85 -75.61 98.65 4.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.844 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -106.51 145.55 31.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.117 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 35.8 t -62.08 148.2 44.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.917 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 41.8 m -92.89 -31.87 14.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.131 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.577 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 55.7 t-105 -49.54 140.23 14.22 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.574 0.702 . . . . 0.0 110.951 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 356' ' ' PRO . . . . . 0.517 ' HD2' ' CG ' ' A' ' 355' ' ' TRP . 53.9 Cg_endo -69.78 140.71 43.28 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.676 2.25 . . . . 0.0 112.349 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 84.03 -41.53 2.99 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.474 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 44.9 t -63.28 150.9 42.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.888 0.375 . . . . 0.0 110.92 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -140.19 44.03 1.09 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.476 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 39.3 m95 -93.91 129.56 40.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.728 0.299 . . . . 0.0 110.946 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 361' ' ' ARG . . . . . 0.426 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 56.7 mtm180 -122.73 164.61 17.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.902 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 362' ' ' PHE . . . . . 0.469 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 11.3 m-85 -151.37 151.01 31.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.857 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 50.4 m -78.15 -25.8 47.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.871 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 78.1 mtt-85 -115.36 163.27 15.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.915 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 88.2 p -72.39 -53.47 12.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.851 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -50.23 -44.61 53.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.87 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -57.24 -34.4 68.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.864 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.677 HD22 ' HB3' ' A' ' 351' ' ' PHE . 6.5 tp -80.49 -44.38 19.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.915 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 14.9 m -57.87 -45.12 86.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.851 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -60.67 -28.27 68.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.839 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 16.8 t60 -76.7 -44.84 31.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.875 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 45.7 mmm-85 -45.43 -28.14 0.83 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.864 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -52.66 -44.57 66.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.878 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 39.2 m -46.69 -38.12 9.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.883 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 375' ' ' HIS . . . . . 0.577 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 38.3 m-70 -93.71 158.47 15.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.878 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 6.1 m -94.08 106.11 18.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.845 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -119.72 -136.17 5.2 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.461 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 14.9 p -133.76 141.54 43.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.873 0.368 . . . . 0.0 111.13 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 379' ' ' LYS . . . . . 0.473 ' CG ' ' HD2' ' A' ' 380' ' ' PRO . 6.0 ttpm? -143.98 139.44 16.01 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.584 0.707 . . . . 0.0 110.902 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 380' ' ' PRO . . . . . 0.473 ' HD2' ' CG ' ' A' ' 379' ' ' LYS . 53.6 Cg_endo -69.81 -171.14 0.45 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.671 2.247 . . . . 0.0 112.285 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 51.1 m -63.64 -56.71 13.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.844 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 122.93 -78.73 0.35 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.452 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 383' ' ' PRO . . . . . 0.407 ' O ' ' C ' ' A' ' 384' ' ' SER . 53.8 Cg_endo -69.71 -6.77 19.38 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.71 2.273 . . . . 0.0 112.357 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 384' ' ' SER . . . . . 0.407 ' C ' ' O ' ' A' ' 383' ' ' PRO . 88.7 p 37.41 42.08 0.3 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.869 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 29.9 t -44.68 -47.31 10.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.843 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.483 -179.975 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 200' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 339' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 16.4 m -105.33 105.05 14.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.889 0.376 . . . . 0.0 110.871 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 1.7 t -95.64 120.48 35.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.882 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 162.77 -159.63 32.01 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.468 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 13.0 t -145.04 157.0 44.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.902 0.382 . . . . 0.0 110.847 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 2.8 t -103.9 96.66 6.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.86 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 114.15 100.26 2.36 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.459 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 7.3 t -142.64 135.88 28.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.875 0.369 . . . . 0.0 111.14 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 139.4 -94.87 0.2 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.502 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -164.2 158.54 19.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.929 0.395 . . . . 0.0 110.877 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 349' ' ' LYS . . . . . 0.43 ' HA ' ' HD2' ' A' ' 350' ' ' PRO . 64.1 mttt -125.79 93.44 44.25 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.592 0.711 . . . . 0.0 110.871 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 350' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 349' ' ' LYS . 53.4 Cg_endo -69.76 -31.57 20.27 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.685 2.256 . . . . 0.0 112.317 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 351' ' ' PHE . . . . . 0.687 ' HB3' HD22 ' A' ' 368' ' ' LEU . 97.0 m-85 -71.74 100.48 2.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.872 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -108.47 132.92 53.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.121 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 353' ' ' CYS . . . . . 0.553 ' HA ' HD11 ' A' ' 368' ' ' LEU . 35.9 t -49.55 153.95 1.05 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.902 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 30.6 m -94.92 -34.55 12.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.191 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.555 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 46.9 t-105 -44.59 140.66 3.1 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.555 0.693 . . . . 0.0 110.932 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 356' ' ' PRO . . . . . 0.521 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 53.7 Cg_endo -69.72 140.07 41.91 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.671 2.247 . . . . 0.0 112.372 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 83.65 -41.97 3.0 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.463 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 34.9 t -58.81 149.69 25.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.936 0.398 . . . . 0.0 110.908 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -139.21 42.53 1.24 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.456 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 37.0 m95 -94.8 128.61 41.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.771 0.319 . . . . 0.0 110.874 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 361' ' ' ARG . . . . . 0.408 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 37.7 mtt180 -121.74 159.15 27.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.923 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 362' ' ' PHE . . . . . 0.434 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 4.8 m-85 -144.64 152.47 40.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.874 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 36.2 t -74.39 -34.57 63.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.874 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 36.3 mtt-85 -110.63 169.7 8.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.872 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 68.2 p -74.76 -57.4 3.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.893 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -47.34 -44.93 24.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.859 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -55.97 -32.67 64.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.906 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.687 HD22 ' HB3' ' A' ' 351' ' ' PHE . 12.5 tp -83.78 -42.72 16.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.913 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 14.8 t -58.66 -46.88 86.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.836 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 48.6 ptt85 -58.01 -29.29 65.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.849 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -74.34 -45.62 46.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.843 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 372' ' ' ARG . . . . . 0.416 ' NH1' ' HB3' ' A' ' 372' ' ' ARG . 4.6 mmm180 -42.98 -29.46 0.34 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.853 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 77.4 mtt180 -50.85 -45.5 59.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.846 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 3.2 m -44.56 -39.48 4.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.879 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 375' ' ' HIS . . . . . 0.555 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 48.2 m-70 -89.86 151.14 21.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.848 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 4.2 t -88.64 56.43 3.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.852 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 56.68 163.78 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.478 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 2.3 t -98.06 52.57 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.935 0.397 . . . . 0.0 111.166 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 379' ' ' LYS . . . . . . . . . . . . . 7.1 ptmm? -158.51 143.98 12.14 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.576 0.703 . . . . 0.0 110.912 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -46.76 1.1 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.687 2.258 . . . . 0.0 112.345 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 29.2 t -78.31 161.71 27.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.851 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 179.53 70.54 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.48 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 383' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 153.53 68.61 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.704 2.27 . . . . 0.0 112.309 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 10.4 m -84.25 99.43 10.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.858 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 32.6 m -158.59 159.35 35.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.882 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.501 179.991 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 200' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 339' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 N-CA-C 112.454 -0.259 . . . . 0.0 112.454 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 1.8 m 52.82 42.02 31.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.856 0.36 . . . . 0.0 110.831 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 11.9 m -46.54 130.28 11.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.848 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . -132.41 -79.72 0.17 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.47 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 33.4 t -81.21 135.42 35.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.86 0.362 . . . . 0.0 110.901 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 3.2 m -124.43 41.86 3.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.869 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -166.57 -79.31 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.516 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 44.2 p -126.63 104.94 8.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.796 0.331 . . . . 0.0 111.167 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -174.56 83.99 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.489 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 348' ' ' GLU . . . . . 0.42 ' CG ' ' N ' ' A' ' 349' ' ' LYS . 27.3 tt0 -160.64 163.3 32.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.941 0.4 . . . . 0.0 110.878 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 349' ' ' LYS . . . . . 0.42 ' N ' ' CG ' ' A' ' 348' ' ' GLU . 47.7 mttm -113.04 93.46 25.32 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.555 0.693 . . . . 0.0 110.877 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 350' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 349' ' ' LYS . 53.7 Cg_endo -69.73 -26.29 27.88 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.705 2.27 . . . . 0.0 112.366 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 351' ' ' PHE . . . . . 0.651 ' HB3' HD22 ' A' ' 368' ' ' LEU . 89.4 m-85 -79.95 97.78 6.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.906 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 352' ' ' ALA . . . . . 0.457 ' CB ' ' HG2' ' A' ' 361' ' ' ARG . . . -110.17 144.0 39.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.12 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 43.5 t -60.13 144.68 49.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.881 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 62.3 p -93.94 -26.14 16.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.178 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.569 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 60.3 t-105 -49.87 139.82 16.4 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.571 0.7 . . . . 0.0 110.927 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 356' ' ' PRO . . . . . 0.525 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 54.1 Cg_endo -69.77 137.93 36.59 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.709 2.273 . . . . 0.0 112.321 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 84.53 -33.83 3.19 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.478 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 49.9 t -72.97 153.77 40.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.904 0.383 . . . . 0.0 110.881 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -143.71 48.55 0.74 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.456 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 39.2 m95 -97.93 128.66 44.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.8 0.333 . . . . 0.0 110.875 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 361' ' ' ARG . . . . . 0.507 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 58.1 mtm180 -121.72 164.21 17.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.905 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 362' ' ' PHE . . . . . 0.507 ' CD1' ' C ' ' A' ' 361' ' ' ARG . 4.5 m-85 -151.23 151.13 31.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.896 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 52.6 m -80.06 -19.43 47.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.896 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 5.5 mpt_? -122.94 162.14 22.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.851 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 9.8 t -70.17 -62.74 1.27 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.874 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -43.66 -41.21 4.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.851 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 367' ' ' GLU . . . . . 0.414 ' O ' ' CG ' ' A' ' 370' ' ' ARG . 24.2 mm-40 -59.29 -40.11 85.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.888 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.651 HD22 ' HB3' ' A' ' 351' ' ' PHE . 12.5 tp -77.06 -44.96 28.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.895 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 30.4 t -55.73 -44.67 77.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.846 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 370' ' ' ARG . . . . . 0.442 ' HG3' ' N ' ' A' ' 371' ' ' HIS . 9.6 ptt180 -59.32 -33.86 71.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.899 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 371' ' ' HIS . . . . . 0.442 ' N ' ' HG3' ' A' ' 370' ' ' ARG . 17.3 t60 -71.31 -46.69 60.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.9 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 372' ' ' ARG . . . . . 0.41 ' NH1' ' HB3' ' A' ' 372' ' ' ARG . 4.9 mmm180 -41.42 -30.13 0.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.838 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -49.67 -44.36 47.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.864 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 1.4 t -46.51 -33.44 4.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.881 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 375' ' ' HIS . . . . . 0.569 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 53.2 m-70 -99.23 166.47 11.2 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.884 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 2.2 m -110.82 166.59 10.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.814 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 155.61 -40.11 0.6 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.494 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 378' ' ' VAL . . . . . 0.479 ' O ' HG13 ' A' ' 378' ' ' VAL . 9.2 p -160.32 125.18 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.851 0.357 . . . . 0.0 111.146 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 379' ' ' LYS . . . . . . . . . . . . . 18.4 pttp -96.47 143.82 26.77 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.603 0.716 . . . . 0.0 110.892 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -176.36 1.47 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.637 2.225 . . . . 0.0 112.308 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 29.3 p -121.86 93.36 3.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.824 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 154.09 83.57 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.434 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 383' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 107.53 1.88 Allowed 'Trans proline' 0 N--CA 1.465 -0.149 0 C-N-CA 122.707 2.271 . . . . 0.0 112.371 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 1.1 t -54.17 -60.22 3.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.847 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 54.6 p -156.65 164.49 38.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.875 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.477 -179.966 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 200' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 339' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 19.8 m 60.98 42.21 13.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.846 0.355 . . . . 0.0 110.827 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 5.1 t -68.05 127.5 33.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.84 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 166.24 55.36 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.469 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 19.6 m -159.71 117.46 2.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.912 0.387 . . . . 0.0 110.845 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 3.8 m -112.31 135.14 53.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.811 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 125.86 74.96 0.23 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.425 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 74.3 p -67.59 150.33 48.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.803 0.335 . . . . 0.0 111.173 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 133.08 107.73 1.04 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.44 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -83.19 157.81 22.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.96 0.41 . . . . 0.0 110.842 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 349' ' ' LYS . . . . . 0.477 ' HB3' ' N ' ' A' ' 362' ' ' PHE . 36.9 mttp -104.41 93.41 5.79 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.574 0.702 . . . . 0.0 110.915 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 350' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 349' ' ' LYS . 54.0 Cg_endo -69.77 -32.2 18.99 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.696 2.264 . . . . 0.0 112.319 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 351' ' ' PHE . . . . . 0.636 ' HB3' HD22 ' A' ' 368' ' ' LEU . 98.3 m-85 -72.16 99.2 2.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.847 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -106.72 141.68 37.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.059 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 39.6 t -58.8 149.18 27.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.881 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 27.0 m -90.75 -33.19 15.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.138 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.573 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 56.2 t-105 -45.21 140.16 3.91 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.587 0.708 . . . . 0.0 110.865 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 356' ' ' PRO . . . . . 0.514 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 53.9 Cg_endo -69.74 142.37 47.84 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.713 2.275 . . . . 0.0 112.329 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 80.95 -37.99 2.36 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.491 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 49.7 t -63.12 154.52 30.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.827 0.346 . . . . 0.0 110.88 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -143.8 39.04 1.3 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.5 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 48.0 m95 -92.61 128.03 38.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.72 0.295 . . . . 0.0 110.899 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 361' ' ' ARG . . . . . 0.515 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 43.7 mtm180 -121.2 169.47 10.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.818 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 362' ' ' PHE . . . . . 0.515 ' CD1' ' C ' ' A' ' 361' ' ' ARG . 9.4 m-85 -154.48 153.51 31.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.876 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 27.2 t -75.83 -35.43 59.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.884 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -108.16 167.6 9.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.891 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 54.6 p -73.83 -55.51 6.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.836 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -48.58 -45.46 37.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.869 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -55.25 -33.72 63.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.884 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.636 HD22 ' HB3' ' A' ' 351' ' ' PHE . 6.8 tp -81.98 -45.41 15.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 27.0 t -56.35 -45.99 80.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.854 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 370' ' ' ARG . . . . . 0.44 ' HG3' ' N ' ' A' ' 371' ' ' HIS . 20.4 ptt180 -59.19 -31.96 69.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.88 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 371' ' ' HIS . . . . . 0.44 ' N ' ' HG3' ' A' ' 370' ' ' ARG . 17.7 t60 -73.75 -38.25 64.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.876 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 19.9 mmm-85 -52.0 -24.96 7.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 37.5 mtt85 -55.56 -43.35 75.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.902 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 32.7 t -48.51 -36.02 14.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.89 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 375' ' ' HIS . . . . . 0.573 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 58.6 m-70 -93.68 144.15 25.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.871 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 3.2 m -88.19 165.63 14.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.816 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -119.14 -132.81 4.53 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.505 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 96.6 t -59.31 119.08 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.884 0.373 . . . . 0.0 111.102 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 379' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -47.84 134.83 11.1 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.601 0.715 . . . . 0.0 110.874 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -51.04 0.41 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.624 2.216 . . . . 0.0 112.367 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 1.8 m -175.11 176.83 2.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.855 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 64.82 146.25 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.492 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 383' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -50.53 0.45 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.697 2.264 . . . . 0.0 112.316 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 3.6 m 41.56 38.54 0.91 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.854 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 3.7 t 44.14 47.06 7.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.848 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.373 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.498 -179.976 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 200' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 339' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.501 -0.239 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 13.9 t -84.32 145.99 27.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.902 0.382 . . . . 0.0 110.877 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 2.1 t -130.13 127.76 40.44 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.863 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 150.81 -57.68 0.45 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.534 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 7.8 t -49.21 -47.08 46.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.924 0.393 . . . . 0.0 110.903 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 51.1 m -143.56 150.06 38.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.876 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 158.98 -153.48 24.59 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.507 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 9.3 t -75.29 -18.65 60.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.853 0.359 . . . . 0.0 111.138 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 347' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 348' ' ' GLU . . . -80.54 -35.86 24.72 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.513 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 348' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 347' ' ' GLY . 22.1 tt0 -35.17 146.5 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.881 0.372 . . . . 0.0 110.951 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 349' ' ' LYS . . . . . 0.46 ' HB3' ' N ' ' A' ' 362' ' ' PHE . 46.2 mttm -133.93 93.35 20.51 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.564 0.697 . . . . 0.0 110.895 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 350' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 349' ' ' LYS . 53.4 Cg_endo -69.79 -30.57 21.91 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.659 2.239 . . . . 0.0 112.298 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 351' ' ' PHE . . . . . 0.745 ' HB3' HD22 ' A' ' 368' ' ' LEU . 95.0 m-85 -74.25 95.68 2.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.883 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 352' ' ' ALA . . . . . 0.522 ' HB2' ' HD3' ' A' ' 361' ' ' ARG . . . -103.97 135.58 45.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.089 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 43.5 t -51.77 150.88 3.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.92 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 70.2 p -95.55 -30.69 13.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.147 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.566 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 55.0 t-105 -46.08 140.21 5.14 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.574 0.702 . . . . 0.0 110.895 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 356' ' ' PRO . . . . . 0.513 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 53.9 Cg_endo -69.73 133.8 26.51 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.681 2.254 . . . . 0.0 112.345 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 88.88 -37.75 3.28 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.528 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 46.8 t -64.78 151.86 44.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.917 0.389 . . . . 0.0 110.846 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -141.5 43.1 1.11 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.482 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 37.9 m95 -95.92 129.16 43.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.778 0.323 . . . . 0.0 110.917 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 361' ' ' ARG . . . . . 0.522 ' HD3' ' HB2' ' A' ' 352' ' ' ALA . 25.7 mtt180 -121.51 161.01 23.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.828 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 362' ' ' PHE . . . . . 0.49 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 10.2 m-85 -145.91 153.18 40.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.845 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 45.2 t -78.3 -29.84 48.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.819 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.14 165.78 11.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.848 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 36.1 t -73.89 -47.61 36.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.852 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -56.36 -46.89 79.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.876 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -54.26 -31.43 53.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.844 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.745 HD22 ' HB3' ' A' ' 351' ' ' PHE . 8.4 tp -83.8 -44.03 14.79 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.948 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 5.5 t -57.7 -47.04 83.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.836 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 25.8 ptt180 -57.93 -33.12 68.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.877 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 22.3 t60 -72.32 -43.92 63.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.875 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 372' ' ' ARG . . . . . 0.412 ' NH1' ' HB3' ' A' ' 372' ' ' ARG . 4.9 mmm180 -44.68 -28.54 0.63 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.906 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 373' ' ' ARG . . . . . 0.432 ' NH1' ' HB3' ' A' ' 373' ' ' ARG . 10.3 mtp-105 -55.39 -42.79 74.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 58.4 m -47.28 -31.43 3.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.863 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 375' ' ' HIS . . . . . 0.566 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 61.8 m-70 -99.03 165.98 11.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.866 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 2.8 m -97.72 133.69 41.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.83 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 156.42 63.55 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.483 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 10.8 p -171.47 149.05 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.879 0.371 . . . . 0.0 111.085 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 379' ' ' LYS . . . . . . . . . . . . . 21.3 mtmt -45.13 144.11 2.22 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.573 0.701 . . . . 0.0 110.893 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 154.19 67.86 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.643 2.229 . . . . 0.0 112.323 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 58.7 m -114.74 102.53 10.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.816 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 67.81 -158.15 51.74 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.53 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 383' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 150.84 68.95 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.714 2.276 . . . . 0.0 112.316 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 4.1 m -86.97 112.98 22.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.915 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 1.1 t -99.21 142.53 30.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.848 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.521 -179.987 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 200' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 339' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.494 -0.243 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 4.4 m -78.55 151.51 32.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.878 0.371 . . . . 0.0 110.874 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 3.2 t -75.19 133.4 41.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.853 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . -102.45 -151.89 23.93 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.484 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 2.7 t -69.03 113.34 6.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.855 0.36 . . . . 0.0 110.853 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 33.2 m -90.69 41.27 1.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.881 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -146.86 64.93 0.43 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.457 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 12.8 t -95.48 145.1 25.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.785 0.326 . . . . 0.0 111.185 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -128.69 -74.3 0.17 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.479 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -142.95 112.37 6.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.874 0.368 . . . . 0.0 110.883 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 349' ' ' LYS . . . . . 0.432 ' NZ ' ' HB2' ' A' ' 361' ' ' ARG . 7.6 mtmp? -134.49 93.04 19.3 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.584 0.706 . . . . 0.0 110.899 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -28.18 25.6 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.705 2.27 . . . . 0.0 112.316 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 351' ' ' PHE . . . . . 0.601 ' HB3' HD22 ' A' ' 368' ' ' LEU . 84.1 m-85 -76.52 102.26 5.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.871 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -115.8 137.59 51.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.088 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 43.2 t -55.59 146.5 20.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.85 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 93.5 m -93.14 -29.05 15.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.154 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.552 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 59.0 t-105 -47.79 139.91 8.71 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.566 0.698 . . . . 0.0 110.932 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 356' ' ' PRO . . . . . 0.523 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 53.8 Cg_endo -69.8 140.97 43.81 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.707 2.271 . . . . 0.0 112.283 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 81.94 -36.87 2.51 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.503 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 47.2 t -68.29 151.51 46.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.853 0.358 . . . . 0.0 110.922 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -140.61 45.33 0.99 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.513 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 39.3 m95 -94.24 128.65 40.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.794 0.33 . . . . 0.0 110.913 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 361' ' ' ARG . . . . . 0.455 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 18.2 mtt85 -122.61 165.33 16.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.843 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 362' ' ' PHE . . . . . 0.534 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 11.3 m-85 -152.72 151.2 30.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 49.9 m -77.04 -33.41 57.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.855 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -104.67 171.65 7.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.833 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 365' ' ' SER . . . . . 0.57 ' HA ' ' CD1' ' A' ' 351' ' ' PHE . 80.7 p -81.13 -55.64 4.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.865 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.62 -34.59 59.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.853 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -62.75 -34.58 77.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.881 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.601 HD22 ' HB3' ' A' ' 351' ' ' PHE . 9.4 tp -81.01 -45.58 16.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.943 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 58.7 m -56.02 -43.7 78.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.877 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -60.17 -28.9 68.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.855 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -76.44 -43.55 39.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.852 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 22.0 mmm-85 -45.97 -27.14 0.84 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.895 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 25.8 mtp85 -51.13 -46.01 61.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.847 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 58.3 m -46.42 -35.29 5.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.841 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 375' ' ' HIS . . . . . 0.552 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 66.3 m-70 -92.41 159.72 15.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.861 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 24.8 p -108.28 174.67 5.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.836 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -103.97 -107.7 3.21 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.477 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 12.6 p -68.1 143.74 15.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.886 0.374 . . . . 0.0 111.146 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 379' ' ' LYS . . . . . . . . . . . . . 24.7 pttt -52.05 144.22 21.57 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.612 0.72 . . . . 0.0 110.878 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 144.86 55.07 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.63 2.22 . . . . 0.0 112.355 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 381' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 382' ' ' GLY . 1.2 t -123.59 -62.01 1.34 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.85 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 382' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 381' ' ' SER . . . 35.92 82.86 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.46 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 383' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -39.85 6.05 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.671 2.247 . . . . 0.0 112.339 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 65.9 p -70.45 -48.04 57.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 2.3 m -125.66 113.63 17.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.884 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.467 -179.992 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 200' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 339' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 112.476 -0.25 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 2.7 m -132.52 141.31 48.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.872 0.368 . . . . 0.0 110.885 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 41.2 t -116.64 153.11 32.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.898 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 169.41 -82.94 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.514 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 30.4 t -123.08 136.59 54.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.863 0.363 . . . . 0.0 110.867 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 17.2 m -50.72 116.62 2.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.822 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -60.54 147.71 45.39 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.454 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 66.7 p -118.15 86.41 2.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.832 0.349 . . . . 0.0 111.138 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 131.54 127.79 2.89 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.475 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 348' ' ' GLU . . . . . 0.404 ' O ' ' HD3' ' A' ' 350' ' ' PRO . 0.2 OUTLIER -54.66 166.23 0.49 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.959 0.409 . . . . 0.0 110.847 -179.871 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 349' ' ' LYS . . . . . 0.421 ' HA ' ' HD2' ' A' ' 350' ' ' PRO . 56.6 mttt -104.31 92.93 5.15 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.559 0.695 . . . . 0.0 110.892 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 350' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 349' ' ' LYS . 54.3 Cg_endo -69.82 -29.4 23.64 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.721 2.28 . . . . 0.0 112.342 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 351' ' ' PHE . . . . . 0.732 ' HB3' HD22 ' A' ' 368' ' ' LEU . 94.4 m-85 -74.98 100.45 4.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.878 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -107.33 150.49 26.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.067 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 41.0 t -68.06 144.12 55.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.891 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 89.4 m -89.09 -28.69 19.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.139 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.578 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 57.8 t-105 -49.87 140.03 16.12 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.51 0.672 . . . . 0.0 110.931 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 356' ' ' PRO . . . . . 0.524 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 53.8 Cg_endo -69.72 138.64 38.41 Favored 'Trans proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.716 2.278 . . . . 0.0 112.358 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 84.34 -39.87 2.92 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.527 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 44.8 t -63.9 155.18 31.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.868 0.366 . . . . 0.0 110.896 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -145.3 45.21 0.84 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.494 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 32.7 m95 -96.13 128.69 43.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.745 0.307 . . . . 0.0 110.957 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 361' ' ' ARG . . . . . 0.519 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 56.6 mtm-85 -120.77 167.14 12.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.848 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 362' ' ' PHE . . . . . 0.519 ' CD1' ' C ' ' A' ' 361' ' ' ARG . 8.2 m-85 -153.2 146.94 25.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.876 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 29.0 t -70.96 -34.01 71.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.868 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 364' ' ' ARG . . . . . 0.456 ' N ' ' HD2' ' A' ' 364' ' ' ARG . 0.0 OUTLIER -109.66 174.0 6.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.855 -179.913 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 7.1 m -79.6 -57.95 3.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -46.59 -39.44 11.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.859 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 -62.43 -31.64 72.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.864 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.732 HD22 ' HB3' ' A' ' 351' ' ' PHE . 9.1 tp -84.92 -45.91 11.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.898 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 37.1 t -56.43 -46.66 80.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.858 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -58.56 -31.91 68.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.867 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 13.4 t60 -70.87 -46.35 62.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.855 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 54.6 mmm-85 -44.09 -29.08 0.56 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.851 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 62.3 mtt-85 -48.74 -45.92 40.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 36.8 t -47.65 -35.78 9.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.875 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 375' ' ' HIS . . . . . 0.578 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 46.4 m-70 -94.98 170.96 9.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.869 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 45.6 t -75.37 -59.21 2.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.853 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 76.31 -75.81 1.54 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.478 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 7.7 p -119.05 144.74 26.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.863 0.363 . . . . 0.0 111.172 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 379' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -124.37 144.13 44.97 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.601 0.715 . . . . 0.0 110.915 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -174.95 1.01 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.686 2.257 . . . . 0.0 112.3 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 3.6 m -133.35 72.52 1.48 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.856 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 128.73 -91.8 0.33 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.539 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 383' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 172.13 13.21 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.666 2.244 . . . . 0.0 112.366 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 36.7 t -128.62 108.63 10.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.889 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 67.9 m -99.11 84.48 3.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.876 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.272 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.463 -179.956 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 200' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 339' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 72.5 m -39.65 121.05 1.18 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.859 0.362 . . . . 0.0 110.817 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 71.7 m -106.91 83.05 1.78 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.848 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . -140.03 167.91 25.25 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.473 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 35.3 p -108.87 93.27 4.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.905 0.383 . . . . 0.0 110.872 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 49.4 m -96.6 40.54 1.13 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.837 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 114.57 -40.57 2.43 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.513 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 6.6 t -94.37 163.04 13.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.896 0.379 . . . . 0.0 111.136 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 159.34 -42.95 0.46 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.482 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -51.72 170.13 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.94 0.4 . . . . 0.0 110.895 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -106.24 93.38 7.97 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.597 0.713 . . . . 0.0 110.904 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -29.82 23.1 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.683 2.255 . . . . 0.0 112.334 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 351' ' ' PHE . . . . . 0.564 ' CD1' ' HA ' ' A' ' 365' ' ' SER . 94.8 m-85 -74.43 95.5 2.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -109.58 139.65 44.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.11 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 53.3 t -58.85 145.07 42.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.865 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 49.9 m -93.11 -27.94 16.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.138 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.526 ' CD2' ' HD2' ' A' ' 356' ' ' PRO . 61.3 t-105 -47.93 139.69 9.22 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.521 0.677 . . . . 0.0 110.918 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 356' ' ' PRO . . . . . 0.526 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 54.0 Cg_endo -69.76 137.62 35.87 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.69 2.26 . . . . 0.0 112.325 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 84.49 -39.94 2.94 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.476 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 41.8 t -62.77 154.64 29.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.884 0.373 . . . . 0.0 110.843 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -142.57 47.71 0.81 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.513 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 31.6 m95 -97.68 132.81 42.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.754 0.311 . . . . 0.0 110.919 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 361' ' ' ARG . . . . . 0.485 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 30.1 mtt180 -128.51 163.23 25.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.875 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 362' ' ' PHE . . . . . 0.551 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 5.6 m-85 -151.94 152.77 32.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 50.7 m -79.06 -27.36 43.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.866 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 364' ' ' ARG . . . . . 0.501 ' C ' ' CD2' ' A' ' 351' ' ' PHE . 66.6 mtt180 -113.27 168.44 9.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.822 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 365' ' ' SER . . . . . 0.564 ' HA ' ' CD1' ' A' ' 351' ' ' PHE . 31.2 t -74.65 -62.85 1.39 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.865 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -44.38 -38.59 4.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.911 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -58.97 -41.79 88.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.885 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.551 ' HA ' ' CD1' ' A' ' 362' ' ' PHE . 6.5 tp -76.0 -45.19 35.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 27.4 t -55.86 -49.45 73.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.868 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 25.8 ptt85 -56.05 -28.24 56.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.887 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 20.0 t60 -79.11 -41.85 27.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.852 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 22.0 mmm-85 -48.99 -24.7 1.61 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.849 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 -55.9 -44.16 77.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.936 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 39.5 t -46.64 -34.75 5.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.855 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 375' ' ' HIS . . . . . 0.479 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 48.5 m-70 -94.11 156.85 16.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.852 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 55.5 p -84.09 51.67 2.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -93.29 -123.23 3.46 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.463 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 87.8 t -62.07 131.55 27.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.902 0.382 . . . . 0.0 111.16 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 379' ' ' LYS . . . . . 0.474 ' CG ' ' HD2' ' A' ' 380' ' ' PRO . 21.2 ttmt -132.06 140.24 37.5 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.568 0.699 . . . . 0.0 110.9 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 380' ' ' PRO . . . . . 0.474 ' HD2' ' CG ' ' A' ' 379' ' ' LYS . 54.1 Cg_endo -69.74 -31.98 19.53 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.665 2.243 . . . . 0.0 112.345 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 74.1 m 51.12 40.96 27.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.876 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -88.82 152.1 22.78 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.514 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 383' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 105.67 1.53 Allowed 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.726 2.284 . . . . 0.0 112.303 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 5.5 m -110.67 154.28 24.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.863 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 7.5 t -129.18 160.88 31.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.89 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.482 -179.994 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 200' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 339' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.464 -0.254 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 2.0 m -98.97 168.13 10.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.853 0.359 . . . . 0.0 110.886 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 90.2 p -106.74 145.04 32.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.884 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . -80.01 -138.29 1.86 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.467 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 24.8 p -79.87 129.35 34.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.872 0.368 . . . . 0.0 110.865 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 4.7 m -85.13 163.35 18.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.849 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 92.19 -88.79 1.35 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.465 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 72.1 p -129.32 133.6 47.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.81 0.338 . . . . 0.0 111.154 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 128.77 56.19 0.11 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.483 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -114.4 157.28 23.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.974 0.416 . . . . 0.0 110.842 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 349' ' ' LYS . . . . . 0.468 ' HB3' ' N ' ' A' ' 362' ' ' PHE . 74.4 mttt -104.2 93.95 6.21 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.548 0.69 . . . . 0.0 110.873 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -36.61 10.62 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.677 2.251 . . . . 0.0 112.408 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 351' ' ' PHE . . . . . 0.622 ' HB3' HD22 ' A' ' 368' ' ' LEU . 86.2 m-85 -67.57 98.28 0.67 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.907 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -107.45 138.83 42.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.07 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 45.3 t -55.35 132.65 48.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.885 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 28.0 m -79.93 -18.86 49.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.125 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.56 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 58.7 t-105 -55.8 139.9 68.92 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.588 0.709 . . . . 0.0 110.949 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 356' ' ' PRO . . . . . 0.525 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 54.1 Cg_endo -69.7 137.73 36.33 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.711 2.274 . . . . 0.0 112.367 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 83.77 -37.29 2.81 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.498 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 47.0 t -65.13 153.81 39.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.859 0.362 . . . . 0.0 110.923 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -142.45 44.73 0.96 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.485 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 43.3 m95 -97.98 130.67 44.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.791 0.329 . . . . 0.0 110.926 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 361' ' ' ARG . . . . . . . . . . . . . 30.7 mtt180 -122.23 163.34 19.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.861 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 362' ' ' PHE . . . . . 0.529 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 23.5 m-85 -148.81 148.93 30.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.896 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 34.4 p -72.13 -35.48 69.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.841 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 64.3 mtt180 -112.9 165.58 12.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.886 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 365' ' ' SER . . . . . 0.446 ' HB2' ' CE2' ' A' ' 351' ' ' PHE . 26.3 t -71.54 -52.7 16.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.909 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -51.02 -31.37 18.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.894 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -71.25 -29.2 64.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.874 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.622 HD22 ' HB3' ' A' ' 351' ' ' PHE . 10.4 tp -86.71 -47.16 9.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.924 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 22.1 t -54.43 -43.5 71.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.836 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -59.69 -35.42 74.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.87 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 22.8 t60 -70.84 -41.77 71.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.883 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -45.96 -27.64 0.95 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.881 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 373' ' ' ARG . . . . . 0.428 ' NH1' ' HB3' ' A' ' 373' ' ' ARG . 10.1 mtp-105 -53.45 -43.86 68.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.892 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 28.5 t -49.91 -33.47 17.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.863 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 375' ' ' HIS . . . . . 0.56 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 78.3 m-70 -95.77 172.39 8.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.87 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 3.3 m -76.99 -65.03 1.0 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.895 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 135.53 -77.99 0.35 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.493 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 31.5 m -113.35 129.19 69.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.94 0.4 . . . . 0.0 111.17 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 379' ' ' LYS . . . . . 0.475 ' CG ' ' HD2' ' A' ' 380' ' ' PRO . 25.3 ttpt -51.45 139.37 27.77 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.59 0.71 . . . . 0.0 110.872 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 380' ' ' PRO . . . . . 0.475 ' HD2' ' CG ' ' A' ' 379' ' ' LYS . 53.7 Cg_endo -69.78 150.09 67.65 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.705 2.27 . . . . 0.0 112.328 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 27.7 t -167.74 120.28 0.9 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.843 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 177.6 138.46 3.04 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.479 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 383' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -15.92 37.52 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.662 2.241 . . . . 0.0 112.345 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 8.4 t -60.12 -62.68 1.69 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.882 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 79.2 p -84.48 136.11 33.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.86 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.512 179.994 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 200' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 339' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 28.4 t -84.73 -44.22 13.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.843 0.354 . . . . 0.0 110.834 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 50.1 p -149.26 171.79 15.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.855 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . -76.65 175.23 53.51 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.497 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 24.0 t -40.95 -54.64 2.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.883 0.373 . . . . 0.0 110.859 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 68.4 m -64.02 -59.11 4.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.872 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 70.64 104.18 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.542 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 28.7 p 38.36 40.64 0.37 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.805 0.336 . . . . 0.0 111.153 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -80.69 -135.1 1.53 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.534 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -161.29 130.99 4.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.919 0.39 . . . . 0.0 110.872 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 349' ' ' LYS . . . . . 0.41 ' HA ' ' HD2' ' A' ' 350' ' ' PRO . 53.0 mttp -134.59 93.34 18.6 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.565 0.697 . . . . 0.0 110.903 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 350' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 349' ' ' LYS . 53.4 Cg_endo -69.74 -25.17 28.97 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.66 2.24 . . . . 0.0 112.335 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 351' ' ' PHE . . . . . 0.558 ' HB3' HD22 ' A' ' 368' ' ' LEU . 84.5 m-85 -80.35 92.88 5.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.912 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -104.09 139.09 39.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.104 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 353' ' ' CYS . . . . . 0.44 ' HA ' HD11 ' A' ' 368' ' ' LEU . 50.2 t -53.28 148.68 8.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.836 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 82.6 p -94.83 -26.55 16.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.111 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.566 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 49.8 t-105 -52.47 140.58 35.73 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.62 0.724 . . . . 0.0 110.924 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 356' ' ' PRO . . . . . 0.512 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 53.3 Cg_endo -69.78 138.94 38.95 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.652 2.235 . . . . 0.0 112.341 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 84.22 -37.82 2.87 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.52 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 49.1 t -63.49 155.64 28.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.927 0.394 . . . . 0.0 110.862 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -142.58 37.91 1.49 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.519 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 42.7 m95 -92.19 128.97 38.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.758 0.313 . . . . 0.0 110.899 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 361' ' ' ARG . . . . . 0.487 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 56.6 mtt180 -124.34 165.01 18.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.926 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 362' ' ' PHE . . . . . 0.487 ' CD1' ' C ' ' A' ' 361' ' ' ARG . 7.6 m-85 -149.98 152.11 34.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.86 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 49.9 m -77.9 -22.85 49.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.867 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -118.72 165.99 13.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.832 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 365' ' ' SER . . . . . 0.492 ' HA ' ' CD1' ' A' ' 351' ' ' PHE . 1.3 t -74.17 -55.76 5.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.836 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -49.36 -45.97 46.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.868 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -54.58 -35.91 63.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.861 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.558 HD22 ' HB3' ' A' ' 351' ' ' PHE . 14.3 tp -79.64 -42.55 24.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 44.7 t -57.8 -49.16 77.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.848 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -56.15 -31.61 63.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.868 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 20.1 t60 -73.15 -46.29 51.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.862 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 372' ' ' ARG . . . . . 0.421 ' NH1' ' HB3' ' A' ' 372' ' ' ARG . 5.6 mmm180 -41.34 -29.98 0.16 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.905 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 84.5 mtt180 -51.08 -46.66 61.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.878 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 85.3 p -43.56 -38.18 2.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 375' ' ' HIS . . . . . 0.566 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 39.0 m-70 -94.8 172.84 7.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.858 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 3.0 m -106.36 158.15 17.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.832 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -167.56 122.81 1.07 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.452 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 378' ' ' VAL . . . . . 0.415 ' O ' HG23 ' A' ' 378' ' ' VAL . 33.0 m -108.63 126.68 65.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.879 0.371 . . . . 0.0 111.092 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 379' ' ' LYS . . . . . 0.478 ' CD ' ' HD2' ' A' ' 380' ' ' PRO . 33.2 tptt -82.14 137.74 45.99 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.589 0.709 . . . . 0.0 110.894 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 380' ' ' PRO . . . . . 0.478 ' HD2' ' CD ' ' A' ' 379' ' ' LYS . 53.4 Cg_endo -69.75 165.95 29.23 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.664 2.242 . . . . 0.0 112.348 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 2.2 m 63.53 38.28 9.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.871 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 122.25 146.12 7.19 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.478 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 383' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 170.88 15.47 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.723 2.282 . . . . 0.0 112.33 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 83.8 p -127.24 168.83 14.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.851 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 14.8 t -60.42 128.25 35.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.868 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.501 -179.996 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 200' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 349' ' ' LYS . . . . . 0.412 ' HB3' ' C ' ' A' ' 362' ' ' PHE . 37.7 mttt . . . . . 0 C--O 1.232 0.148 0 CA-C-O 121.599 0.714 . . . . 0.0 110.943 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 350' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 349' ' ' LYS . 54.0 Cg_endo -69.77 -25.64 28.33 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.698 2.265 . . . . 0.0 112.323 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 351' ' ' PHE . . . . . 0.688 ' HB3' HD22 ' A' ' 368' ' ' LEU . 90.0 m-85 -79.88 96.46 6.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.898 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -106.63 131.58 53.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.074 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 42.5 t -48.38 150.7 1.23 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.87 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 47.9 p -95.85 -30.68 13.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.153 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.577 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 44.7 t-105 -47.45 140.82 7.25 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.518 0.675 . . . . 0.0 110.918 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 356' ' ' PRO . . . . . 0.532 ' O ' ' CD1' ' A' ' 355' ' ' TRP . 54.0 Cg_endo -69.73 141.18 44.64 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.682 2.255 . . . . 0.0 112.375 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 81.88 -36.05 2.51 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.467 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 49.4 t -65.97 150.77 48.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.866 0.365 . . . . 0.0 110.874 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -142.37 46.15 0.89 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.476 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 44.0 m95 -99.06 128.86 45.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.746 0.308 . . . . 0.0 110.959 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 361' ' ' ARG . . . . . . . . . . . . . 29.6 mtt180 -120.64 156.55 31.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.87 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 362' ' ' PHE . . . . . 0.529 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 23.2 m-85 -140.92 147.02 38.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.932 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 74.3 m -76.23 -22.11 55.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.864 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -118.27 161.62 19.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.846 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 85.8 p -70.95 -56.15 6.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.88 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -49.71 -40.61 41.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.903 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -59.62 -33.14 71.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.856 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.688 HD22 ' HB3' ' A' ' 351' ' ' PHE . 8.4 tp -81.6 -42.56 19.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.927 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 42.8 t -60.1 -46.7 88.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.831 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -59.86 -30.88 69.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.883 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 371' ' ' HIS . . . . . 0.412 ' CB ' ' CZ ' ' A' ' 362' ' ' PHE . 20.0 t60 -73.94 -48.5 30.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.85 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 27.0 mmm-85 -41.44 -29.5 0.16 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.864 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 73.0 mtt180 -52.91 -45.69 67.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.883 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 61.9 m -44.36 -34.01 1.84 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.843 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 375' ' ' HIS . . . . . 0.577 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 57.3 m-70 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.873 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 349' ' ' LYS . . . . . 0.475 ' HB3' ' N ' ' A' ' 362' ' ' PHE . 53.3 mttm . . . . . 0 C--O 1.231 0.122 0 CA-C-O 121.527 0.68 . . . . 0.0 110.858 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 350' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 349' ' ' LYS . 53.6 Cg_endo -69.76 -34.94 13.55 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.716 2.277 . . . . 0.0 112.349 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 351' ' ' PHE . . . . . 0.717 ' HB3' HD22 ' A' ' 368' ' ' LEU . 97.7 m-85 -68.2 103.25 1.52 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.868 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -107.66 129.59 55.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.082 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 353' ' ' CYS . . . . . 0.455 ' HA ' HD11 ' A' ' 368' ' ' LEU . 40.5 t -47.41 146.12 2.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.889 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 58.5 m -91.37 -32.14 15.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.16 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.522 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 46.7 t-105 -47.13 140.72 6.51 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.593 0.711 . . . . 0.0 110.915 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 356' ' ' PRO . . . . . 0.517 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 53.8 Cg_endo -69.77 139.46 40.26 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.636 2.224 . . . . 0.0 112.367 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 83.39 -41.13 2.89 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.552 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 36.1 t -61.39 150.14 36.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.928 0.394 . . . . 0.0 110.839 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -139.78 45.16 1.02 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.532 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 25.2 m95 -97.68 130.99 44.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.758 0.313 . . . . 0.0 110.896 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 361' ' ' ARG . . . . . 0.421 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 67.5 mtt180 -121.49 165.66 15.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.867 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 362' ' ' PHE . . . . . 0.475 ' N ' ' HB3' ' A' ' 349' ' ' LYS . 14.5 m-85 -150.83 156.43 41.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.853 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 15.3 t -78.92 -37.46 39.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.872 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -106.91 161.25 14.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.894 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 365' ' ' SER . . . . . 0.538 ' HB3' ' CE1' ' A' ' 351' ' ' PHE . 54.4 p -71.3 -38.1 71.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.879 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -62.51 -45.62 92.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.89 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -55.51 -34.48 64.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.873 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.717 HD22 ' HB3' ' A' ' 351' ' ' PHE . 9.0 tp -79.25 -42.96 24.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.902 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 18.3 t -58.13 -44.9 88.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.809 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 370' ' ' ARG . . . . . 0.411 ' HG3' ' N ' ' A' ' 371' ' ' HIS . 29.6 ptt85 -61.82 -30.46 70.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.848 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 371' ' ' HIS . . . . . 0.411 ' N ' ' HG3' ' A' ' 370' ' ' ARG . 22.5 t60 -74.4 -39.0 62.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.863 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 26.3 mmm-85 -51.31 -25.1 5.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.863 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 28.8 mtt85 -57.56 -40.87 79.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 58.0 m -50.35 -30.87 13.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.879 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 375' ' ' HIS . . . . . 0.522 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 68.5 m-70 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.848 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 349' ' ' LYS . . . . . 0.424 ' HA ' ' HD2' ' A' ' 350' ' ' PRO . 79.4 mttt . . . . . 0 C--O 1.232 0.157 0 CA-C-O 121.6 0.714 . . . . 0.0 110.901 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 350' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 349' ' ' LYS . 53.8 Cg_endo -69.75 -31.23 20.96 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.69 2.26 . . . . 0.0 112.355 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 351' ' ' PHE . . . . . 0.594 ' HB3' HD22 ' A' ' 368' ' ' LEU . 95.4 m-85 -73.53 97.12 2.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.896 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -108.39 143.85 36.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.043 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 51.5 t -59.94 147.95 36.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.868 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 57.7 m -90.64 -29.25 17.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.157 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.575 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 52.8 t-105 -48.23 140.36 9.56 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.547 0.689 . . . . 0.0 110.92 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 356' ' ' PRO . . . . . 0.509 ' HD2' ' CG ' ' A' ' 355' ' ' TRP . 54.2 Cg_endo -69.77 140.45 42.65 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.715 2.276 . . . . 0.0 112.342 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 83.05 -36.94 2.7 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.475 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 42.4 t -64.55 152.71 41.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.884 0.373 . . . . 0.0 110.857 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -141.92 38.9 1.44 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.477 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 30.4 m95 -91.46 127.89 37.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.713 0.292 . . . . 0.0 110.916 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 361' ' ' ARG . . . . . 0.441 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 33.2 mtt180 -123.19 161.36 24.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.861 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 362' ' ' PHE . . . . . 0.441 ' CD1' ' C ' ' A' ' 361' ' ' ARG . 4.7 m-85 -147.67 153.38 39.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 33.8 t -75.8 -34.94 60.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.837 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -108.74 168.37 9.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 74.0 p -75.24 -56.82 4.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.868 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -46.46 -41.47 13.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.856 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -60.33 -35.02 74.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.863 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.594 HD22 ' HB3' ' A' ' 351' ' ' PHE . 11.7 tp -80.71 -44.17 19.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.922 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 14.7 t -57.87 -46.43 84.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.857 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -58.85 -27.96 65.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.884 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 19.8 t60 -76.99 -46.46 23.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.864 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 41.0 mmm-85 -43.55 -28.83 0.41 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.883 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 79.1 mtt180 -50.51 -45.36 56.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.848 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 1.3 t -44.73 -39.59 5.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.846 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 375' ' ' HIS . . . . . 0.575 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 42.8 m-70 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.871 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 349' ' ' LYS . . . . . 0.424 ' HA ' ' HD2' ' A' ' 350' ' ' PRO . 79.3 mttt . . . . . 0 C--O 1.231 0.109 0 CA-C-O 121.539 0.685 . . . . 0.0 110.938 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 350' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 349' ' ' LYS . 53.3 Cg_endo -69.74 -30.55 22.18 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.701 2.267 . . . . 0.0 112.319 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 351' ' ' PHE . . . . . 0.669 ' HB3' HD22 ' A' ' 368' ' ' LEU . 99.0 m-85 -73.24 99.65 2.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -106.76 138.09 43.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.106 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 353' ' ' CYS . . . . . 0.419 ' HA ' HD11 ' A' ' 368' ' ' LEU . 42.0 t -54.11 151.96 6.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.868 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 61.4 p -94.5 -31.83 13.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.151 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.562 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 52.8 t-105 -49.2 140.46 12.39 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.566 0.698 . . . . 0.0 110.909 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 356' ' ' PRO . . . . . 0.514 ' HD2' ' CG ' ' A' ' 355' ' ' TRP . 53.6 Cg_endo -69.78 140.27 42.19 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.682 2.255 . . . . 0.0 112.358 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 83.71 -42.5 3.05 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.497 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 49.6 t -59.34 151.12 24.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.87 0.367 . . . . 0.0 110.91 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -139.02 41.64 1.33 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.47 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 23.1 m95 -93.23 128.1 39.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.81 0.338 . . . . 0.0 110.92 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 361' ' ' ARG . . . . . 0.408 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 65.7 mtt180 -123.21 162.97 21.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.923 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 362' ' ' PHE . . . . . 0.489 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 11.0 m-85 -149.34 154.56 39.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.883 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 30.6 t -76.6 -35.43 58.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.917 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -108.36 170.99 7.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.877 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 12.6 t -76.06 -57.08 4.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.885 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -46.6 -46.18 19.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.879 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 367' ' ' GLU . . . . . 0.422 ' HA ' ' NE ' ' A' ' 370' ' ' ARG . 5.4 mm-40 -54.89 -34.01 62.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.928 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.669 HD22 ' HB3' ' A' ' 351' ' ' PHE . 13.1 tp -82.42 -42.34 18.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.897 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 46.0 m -60.1 -43.65 95.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.845 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 370' ' ' ARG . . . . . 0.422 ' NE ' ' HA ' ' A' ' 367' ' ' GLU . 19.6 ptp180 -61.97 -28.6 69.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.855 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 19.9 t60 -76.9 -44.16 32.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.889 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 28.7 mmm-85 -45.8 -27.63 0.89 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.85 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 48.8 mtm180 -51.66 -45.89 63.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.874 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 14.4 t -45.73 -36.59 5.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.869 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 375' ' ' HIS . . . . . 0.562 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 39.1 m-70 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.829 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 349' ' ' LYS . . . . . 0.455 ' HB3' ' N ' ' A' ' 362' ' ' PHE . 40.1 mttm . . . . . 0 C--O 1.232 0.14 0 CA-C-O 121.572 0.701 . . . . 0.0 110.859 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 350' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 349' ' ' LYS . 53.6 Cg_endo -69.8 -36.36 10.86 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.693 2.262 . . . . 0.0 112.364 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 351' ' ' PHE . . . . . 0.552 ' HB3' HD22 ' A' ' 368' ' ' LEU . 97.0 m-85 -68.47 98.96 0.9 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.832 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -107.95 136.8 47.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.118 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 353' ' ' CYS . . . . . 0.607 ' HA ' HD11 ' A' ' 368' ' ' LEU . 45.0 t -50.76 151.45 2.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.91 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 76.9 m -93.79 -33.76 13.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.151 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.566 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 50.8 t-105 -45.12 140.42 3.69 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.605 0.717 . . . . 0.0 110.916 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 356' ' ' PRO . . . . . 0.505 ' HD2' ' CG ' ' A' ' 355' ' ' TRP . 53.4 Cg_endo -69.81 140.48 42.61 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.666 2.244 . . . . 0.0 112.347 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 83.49 -39.62 2.81 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.51 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 45.9 t -61.48 152.35 30.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.886 0.374 . . . . 0.0 110.881 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -140.55 41.67 1.26 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.524 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 29.3 m95 -94.08 129.29 40.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.765 0.317 . . . . 0.0 110.888 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 361' ' ' ARG . . . . . 0.424 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 32.3 mtt180 -122.91 164.33 18.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.879 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 362' ' ' PHE . . . . . 0.509 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 10.7 m-85 -150.69 155.36 39.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.938 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 28.7 t -77.21 -36.58 54.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.912 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 69.9 mtt180 -108.73 161.53 15.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.91 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 82.7 p -67.74 -52.71 34.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.05 -40.22 57.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.867 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -60.68 -30.35 69.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.88 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.607 HD11 ' HA ' ' A' ' 353' ' ' CYS . 10.4 tp -85.73 -44.47 12.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.91 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 23.2 t -57.61 -46.42 84.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.847 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -57.84 -34.42 69.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.873 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 27.0 t60 -69.58 -47.49 63.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.823 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 45.0 mmm-85 -41.21 -30.29 0.16 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 47.5 mtm180 -48.21 -46.98 35.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.844 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 93.0 p -44.83 -41.52 7.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.888 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 375' ' ' HIS . . . . . 0.566 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 49.1 m-70 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.906 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 349' ' ' LYS . . . . . 0.417 ' HB3' ' N ' ' A' ' 362' ' ' PHE . 39.4 mttp . . . . . 0 C--O 1.231 0.101 0 CA-C-O 121.559 0.695 . . . . 0.0 110.896 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -32.62 18.23 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.668 2.245 . . . . 0.0 112.349 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 351' ' ' PHE . . . . . 0.671 ' HB3' HD22 ' A' ' 368' ' ' LEU . 79.6 m-85 -70.1 98.09 1.27 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -105.56 132.84 51.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.11 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 40.6 t -51.25 144.81 8.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.903 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 86.8 m -86.85 -33.25 19.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.114 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.578 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 60.5 t-105 -43.91 139.81 2.84 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.57 0.7 . . . . 0.0 110.891 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 356' ' ' PRO . . . . . 0.524 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 53.9 Cg_endo -69.75 138.69 38.46 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.661 2.24 . . . . 0.0 112.372 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 83.6 -45.26 3.43 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.509 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 54.0 t -53.27 157.4 1.95 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.854 0.359 . . . . 0.0 110.89 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -145.49 44.8 0.85 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.451 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 21.8 m95 -97.6 128.96 44.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.766 0.317 . . . . 0.0 110.91 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 361' ' ' ARG . . . . . . . . . . . . . 47.2 mtt180 -122.47 160.35 25.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.887 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 362' ' ' PHE . . . . . 0.509 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 6.1 m-85 -147.31 155.77 42.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.883 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 46.7 t -83.9 -29.48 27.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.884 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 31.7 mtp180 -113.21 165.38 12.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.904 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 1.2 m -70.23 -62.43 1.39 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.819 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -45.38 -38.33 5.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.862 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -60.22 -37.51 80.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.903 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.671 HD22 ' HB3' ' A' ' 351' ' ' PHE . 10.1 tp -80.79 -44.8 17.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.907 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 74.6 m -56.5 -48.02 78.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.887 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 370' ' ' ARG . . . . . 0.456 ' HG3' ' N ' ' A' ' 371' ' ' HIS . 6.8 ptm180 -56.38 -30.29 62.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.911 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 371' ' ' HIS . . . . . 0.456 ' N ' ' HG3' ' A' ' 370' ' ' ARG . 23.8 t60 -74.23 -45.91 45.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.843 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 42.3 mmm-85 -43.28 -29.26 0.39 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 60.6 mtt180 -49.64 -47.45 49.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.892 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 56.0 p -45.17 -38.79 5.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.833 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 375' ' ' HIS . . . . . 0.578 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 45.2 m-70 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.898 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 349' ' ' LYS . . . . . 0.424 ' HA ' ' HD2' ' A' ' 350' ' ' PRO . 46.0 mttp . . . . . 0 C--O 1.231 0.118 0 CA-C-O 121.619 0.723 . . . . 0.0 110.919 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 350' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 349' ' ' LYS . 53.5 Cg_endo -69.76 -28.25 25.49 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.7 2.267 . . . . 0.0 112.308 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 351' ' ' PHE . . . . . 0.808 ' HB3' HD22 ' A' ' 368' ' ' LEU . 80.8 m-85 -74.39 102.04 4.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.864 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -109.58 131.75 54.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.097 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 51.1 t -48.63 147.4 2.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.905 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 88.7 m -92.06 -34.6 14.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.181 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.574 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 58.0 t-105 -44.29 139.99 3.1 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.542 0.687 . . . . 0.0 110.941 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 356' ' ' PRO . . . . . 0.516 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 54.0 Cg_endo -69.72 138.18 37.33 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.693 2.262 . . . . 0.0 112.381 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 84.28 -41.58 3.01 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.471 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 42.4 t -60.23 152.08 25.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.863 0.364 . . . . 0.0 110.903 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -140.51 45.96 0.95 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.446 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 25.0 m95 -98.03 129.81 44.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.786 0.327 . . . . 0.0 110.913 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 361' ' ' ARG . . . . . 0.49 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 72.3 mtt180 -121.0 167.46 12.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.868 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 362' ' ' PHE . . . . . 0.518 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 7.4 m-85 -153.13 147.77 26.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.854 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 68.1 m -73.16 -33.48 65.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.899 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -110.45 171.13 7.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.88 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 37.4 t -75.68 -55.09 5.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.858 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -49.87 -48.08 51.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.877 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -52.42 -32.8 40.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.875 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.808 HD22 ' HB3' ' A' ' 351' ' ' PHE . 10.9 tp -84.13 -43.29 15.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.92 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 12.2 t -58.28 -45.06 88.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.853 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 370' ' ' ARG . . . . . 0.476 ' CZ ' ' HB2' ' A' ' 370' ' ' ARG . 3.8 ptm85 -58.81 -31.34 68.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.861 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 371' ' ' HIS . . . . . 0.415 ' CB ' ' CZ ' ' A' ' 362' ' ' PHE . 11.0 t60 -73.34 -47.44 42.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.838 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 24.8 mmm-85 -43.55 -28.24 0.36 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.867 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 81.2 mtt180 -51.87 -44.75 63.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.897 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 4.9 t -48.58 -32.16 7.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.836 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 375' ' ' HIS . . . . . 0.574 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 57.7 m-70 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.844 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 349' ' ' LYS . . . . . 0.462 ' HB3' ' N ' ' A' ' 362' ' ' PHE . 46.2 mttm . . . . . 0 C--O 1.231 0.112 0 CA-C-O 121.538 0.685 . . . . 0.0 110.912 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 350' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 349' ' ' LYS . 53.7 Cg_endo -69.76 -31.69 20.04 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.696 2.264 . . . . 0.0 112.344 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 351' ' ' PHE . . . . . 0.544 ' HB3' HD22 ' A' ' 368' ' ' LEU . 93.6 m-85 -72.96 94.04 1.81 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.897 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -101.46 147.0 26.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.096 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 53.2 t -66.24 145.02 56.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 46.2 p -90.63 -27.38 19.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.126 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.575 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 61.7 t-105 -47.86 139.64 9.08 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.58 0.705 . . . . 0.0 110.886 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 356' ' ' PRO . . . . . 0.527 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 54.0 Cg_endo -69.77 136.97 34.33 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.703 2.269 . . . . 0.0 112.319 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 84.16 -36.13 2.92 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.493 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 48.3 t -65.93 156.64 32.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.87 0.366 . . . . 0.0 110.879 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -147.04 44.79 0.8 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.481 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 39.8 m95 -96.74 129.99 44.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.813 0.34 . . . . 0.0 110.884 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 361' ' ' ARG . . . . . 0.449 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 51.1 mtm-85 -121.71 163.67 18.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.853 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 362' ' ' PHE . . . . . 0.47 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 7.3 m-85 -149.35 151.83 34.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.865 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 29.6 t -75.02 -36.66 61.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.846 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 40.9 mtp85 -109.38 162.91 13.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 90.1 p -68.11 -57.47 6.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.847 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -47.65 -38.15 14.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.91 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -61.66 -32.25 72.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.856 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.544 HD22 ' HB3' ' A' ' 351' ' ' PHE . 7.8 tp -84.53 -46.99 11.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.952 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 46.9 t -54.37 -44.33 72.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.822 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -59.18 -36.3 75.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.815 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 371' ' ' HIS . . . . . 0.413 ' CB ' ' CZ ' ' A' ' 362' ' ' PHE . 18.8 t60 -70.0 -43.46 71.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.877 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 9.3 mmt85 -45.29 -28.21 0.78 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.879 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 47.6 mtp180 -53.04 -43.72 66.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.891 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 49.1 m -47.67 -33.65 7.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.856 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 375' ' ' HIS . . . . . 0.575 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 70.6 m-70 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.859 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 349' ' ' LYS . . . . . 0.405 ' HB3' ' C ' ' A' ' 362' ' ' PHE . 65.8 mttt . . . . . 0 C--O 1.231 0.104 0 CA-C-O 121.598 0.714 . . . . 0.0 110.874 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -33.61 16.34 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.653 2.235 . . . . 0.0 112.357 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 351' ' ' PHE . . . . . 0.729 ' HB3' HD22 ' A' ' 368' ' ' LEU . 90.6 m-85 -69.03 104.81 2.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.869 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -109.53 145.44 36.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.114 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 40.4 t -62.84 150.4 41.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.858 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 71.6 p -94.34 -31.94 13.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.193 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.573 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 58.4 t-105 -46.87 140.03 6.39 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.536 0.684 . . . . 0.0 110.876 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 356' ' ' PRO . . . . . 0.523 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 53.5 Cg_endo -69.82 138.57 37.94 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.662 2.241 . . . . 0.0 112.317 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 83.94 -38.64 2.83 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.483 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 45.3 t -64.04 157.08 26.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.894 0.378 . . . . 0.0 110.87 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -146.36 42.34 0.95 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.476 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 35.8 m95 -92.53 128.45 38.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.761 0.315 . . . . 0.0 110.925 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 361' ' ' ARG . . . . . 0.527 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 50.2 mtm180 -119.88 167.48 12.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.934 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 362' ' ' PHE . . . . . 0.527 ' CD1' ' C ' ' A' ' 361' ' ' ARG . 13.9 m-85 -154.19 149.32 26.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.925 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 72.7 m -77.44 -26.53 51.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.849 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 70.8 mtt180 -116.85 162.16 18.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.854 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 93.8 p -69.42 -57.96 4.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.891 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -48.29 -40.96 26.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.877 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -60.68 -32.91 72.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.908 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.729 HD22 ' HB3' ' A' ' 351' ' ' PHE . 7.1 tp -83.17 -44.78 14.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.929 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 42.7 m -58.09 -45.53 87.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -58.75 -29.03 66.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.87 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 12.0 t60 -75.21 -46.91 30.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.88 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 41.6 mmm-85 -42.4 -29.31 0.26 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.866 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 43.4 mtp180 -49.63 -47.36 49.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.888 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 9.4 t -44.77 -38.93 4.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.85 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 375' ' ' HIS . . . . . 0.573 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 56.2 m-70 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.88 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 349' ' ' LYS . . . . . 0.413 ' HA ' ' HD2' ' A' ' 350' ' ' PRO . 76.6 mttt . . . . . 0 C--O 1.231 0.103 0 CA-C-O 121.566 0.698 . . . . 0.0 110.916 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 350' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 349' ' ' LYS . 54.6 Cg_endo -69.69 -31.32 21.06 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.648 2.232 . . . . 0.0 112.357 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 351' ' ' PHE . . . . . 0.683 ' HB3' HD22 ' A' ' 368' ' ' LEU . 96.1 m-85 -72.69 103.76 3.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.889 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -111.57 139.65 46.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.097 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 39.9 t -59.18 148.29 32.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.934 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 34.2 m -92.9 -31.39 14.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.12 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.572 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 56.3 t-105 -46.97 140.16 6.45 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.54 0.686 . . . . 0.0 110.938 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 356' ' ' PRO . . . . . 0.522 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 53.7 Cg_endo -69.72 141.85 46.54 Favored 'Trans proline' 0 C--N 1.34 0.13 0 C-N-CA 122.69 2.26 . . . . 0.0 112.341 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 81.4 -36.57 2.41 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.465 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 42.8 t -67.4 153.63 43.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.924 0.392 . . . . 0.0 110.86 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -144.36 42.06 1.06 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.5 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 33.4 m95 -93.17 128.54 39.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.781 0.324 . . . . 0.0 110.921 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 361' ' ' ARG . . . . . 0.465 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 40.9 mtm180 -120.71 166.05 14.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.888 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 362' ' ' PHE . . . . . 0.494 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 7.2 m-85 -151.94 151.59 31.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.927 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 24.1 m -80.6 -23.24 39.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.86 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 5.4 mtp-105 -120.0 154.11 35.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.857 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 365' ' ' SER . . . . . 0.401 ' O ' ' N ' ' A' ' 368' ' ' LEU . 89.8 p -62.41 -63.43 1.23 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.867 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -41.65 -42.01 2.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.872 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -59.26 -39.73 83.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.869 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.683 HD22 ' HB3' ' A' ' 351' ' ' PHE . 8.0 tp -77.14 -42.43 37.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.933 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 24.5 t -58.84 -47.22 85.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.824 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -58.71 -28.31 65.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.916 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 24.7 t60 -75.36 -46.38 33.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 44.2 mmm-85 -43.12 -29.44 0.37 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.853 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 68.8 mtm180 -52.2 -44.31 64.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.889 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 58.8 m -46.36 -38.14 8.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.876 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 375' ' ' HIS . . . . . 0.572 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 55.0 m-70 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.852 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 349' ' ' LYS . . . . . 0.411 ' HA ' ' HD2' ' A' ' 350' ' ' PRO . 30.5 mttm . . . . . 0 C--O 1.232 0.139 0 CA-C-O 121.546 0.689 . . . . 0.0 110.923 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 350' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 349' ' ' LYS . 53.6 Cg_endo -69.78 -28.69 24.85 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.719 2.28 . . . . 0.0 112.321 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 351' ' ' PHE . . . . . 0.677 ' HB3' HD22 ' A' ' 368' ' ' LEU . 94.6 m-85 -75.61 98.65 4.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.844 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -106.51 145.55 31.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.117 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 35.8 t -62.08 148.2 44.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.917 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 41.8 m -92.89 -31.87 14.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.131 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.577 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 55.7 t-105 -49.54 140.23 14.22 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.574 0.702 . . . . 0.0 110.951 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 356' ' ' PRO . . . . . 0.517 ' HD2' ' CG ' ' A' ' 355' ' ' TRP . 53.9 Cg_endo -69.78 140.71 43.28 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.676 2.25 . . . . 0.0 112.349 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 84.03 -41.53 2.99 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.474 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 44.9 t -63.28 150.9 42.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.888 0.375 . . . . 0.0 110.92 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -140.19 44.03 1.09 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.476 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 39.3 m95 -93.91 129.56 40.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.728 0.299 . . . . 0.0 110.946 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 361' ' ' ARG . . . . . 0.426 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 56.7 mtm180 -122.73 164.61 17.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.902 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 362' ' ' PHE . . . . . 0.469 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 11.3 m-85 -151.37 151.01 31.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.857 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 50.4 m -78.15 -25.8 47.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.871 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 78.1 mtt-85 -115.36 163.27 15.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.915 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 88.2 p -72.39 -53.47 12.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.851 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -50.23 -44.61 53.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.87 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -57.24 -34.4 68.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.864 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.677 HD22 ' HB3' ' A' ' 351' ' ' PHE . 6.5 tp -80.49 -44.38 19.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.915 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 14.9 m -57.87 -45.12 86.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.851 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -60.67 -28.27 68.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.839 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 16.8 t60 -76.7 -44.84 31.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.875 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 45.7 mmm-85 -45.43 -28.14 0.83 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.864 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -52.66 -44.57 66.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.878 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 39.2 m -46.69 -38.12 9.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.883 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 375' ' ' HIS . . . . . 0.577 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 38.3 m-70 . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.878 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 349' ' ' LYS . . . . . 0.43 ' HA ' ' HD2' ' A' ' 350' ' ' PRO . 64.1 mttt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 121.592 0.711 . . . . 0.0 110.871 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 350' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 349' ' ' LYS . 53.4 Cg_endo -69.76 -31.57 20.27 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.685 2.256 . . . . 0.0 112.317 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 351' ' ' PHE . . . . . 0.687 ' HB3' HD22 ' A' ' 368' ' ' LEU . 97.0 m-85 -71.74 100.48 2.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.872 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -108.47 132.92 53.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.121 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 353' ' ' CYS . . . . . 0.553 ' HA ' HD11 ' A' ' 368' ' ' LEU . 35.9 t -49.55 153.95 1.05 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.902 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 30.6 m -94.92 -34.55 12.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.191 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.555 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 46.9 t-105 -44.59 140.66 3.1 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.555 0.693 . . . . 0.0 110.932 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 356' ' ' PRO . . . . . 0.521 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 53.7 Cg_endo -69.72 140.07 41.91 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.671 2.247 . . . . 0.0 112.372 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 83.65 -41.97 3.0 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.463 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 34.9 t -58.81 149.69 25.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.936 0.398 . . . . 0.0 110.908 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -139.21 42.53 1.24 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.456 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 37.0 m95 -94.8 128.61 41.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.771 0.319 . . . . 0.0 110.874 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 361' ' ' ARG . . . . . 0.408 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 37.7 mtt180 -121.74 159.15 27.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.923 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 362' ' ' PHE . . . . . 0.434 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 4.8 m-85 -144.64 152.47 40.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.874 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 36.2 t -74.39 -34.57 63.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.874 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 36.3 mtt-85 -110.63 169.7 8.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.872 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 68.2 p -74.76 -57.4 3.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.893 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -47.34 -44.93 24.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.859 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -55.97 -32.67 64.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.906 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.687 HD22 ' HB3' ' A' ' 351' ' ' PHE . 12.5 tp -83.78 -42.72 16.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.913 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 14.8 t -58.66 -46.88 86.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.836 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 48.6 ptt85 -58.01 -29.29 65.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.849 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -74.34 -45.62 46.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.843 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . 0.416 ' HB3' ' NH1' ' A' ' 372' ' ' ARG . 4.6 mmm180 -42.98 -29.46 0.34 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.853 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 77.4 mtt180 -50.85 -45.5 59.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.846 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 3.2 m -44.56 -39.48 4.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.879 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 375' ' ' HIS . . . . . 0.555 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 48.2 m-70 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.848 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 349' ' ' LYS . . . . . 0.414 ' HB3' ' C ' ' A' ' 362' ' ' PHE . 47.7 mttm . . . . . 0 C--O 1.231 0.128 0 CA-C-O 121.555 0.693 . . . . 0.0 110.877 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 350' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 349' ' ' LYS . 53.7 Cg_endo -69.73 -26.29 27.88 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.705 2.27 . . . . 0.0 112.366 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 351' ' ' PHE . . . . . 0.651 ' HB3' HD22 ' A' ' 368' ' ' LEU . 89.4 m-85 -79.95 97.78 6.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.906 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 352' ' ' ALA . . . . . 0.457 ' CB ' ' HG2' ' A' ' 361' ' ' ARG . . . -110.17 144.0 39.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.12 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 43.5 t -60.13 144.68 49.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.881 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 62.3 p -93.94 -26.14 16.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.178 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.569 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 60.3 t-105 -49.87 139.82 16.4 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.571 0.7 . . . . 0.0 110.927 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 356' ' ' PRO . . . . . 0.525 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 54.1 Cg_endo -69.77 137.93 36.59 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.709 2.273 . . . . 0.0 112.321 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 84.53 -33.83 3.19 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.478 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 49.9 t -72.97 153.77 40.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.904 0.383 . . . . 0.0 110.881 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -143.71 48.55 0.74 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.456 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 39.2 m95 -97.93 128.66 44.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.8 0.333 . . . . 0.0 110.875 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 361' ' ' ARG . . . . . 0.507 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 58.1 mtm180 -121.72 164.21 17.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.905 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 362' ' ' PHE . . . . . 0.507 ' CD1' ' C ' ' A' ' 361' ' ' ARG . 4.5 m-85 -151.23 151.13 31.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.896 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 52.6 m -80.06 -19.43 47.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.896 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 5.5 mpt_? -122.94 162.14 22.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.851 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 9.8 t -70.17 -62.74 1.27 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.874 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -43.66 -41.21 4.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.851 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 367' ' ' GLU . . . . . 0.414 ' O ' ' CG ' ' A' ' 370' ' ' ARG . 24.2 mm-40 -59.29 -40.11 85.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.888 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.651 HD22 ' HB3' ' A' ' 351' ' ' PHE . 12.5 tp -77.06 -44.96 28.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.895 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 30.4 t -55.73 -44.67 77.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.846 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 370' ' ' ARG . . . . . 0.442 ' HG3' ' N ' ' A' ' 371' ' ' HIS . 9.6 ptt180 -59.32 -33.86 71.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.899 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 371' ' ' HIS . . . . . 0.442 ' N ' ' HG3' ' A' ' 370' ' ' ARG . 17.3 t60 -71.31 -46.69 60.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.9 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . 0.41 ' HB3' ' NH1' ' A' ' 372' ' ' ARG . 4.9 mmm180 -41.42 -30.13 0.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.838 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -49.67 -44.36 47.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.864 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 1.4 t -46.51 -33.44 4.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.881 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 375' ' ' HIS . . . . . 0.569 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 53.2 m-70 . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.884 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 349' ' ' LYS . . . . . 0.477 ' HB3' ' N ' ' A' ' 362' ' ' PHE . 36.9 mttp . . . . . 0 N--CA 1.457 -0.099 0 CA-C-O 121.574 0.702 . . . . 0.0 110.915 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 350' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 349' ' ' LYS . 54.0 Cg_endo -69.77 -32.2 18.99 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.696 2.264 . . . . 0.0 112.319 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 351' ' ' PHE . . . . . 0.636 ' HB3' HD22 ' A' ' 368' ' ' LEU . 98.3 m-85 -72.16 99.2 2.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.847 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -106.72 141.68 37.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.059 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 39.6 t -58.8 149.18 27.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.881 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 27.0 m -90.75 -33.19 15.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.138 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.573 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 56.2 t-105 -45.21 140.16 3.91 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.587 0.708 . . . . 0.0 110.865 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 356' ' ' PRO . . . . . 0.514 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 53.9 Cg_endo -69.74 142.37 47.84 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.713 2.275 . . . . 0.0 112.329 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 80.95 -37.99 2.36 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.491 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 49.7 t -63.12 154.52 30.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.827 0.346 . . . . 0.0 110.88 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -143.8 39.04 1.3 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.5 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 48.0 m95 -92.61 128.03 38.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.72 0.295 . . . . 0.0 110.899 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 361' ' ' ARG . . . . . 0.515 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 43.7 mtm180 -121.2 169.47 10.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.818 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 362' ' ' PHE . . . . . 0.515 ' CD1' ' C ' ' A' ' 361' ' ' ARG . 9.4 m-85 -154.48 153.51 31.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.876 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 27.2 t -75.83 -35.43 59.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.884 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -108.16 167.6 9.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.891 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 54.6 p -73.83 -55.51 6.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.836 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -48.58 -45.46 37.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.869 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -55.25 -33.72 63.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.884 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.636 HD22 ' HB3' ' A' ' 351' ' ' PHE . 6.8 tp -81.98 -45.41 15.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 27.0 t -56.35 -45.99 80.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.854 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 370' ' ' ARG . . . . . 0.44 ' HG3' ' N ' ' A' ' 371' ' ' HIS . 20.4 ptt180 -59.19 -31.96 69.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.88 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 371' ' ' HIS . . . . . 0.44 ' N ' ' HG3' ' A' ' 370' ' ' ARG . 17.7 t60 -73.75 -38.25 64.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.876 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 19.9 mmm-85 -52.0 -24.96 7.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 37.5 mtt85 -55.56 -43.35 75.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.902 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 32.7 t -48.51 -36.02 14.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.89 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 375' ' ' HIS . . . . . 0.573 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 58.6 m-70 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.871 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 349' ' ' LYS . . . . . 0.46 ' HB3' ' N ' ' A' ' 362' ' ' PHE . 46.2 mttm . . . . . 0 C--O 1.231 0.109 0 CA-C-O 121.564 0.697 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 350' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 349' ' ' LYS . 53.4 Cg_endo -69.79 -30.57 21.91 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.659 2.239 . . . . 0.0 112.298 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 351' ' ' PHE . . . . . 0.745 ' HB3' HD22 ' A' ' 368' ' ' LEU . 95.0 m-85 -74.25 95.68 2.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.883 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 352' ' ' ALA . . . . . 0.522 ' HB2' ' HD3' ' A' ' 361' ' ' ARG . . . -103.97 135.58 45.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.089 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 43.5 t -51.77 150.88 3.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.92 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 70.2 p -95.55 -30.69 13.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.147 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.566 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 55.0 t-105 -46.08 140.21 5.14 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.574 0.702 . . . . 0.0 110.895 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 356' ' ' PRO . . . . . 0.513 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 53.9 Cg_endo -69.73 133.8 26.51 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.681 2.254 . . . . 0.0 112.345 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 88.88 -37.75 3.28 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.528 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 46.8 t -64.78 151.86 44.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.917 0.389 . . . . 0.0 110.846 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -141.5 43.1 1.11 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.482 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 37.9 m95 -95.92 129.16 43.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.778 0.323 . . . . 0.0 110.917 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 361' ' ' ARG . . . . . 0.522 ' HD3' ' HB2' ' A' ' 352' ' ' ALA . 25.7 mtt180 -121.51 161.01 23.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.828 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 362' ' ' PHE . . . . . 0.49 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 10.2 m-85 -145.91 153.18 40.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.845 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 45.2 t -78.3 -29.84 48.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.819 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.14 165.78 11.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.848 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 36.1 t -73.89 -47.61 36.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.852 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -56.36 -46.89 79.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.876 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -54.26 -31.43 53.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.844 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.745 HD22 ' HB3' ' A' ' 351' ' ' PHE . 8.4 tp -83.8 -44.03 14.79 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.948 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 5.5 t -57.7 -47.04 83.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.836 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 25.8 ptt180 -57.93 -33.12 68.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.877 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 22.3 t60 -72.32 -43.92 63.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.875 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . 0.412 ' HB3' ' NH1' ' A' ' 372' ' ' ARG . 4.9 mmm180 -44.68 -28.54 0.63 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.906 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 373' ' ' ARG . . . . . 0.432 ' NH1' ' HB3' ' A' ' 373' ' ' ARG . 10.3 mtp-105 -55.39 -42.79 74.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 58.4 m -47.28 -31.43 3.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.863 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 375' ' ' HIS . . . . . 0.566 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 61.8 m-70 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.866 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 349' ' ' LYS . . . . . 0.432 ' NZ ' ' HB2' ' A' ' 361' ' ' ARG . 7.6 mtmp? . . . . . 0 C--O 1.231 0.09 0 CA-C-O 121.584 0.706 . . . . 0.0 110.899 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -28.18 25.6 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.705 2.27 . . . . 0.0 112.316 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 351' ' ' PHE . . . . . 0.601 ' HB3' HD22 ' A' ' 368' ' ' LEU . 84.1 m-85 -76.52 102.26 5.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.871 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -115.8 137.59 51.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.088 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 43.2 t -55.59 146.5 20.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.85 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 93.5 m -93.14 -29.05 15.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.154 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.552 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 59.0 t-105 -47.79 139.91 8.71 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.566 0.698 . . . . 0.0 110.932 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 356' ' ' PRO . . . . . 0.523 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 53.8 Cg_endo -69.8 140.97 43.81 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.707 2.271 . . . . 0.0 112.283 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 81.94 -36.87 2.51 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.503 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 47.2 t -68.29 151.51 46.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.853 0.358 . . . . 0.0 110.922 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -140.61 45.33 0.99 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.513 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 39.3 m95 -94.24 128.65 40.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.794 0.33 . . . . 0.0 110.913 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 361' ' ' ARG . . . . . 0.455 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 18.2 mtt85 -122.61 165.33 16.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.843 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 362' ' ' PHE . . . . . 0.534 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 11.3 m-85 -152.72 151.2 30.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 49.9 m -77.04 -33.41 57.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.855 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -104.67 171.65 7.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.833 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 365' ' ' SER . . . . . 0.57 ' HA ' ' CD1' ' A' ' 351' ' ' PHE . 80.7 p -81.13 -55.64 4.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.865 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.62 -34.59 59.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.853 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -62.75 -34.58 77.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.881 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.601 HD22 ' HB3' ' A' ' 351' ' ' PHE . 9.4 tp -81.01 -45.58 16.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.943 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 58.7 m -56.02 -43.7 78.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.877 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -60.17 -28.9 68.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.855 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -76.44 -43.55 39.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.852 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 22.0 mmm-85 -45.97 -27.14 0.84 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.895 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 25.8 mtp85 -51.13 -46.01 61.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.847 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 58.3 m -46.42 -35.29 5.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.841 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 375' ' ' HIS . . . . . 0.552 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 66.3 m-70 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.861 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 349' ' ' LYS . . . . . 0.421 ' HA ' ' HD2' ' A' ' 350' ' ' PRO . 56.6 mttt . . . . . 0 C--O 1.232 0.14 0 CA-C-O 121.559 0.695 . . . . 0.0 110.892 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 350' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 349' ' ' LYS . 54.3 Cg_endo -69.82 -29.4 23.64 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.721 2.28 . . . . 0.0 112.342 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 351' ' ' PHE . . . . . 0.732 ' HB3' HD22 ' A' ' 368' ' ' LEU . 94.4 m-85 -74.98 100.45 4.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.878 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -107.33 150.49 26.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.067 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 41.0 t -68.06 144.12 55.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.891 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 89.4 m -89.09 -28.69 19.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.139 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.578 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 57.8 t-105 -49.87 140.03 16.12 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.51 0.672 . . . . 0.0 110.931 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 356' ' ' PRO . . . . . 0.524 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 53.8 Cg_endo -69.72 138.64 38.41 Favored 'Trans proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.716 2.278 . . . . 0.0 112.358 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 84.34 -39.87 2.92 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.527 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 44.8 t -63.9 155.18 31.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.868 0.366 . . . . 0.0 110.896 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -145.3 45.21 0.84 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.494 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 32.7 m95 -96.13 128.69 43.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.745 0.307 . . . . 0.0 110.957 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 361' ' ' ARG . . . . . 0.519 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 56.6 mtm-85 -120.77 167.14 12.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.848 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 362' ' ' PHE . . . . . 0.519 ' CD1' ' C ' ' A' ' 361' ' ' ARG . 8.2 m-85 -153.2 146.94 25.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.876 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 29.0 t -70.96 -34.01 71.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.868 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 364' ' ' ARG . . . . . 0.456 ' HD2' ' N ' ' A' ' 364' ' ' ARG . 0.0 OUTLIER -109.66 174.0 6.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.855 -179.913 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 7.1 m -79.6 -57.95 3.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -46.59 -39.44 11.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.859 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 -62.43 -31.64 72.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.864 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.732 HD22 ' HB3' ' A' ' 351' ' ' PHE . 9.1 tp -84.92 -45.91 11.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.898 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 37.1 t -56.43 -46.66 80.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.858 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -58.56 -31.91 68.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.867 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 13.4 t60 -70.87 -46.35 62.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.855 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 54.6 mmm-85 -44.09 -29.08 0.56 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.851 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 62.3 mtt-85 -48.74 -45.92 40.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 36.8 t -47.65 -35.78 9.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.875 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 375' ' ' HIS . . . . . 0.578 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 46.4 m-70 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.869 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? . . . . . 0 C--O 1.231 0.084 0 CA-C-O 121.597 0.713 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -29.82 23.1 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.683 2.255 . . . . 0.0 112.334 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 351' ' ' PHE . . . . . 0.564 ' CD1' ' HA ' ' A' ' 365' ' ' SER . 94.8 m-85 -74.43 95.5 2.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -109.58 139.65 44.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.11 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 53.3 t -58.85 145.07 42.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.865 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 49.9 m -93.11 -27.94 16.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.138 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.526 ' CD2' ' HD2' ' A' ' 356' ' ' PRO . 61.3 t-105 -47.93 139.69 9.22 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.521 0.677 . . . . 0.0 110.918 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 356' ' ' PRO . . . . . 0.526 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 54.0 Cg_endo -69.76 137.62 35.87 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.69 2.26 . . . . 0.0 112.325 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 84.49 -39.94 2.94 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.476 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 41.8 t -62.77 154.64 29.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.884 0.373 . . . . 0.0 110.843 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -142.57 47.71 0.81 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.513 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 31.6 m95 -97.68 132.81 42.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.754 0.311 . . . . 0.0 110.919 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 361' ' ' ARG . . . . . 0.485 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 30.1 mtt180 -128.51 163.23 25.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.875 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 362' ' ' PHE . . . . . 0.551 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 5.6 m-85 -151.94 152.77 32.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 50.7 m -79.06 -27.36 43.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.866 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 364' ' ' ARG . . . . . 0.501 ' C ' ' CD2' ' A' ' 351' ' ' PHE . 66.6 mtt180 -113.27 168.44 9.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.822 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 365' ' ' SER . . . . . 0.564 ' HA ' ' CD1' ' A' ' 351' ' ' PHE . 31.2 t -74.65 -62.85 1.39 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.865 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -44.38 -38.59 4.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.911 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -58.97 -41.79 88.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.885 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.551 ' HA ' ' CD1' ' A' ' 362' ' ' PHE . 6.5 tp -76.0 -45.19 35.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 27.4 t -55.86 -49.45 73.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.868 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 25.8 ptt85 -56.05 -28.24 56.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.887 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 20.0 t60 -79.11 -41.85 27.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.852 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 22.0 mmm-85 -48.99 -24.7 1.61 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.849 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 -55.9 -44.16 77.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.936 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 39.5 t -46.64 -34.75 5.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.855 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 375' ' ' HIS . . . . . 0.479 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 48.5 m-70 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.852 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 349' ' ' LYS . . . . . 0.468 ' HB3' ' N ' ' A' ' 362' ' ' PHE . 74.4 mttt . . . . . 0 C--O 1.231 0.104 0 CA-C-O 121.548 0.69 . . . . 0.0 110.873 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -36.61 10.62 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.677 2.251 . . . . 0.0 112.408 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 351' ' ' PHE . . . . . 0.622 ' HB3' HD22 ' A' ' 368' ' ' LEU . 86.2 m-85 -67.57 98.28 0.67 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.907 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -107.45 138.83 42.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.07 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 45.3 t -55.35 132.65 48.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.885 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 28.0 m -79.93 -18.86 49.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.125 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.56 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 58.7 t-105 -55.8 139.9 68.92 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.588 0.709 . . . . 0.0 110.949 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 356' ' ' PRO . . . . . 0.525 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 54.1 Cg_endo -69.7 137.73 36.33 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.711 2.274 . . . . 0.0 112.367 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 83.77 -37.29 2.81 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.498 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 47.0 t -65.13 153.81 39.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.859 0.362 . . . . 0.0 110.923 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -142.45 44.73 0.96 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.485 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 43.3 m95 -97.98 130.67 44.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.791 0.329 . . . . 0.0 110.926 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 361' ' ' ARG . . . . . . . . . . . . . 30.7 mtt180 -122.23 163.34 19.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.861 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 362' ' ' PHE . . . . . 0.529 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 23.5 m-85 -148.81 148.93 30.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.896 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 34.4 p -72.13 -35.48 69.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.841 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 64.3 mtt180 -112.9 165.58 12.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.886 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 365' ' ' SER . . . . . 0.446 ' HB2' ' CE2' ' A' ' 351' ' ' PHE . 26.3 t -71.54 -52.7 16.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.909 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -51.02 -31.37 18.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.894 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -71.25 -29.2 64.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.874 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.622 HD22 ' HB3' ' A' ' 351' ' ' PHE . 10.4 tp -86.71 -47.16 9.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.924 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 22.1 t -54.43 -43.5 71.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.836 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -59.69 -35.42 74.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.87 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 22.8 t60 -70.84 -41.77 71.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.883 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -45.96 -27.64 0.95 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.881 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 373' ' ' ARG . . . . . 0.428 ' NH1' ' HB3' ' A' ' 373' ' ' ARG . 10.1 mtp-105 -53.45 -43.86 68.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.892 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 28.5 t -49.91 -33.47 17.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.863 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 375' ' ' HIS . . . . . 0.56 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 78.3 m-70 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.87 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 349' ' ' LYS . . . . . 0.41 ' HA ' ' HD2' ' A' ' 350' ' ' PRO . 53.0 mttp . . . . . 0 C--O 1.23 0.078 0 CA-C-O 121.565 0.697 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 350' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 349' ' ' LYS . 53.4 Cg_endo -69.74 -25.17 28.97 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.66 2.24 . . . . 0.0 112.335 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 351' ' ' PHE . . . . . 0.558 ' HB3' HD22 ' A' ' 368' ' ' LEU . 84.5 m-85 -80.35 92.88 5.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.912 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -104.09 139.09 39.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.104 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 353' ' ' CYS . . . . . 0.44 ' HA ' HD11 ' A' ' 368' ' ' LEU . 50.2 t -53.28 148.68 8.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.836 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 82.6 p -94.83 -26.55 16.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.111 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.566 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 49.8 t-105 -52.47 140.58 35.73 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.62 0.724 . . . . 0.0 110.924 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 356' ' ' PRO . . . . . 0.512 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 53.3 Cg_endo -69.78 138.94 38.95 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.652 2.235 . . . . 0.0 112.341 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 84.22 -37.82 2.87 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.52 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 49.1 t -63.49 155.64 28.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.927 0.394 . . . . 0.0 110.862 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -142.58 37.91 1.49 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.519 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 42.7 m95 -92.19 128.97 38.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.758 0.313 . . . . 0.0 110.899 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 361' ' ' ARG . . . . . 0.487 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 56.6 mtt180 -124.34 165.01 18.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.926 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 362' ' ' PHE . . . . . 0.487 ' CD1' ' C ' ' A' ' 361' ' ' ARG . 7.6 m-85 -149.98 152.11 34.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.86 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 49.9 m -77.9 -22.85 49.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.867 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -118.72 165.99 13.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.832 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 365' ' ' SER . . . . . 0.492 ' HA ' ' CD1' ' A' ' 351' ' ' PHE . 1.3 t -74.17 -55.76 5.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.836 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -49.36 -45.97 46.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.868 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -54.58 -35.91 63.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.861 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.558 HD22 ' HB3' ' A' ' 351' ' ' PHE . 14.3 tp -79.64 -42.55 24.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 44.7 t -57.8 -49.16 77.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.848 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -56.15 -31.61 63.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.868 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 20.1 t60 -73.15 -46.29 51.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.862 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 372' ' ' ARG . . . . . 0.421 ' HB3' ' NH1' ' A' ' 372' ' ' ARG . 5.6 mmm180 -41.34 -29.98 0.16 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.905 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 84.5 mtt180 -51.08 -46.66 61.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.878 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 85.3 p -43.56 -38.18 2.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 375' ' ' HIS . . . . . 0.566 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 39.0 m-70 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.858 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 54.3 m -112.27 -53.52 2.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.838 0.351 . . . . 0.0 110.849 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 2.0 t -61.68 122.35 15.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.833 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . -89.24 -159.46 35.41 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.534 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 59.5 p -112.7 126.77 55.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.882 0.372 . . . . 0.0 110.868 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 15.4 t -128.59 -46.59 1.3 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.872 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -62.11 -63.44 4.74 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.488 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 73.9 p -107.57 158.47 17.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.823 0.344 . . . . 0.0 111.179 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 150.24 71.31 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.451 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -157.54 119.5 3.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.91 0.386 . . . . 0.0 110.896 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 349' ' ' LYS . . . . . 0.412 ' HB3' ' C ' ' A' ' 362' ' ' PHE . 37.7 mttt -134.81 92.93 18.44 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.599 0.714 . . . . 0.0 110.943 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 349' ' ' LYS . 54.0 Cg_endo -69.77 -25.64 28.33 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.698 2.265 . . . . 0.0 112.323 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 351' ' ' PHE . . . . . 0.688 ' HB3' HD22 ' A' ' 368' ' ' LEU . 90.0 m-85 -79.88 96.46 6.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.898 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -106.63 131.58 53.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.074 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 42.5 t -48.38 150.7 1.23 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.87 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 47.9 p -95.85 -30.68 13.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.153 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.577 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 44.7 t-105 -47.45 140.82 7.25 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.518 0.675 . . . . 0.0 110.918 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . 0.532 ' O ' ' CD1' ' A' ' 355' ' ' TRP . 54.0 Cg_endo -69.73 141.18 44.64 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.682 2.255 . . . . 0.0 112.375 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 81.88 -36.05 2.51 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.467 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 49.4 t -65.97 150.77 48.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.866 0.365 . . . . 0.0 110.874 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -142.37 46.15 0.89 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.476 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 44.0 m95 -99.06 128.86 45.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.746 0.308 . . . . 0.0 110.959 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' ARG . . . . . . . . . . . . . 29.6 mtt180 -120.64 156.55 31.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.87 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' PHE . . . . . 0.529 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 23.2 m-85 -140.92 147.02 38.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.932 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 74.3 m -76.23 -22.11 55.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.864 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -118.27 161.62 19.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.846 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 85.8 p -70.95 -56.15 6.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.88 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -49.71 -40.61 41.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.903 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -59.62 -33.14 71.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.856 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.688 HD22 ' HB3' ' A' ' 351' ' ' PHE . 8.4 tp -81.6 -42.56 19.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.927 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 42.8 t -60.1 -46.7 88.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.831 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -59.86 -30.88 69.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.883 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 371' ' ' HIS . . . . . 0.412 ' CB ' ' CZ ' ' A' ' 362' ' ' PHE . 20.0 t60 -73.94 -48.5 30.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.85 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 27.0 mmm-85 -41.44 -29.5 0.16 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.864 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 73.0 mtt180 -52.91 -45.69 67.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.883 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 61.9 m -44.36 -34.01 1.84 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.843 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 375' ' ' HIS . . . . . 0.577 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 57.3 m-70 -94.75 165.39 12.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.873 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 59.2 p -97.11 109.32 22.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.876 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -152.93 156.72 26.88 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.505 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 95.5 t -50.81 119.97 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.923 0.392 . . . . 0.0 111.095 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 379' ' ' LYS . . . . . . . . . . . . . 10.5 pttm -95.26 146.44 31.31 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.554 0.692 . . . . 0.0 110.896 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -3.41 11.97 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.695 2.263 . . . . 0.0 112.382 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 84.7 p -112.39 172.35 6.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.845 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -153.6 -92.73 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.512 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -17.0 37.86 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.727 2.284 . . . . 0.0 112.307 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 28.3 m -156.55 153.49 28.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.9 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 8.7 t -158.78 151.17 21.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.875 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.472 -179.975 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.29 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 5.0 m -125.8 147.53 49.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.879 0.371 . . . . 0.0 110.868 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 23.5 m -116.37 114.73 24.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.887 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 97.33 88.05 1.85 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.48 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 18.7 m -80.58 146.23 31.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.88 0.371 . . . . 0.0 110.861 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 3.0 m -80.66 139.14 36.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.892 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -104.19 -94.33 2.32 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.521 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 4.1 t -67.73 -18.12 64.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.846 0.355 . . . . 0.0 111.184 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 112.97 -123.27 6.15 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.508 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 -128.83 157.67 40.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.884 0.373 . . . . 0.0 110.927 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 349' ' ' LYS . . . . . 0.475 ' HB3' ' N ' ' A' ' 362' ' ' PHE . 53.3 mttm -104.55 93.45 5.97 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.527 0.68 . . . . 0.0 110.858 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 349' ' ' LYS . 53.6 Cg_endo -69.76 -34.94 13.55 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.716 2.277 . . . . 0.0 112.349 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 351' ' ' PHE . . . . . 0.717 ' HB3' HD22 ' A' ' 368' ' ' LEU . 97.7 m-85 -68.2 103.25 1.52 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.868 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -107.66 129.59 55.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.082 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 353' ' ' CYS . . . . . 0.455 ' HA ' HD11 ' A' ' 368' ' ' LEU . 40.5 t -47.41 146.12 2.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.889 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 58.5 m -91.37 -32.14 15.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.16 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.522 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 46.7 t-105 -47.13 140.72 6.51 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.593 0.711 . . . . 0.0 110.915 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . 0.517 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 53.8 Cg_endo -69.77 139.46 40.26 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.636 2.224 . . . . 0.0 112.367 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 83.39 -41.13 2.89 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.552 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 36.1 t -61.39 150.14 36.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.928 0.394 . . . . 0.0 110.839 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -139.78 45.16 1.02 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.532 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 25.2 m95 -97.68 130.99 44.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.758 0.313 . . . . 0.0 110.896 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 361' ' ' ARG . . . . . 0.421 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 67.5 mtt180 -121.49 165.66 15.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.867 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 362' ' ' PHE . . . . . 0.475 ' N ' ' HB3' ' A' ' 349' ' ' LYS . 14.5 m-85 -150.83 156.43 41.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.853 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 15.3 t -78.92 -37.46 39.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.872 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -106.91 161.25 14.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.894 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . 0.538 ' HB3' ' CE1' ' A' ' 351' ' ' PHE . 54.4 p -71.3 -38.1 71.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.879 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -62.51 -45.62 92.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.89 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -55.51 -34.48 64.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.873 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.717 HD22 ' HB3' ' A' ' 351' ' ' PHE . 9.0 tp -79.25 -42.96 24.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.902 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 18.3 t -58.13 -44.9 88.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.809 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 370' ' ' ARG . . . . . 0.411 ' HG3' ' N ' ' A' ' 371' ' ' HIS . 29.6 ptt85 -61.82 -30.46 70.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.848 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 371' ' ' HIS . . . . . 0.411 ' N ' ' HG3' ' A' ' 370' ' ' ARG . 22.5 t60 -74.4 -39.0 62.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.863 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 26.3 mmm-85 -51.31 -25.1 5.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.863 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 28.8 mtt85 -57.56 -40.87 79.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 58.0 m -50.35 -30.87 13.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.879 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 375' ' ' HIS . . . . . 0.522 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 68.5 m-70 -94.75 169.13 10.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.848 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 36.9 p -93.28 49.11 1.37 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.861 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -72.24 130.19 15.79 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.481 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 34.8 m -83.9 143.63 11.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.928 0.394 . . . . 0.0 111.064 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 379' ' ' LYS . . . . . . . . . . . . . 25.6 mmtp -116.68 153.14 49.08 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.542 0.686 . . . . 0.0 110.885 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 158.71 55.99 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.661 2.241 . . . . 0.0 112.338 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 49.1 m 47.34 38.87 7.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.853 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 168.29 83.19 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.536 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 383' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 174.77 9.04 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.636 2.224 . . . . 0.0 112.401 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 52.7 p -134.37 154.97 51.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.86 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 22.4 p -75.45 -56.15 4.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.853 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.477 -179.964 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.521 -0.232 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 67.7 m -74.63 97.35 3.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.89 0.376 . . . . 0.0 110.861 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 28.8 t -172.2 115.24 0.33 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.889 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . -143.8 89.61 0.17 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.488 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 1.9 m -127.26 160.19 32.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.917 0.389 . . . . 0.0 110.809 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 78.7 p -101.12 41.95 1.15 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.866 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -86.59 156.62 29.26 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.483 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 8.8 t -163.41 153.98 16.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.819 0.343 . . . . 0.0 111.165 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 131.9 -122.59 3.4 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.461 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -155.98 143.19 19.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.94 0.4 . . . . 0.0 110.867 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 349' ' ' LYS . . . . . 0.424 ' HA ' ' HD2' ' A' ' 350' ' ' PRO . 79.4 mttt -104.39 93.37 5.72 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.6 0.714 . . . . 0.0 110.901 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 349' ' ' LYS . 53.8 Cg_endo -69.75 -31.23 20.96 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.69 2.26 . . . . 0.0 112.355 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 351' ' ' PHE . . . . . 0.594 ' HB3' HD22 ' A' ' 368' ' ' LEU . 95.4 m-85 -73.53 97.12 2.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.896 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -108.39 143.85 36.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.043 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 51.5 t -59.94 147.95 36.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.868 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 57.7 m -90.64 -29.25 17.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.157 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.575 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 52.8 t-105 -48.23 140.36 9.56 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.547 0.689 . . . . 0.0 110.92 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . 0.509 ' HD2' ' CG ' ' A' ' 355' ' ' TRP . 54.2 Cg_endo -69.77 140.45 42.65 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.715 2.276 . . . . 0.0 112.342 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 83.05 -36.94 2.7 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.475 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 42.4 t -64.55 152.71 41.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.884 0.373 . . . . 0.0 110.857 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -141.92 38.9 1.44 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.477 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 30.4 m95 -91.46 127.89 37.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.713 0.292 . . . . 0.0 110.916 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 361' ' ' ARG . . . . . 0.441 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 33.2 mtt180 -123.19 161.36 24.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.861 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 362' ' ' PHE . . . . . 0.441 ' CD1' ' C ' ' A' ' 361' ' ' ARG . 4.7 m-85 -147.67 153.38 39.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 33.8 t -75.8 -34.94 60.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.837 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -108.74 168.37 9.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 74.0 p -75.24 -56.82 4.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.868 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -46.46 -41.47 13.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.856 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -60.33 -35.02 74.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.863 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.594 HD22 ' HB3' ' A' ' 351' ' ' PHE . 11.7 tp -80.71 -44.17 19.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.922 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 14.7 t -57.87 -46.43 84.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.857 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -58.85 -27.96 65.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.884 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 19.8 t60 -76.99 -46.46 23.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.864 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 41.0 mmm-85 -43.55 -28.83 0.41 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.883 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 79.1 mtt180 -50.51 -45.36 56.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.848 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 1.3 t -44.73 -39.59 5.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.846 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 375' ' ' HIS . . . . . 0.575 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 42.8 m-70 -92.27 154.89 18.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.871 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 2.3 m -82.25 -50.57 8.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.818 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 118.91 133.01 4.61 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.505 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . 0.631 ' O ' HG23 ' A' ' 378' ' ' VAL . 34.4 m -110.33 108.54 25.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.908 0.385 . . . . 0.0 111.115 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 379' ' ' LYS . . . . . . . . . . . . . 17.1 mmmt -139.34 153.67 71.13 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.587 0.708 . . . . 0.0 110.883 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -7.84 22.08 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.669 2.246 . . . . 0.0 112.336 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 94.4 p -52.15 -48.35 64.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.927 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 39.99 68.55 0.54 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.472 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 383' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 148.7 65.5 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.696 2.264 . . . . 0.0 112.35 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 21.9 p -67.67 -60.12 2.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.875 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 71.9 p -128.4 152.55 48.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.893 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.477 -179.991 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.489 -0.245 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 95.1 p -112.7 151.85 29.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.843 0.354 . . . . 0.0 110.848 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 73.9 p -138.45 162.7 33.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.844 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 99.36 44.96 2.25 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.473 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 4.5 m -142.58 147.26 35.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.848 0.356 . . . . 0.0 110.868 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 76.2 p -128.71 134.91 48.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.867 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 119.52 85.54 0.95 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.489 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 74.6 p -103.87 -42.78 5.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.848 0.356 . . . . 0.0 111.167 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 134.52 140.12 4.22 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.508 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -106.3 139.8 40.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.906 0.384 . . . . 0.0 110.883 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 349' ' ' LYS . . . . . 0.424 ' HA ' ' HD2' ' A' ' 350' ' ' PRO . 79.3 mttt -104.73 93.44 6.13 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.539 0.685 . . . . 0.0 110.938 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 349' ' ' LYS . 53.3 Cg_endo -69.74 -30.55 22.18 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.701 2.267 . . . . 0.0 112.319 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 351' ' ' PHE . . . . . 0.669 ' HB3' HD22 ' A' ' 368' ' ' LEU . 99.0 m-85 -73.24 99.65 2.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -106.76 138.09 43.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.106 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 353' ' ' CYS . . . . . 0.419 ' HA ' HD11 ' A' ' 368' ' ' LEU . 42.0 t -54.11 151.96 6.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.868 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 61.4 p -94.5 -31.83 13.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.151 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.562 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 52.8 t-105 -49.2 140.46 12.39 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.566 0.698 . . . . 0.0 110.909 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . 0.514 ' HD2' ' CG ' ' A' ' 355' ' ' TRP . 53.6 Cg_endo -69.78 140.27 42.19 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.682 2.255 . . . . 0.0 112.358 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 83.71 -42.5 3.05 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.497 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 49.6 t -59.34 151.12 24.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.87 0.367 . . . . 0.0 110.91 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -139.02 41.64 1.33 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.47 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 23.1 m95 -93.23 128.1 39.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.81 0.338 . . . . 0.0 110.92 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 361' ' ' ARG . . . . . 0.408 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 65.7 mtt180 -123.21 162.97 21.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.923 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 362' ' ' PHE . . . . . 0.489 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 11.0 m-85 -149.34 154.56 39.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.883 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 30.6 t -76.6 -35.43 58.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.917 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -108.36 170.99 7.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.877 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 12.6 t -76.06 -57.08 4.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.885 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -46.6 -46.18 19.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.879 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . 0.422 ' HA ' ' NE ' ' A' ' 370' ' ' ARG . 5.4 mm-40 -54.89 -34.01 62.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.928 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.669 HD22 ' HB3' ' A' ' 351' ' ' PHE . 13.1 tp -82.42 -42.34 18.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.897 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 46.0 m -60.1 -43.65 95.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.845 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 370' ' ' ARG . . . . . 0.422 ' NE ' ' HA ' ' A' ' 367' ' ' GLU . 19.6 ptp180 -61.97 -28.6 69.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.855 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 19.9 t60 -76.9 -44.16 32.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.889 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 28.7 mmm-85 -45.8 -27.63 0.89 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.85 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 48.8 mtm180 -51.66 -45.89 63.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.874 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 14.4 t -45.73 -36.59 5.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.869 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 375' ' ' HIS . . . . . 0.562 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 39.1 m-70 -93.69 157.71 16.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.829 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 7.5 t -93.82 95.23 8.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.898 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -93.14 -157.04 33.2 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.462 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . 0.462 ' O ' HG23 ' A' ' 378' ' ' VAL . 35.9 m -127.78 122.66 59.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.861 0.363 . . . . 0.0 111.144 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 379' ' ' LYS . . . . . . . . . . . . . 28.8 mmtm -106.78 144.33 28.84 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.538 0.685 . . . . 0.0 110.886 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 -11.89 31.87 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.67 2.247 . . . . 0.0 112.381 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 66.2 m -78.71 -51.49 9.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.83 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 144.96 149.55 5.05 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.503 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 383' ' ' PRO . . . . . 0.44 ' O ' ' C ' ' A' ' 384' ' ' SER . 53.6 Cg_endo -69.75 0.85 5.03 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.686 2.257 . . . . 0.0 112.329 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . 0.44 ' C ' ' O ' ' A' ' 383' ' ' PRO . 74.1 p -34.58 113.95 0.2 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.875 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 4.1 m -164.46 161.13 21.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.844 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.263 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.465 -179.995 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.474 -0.25 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 49.6 m -146.3 156.91 43.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.889 0.376 . . . . 0.0 110.852 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 28.9 t -95.17 144.83 25.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.831 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . -125.93 -76.42 0.25 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.486 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 17.3 m -61.92 164.05 6.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.877 0.37 . . . . 0.0 110.826 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 39.2 t -132.81 121.7 23.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.887 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 37.07 58.7 1.22 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.507 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 62.1 p -55.52 -52.94 62.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.868 0.366 . . . . 0.0 111.153 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 171.14 119.4 0.51 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.486 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -59.06 159.61 7.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.889 0.376 . . . . 0.0 110.902 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 349' ' ' LYS . . . . . 0.455 ' HB3' ' N ' ' A' ' 362' ' ' PHE . 40.1 mttm -104.53 93.54 6.06 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.572 0.701 . . . . 0.0 110.859 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 349' ' ' LYS . 53.6 Cg_endo -69.8 -36.36 10.86 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.693 2.262 . . . . 0.0 112.364 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 351' ' ' PHE . . . . . 0.552 ' HB3' HD22 ' A' ' 368' ' ' LEU . 97.0 m-85 -68.47 98.96 0.9 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.832 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -107.95 136.8 47.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.118 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 353' ' ' CYS . . . . . 0.607 ' HA ' HD11 ' A' ' 368' ' ' LEU . 45.0 t -50.76 151.45 2.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.91 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 76.9 m -93.79 -33.76 13.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.151 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.566 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 50.8 t-105 -45.12 140.42 3.69 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.605 0.717 . . . . 0.0 110.916 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . 0.505 ' HD2' ' CG ' ' A' ' 355' ' ' TRP . 53.4 Cg_endo -69.81 140.48 42.61 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.666 2.244 . . . . 0.0 112.347 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 83.49 -39.62 2.81 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.51 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 45.9 t -61.48 152.35 30.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.886 0.374 . . . . 0.0 110.881 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -140.55 41.67 1.26 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.524 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 29.3 m95 -94.08 129.29 40.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.765 0.317 . . . . 0.0 110.888 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 361' ' ' ARG . . . . . 0.424 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 32.3 mtt180 -122.91 164.33 18.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.879 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 362' ' ' PHE . . . . . 0.509 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 10.7 m-85 -150.69 155.36 39.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.938 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 28.7 t -77.21 -36.58 54.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.912 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 69.9 mtt180 -108.73 161.53 15.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.91 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 82.7 p -67.74 -52.71 34.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.05 -40.22 57.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.867 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -60.68 -30.35 69.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.88 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.607 HD11 ' HA ' ' A' ' 353' ' ' CYS . 10.4 tp -85.73 -44.47 12.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.91 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 23.2 t -57.61 -46.42 84.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.847 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -57.84 -34.42 69.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.873 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 27.0 t60 -69.58 -47.49 63.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.823 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 45.0 mmm-85 -41.21 -30.29 0.16 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 47.5 mtm180 -48.21 -46.98 35.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.844 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 93.0 p -44.83 -41.52 7.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.888 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 375' ' ' HIS . . . . . 0.566 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 49.1 m-70 -89.09 158.25 18.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.906 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 3.5 m -97.43 127.0 43.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.854 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -118.42 152.9 17.28 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.469 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 6.8 m -70.42 128.37 33.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.925 0.393 . . . . 0.0 111.149 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 379' ' ' LYS . . . . . . . . . . . . . 30.6 mtmm -134.78 143.94 48.47 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.568 0.699 . . . . 0.0 110.927 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.67 -16.31 37.87 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.723 2.282 . . . . 0.0 112.357 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 1.1 t -103.56 109.18 20.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.844 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -166.76 75.95 0.13 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.497 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 383' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 -49.86 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.707 2.271 . . . . 0.0 112.335 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 5.4 t -88.62 41.63 1.03 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.871 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 3.5 m -161.5 143.5 11.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.871 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.479 -179.947 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 339' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 3.4 m -124.7 96.17 4.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.896 0.379 . . . . 0.0 110.874 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 73.4 m -65.02 159.64 22.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.876 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . -117.97 137.25 12.97 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.499 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 17.2 m -72.84 96.83 2.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.868 0.366 . . . . 0.0 110.87 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 21.3 m -62.64 174.75 0.93 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.835 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 71.01 156.5 2.09 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.446 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 23.8 p -139.48 110.51 6.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.845 0.355 . . . . 0.0 111.156 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -138.56 168.58 24.65 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.487 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -139.8 154.38 47.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.935 0.398 . . . . 0.0 110.878 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 349' ' ' LYS . . . . . 0.417 ' HB3' ' N ' ' A' ' 362' ' ' PHE . 39.4 mttp -133.88 93.26 20.83 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.559 0.695 . . . . 0.0 110.896 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -32.62 18.23 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.668 2.245 . . . . 0.0 112.349 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 351' ' ' PHE . . . . . 0.671 ' HB3' HD22 ' A' ' 368' ' ' LEU . 79.6 m-85 -70.1 98.09 1.27 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -105.56 132.84 51.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.11 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 40.6 t -51.25 144.81 8.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.903 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 86.8 m -86.85 -33.25 19.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.114 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.578 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 60.5 t-105 -43.91 139.81 2.84 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.57 0.7 . . . . 0.0 110.891 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . 0.524 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 53.9 Cg_endo -69.75 138.69 38.46 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.661 2.24 . . . . 0.0 112.372 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 83.6 -45.26 3.43 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.509 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 54.0 t -53.27 157.4 1.95 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.854 0.359 . . . . 0.0 110.89 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -145.49 44.8 0.85 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.451 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 21.8 m95 -97.6 128.96 44.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.766 0.317 . . . . 0.0 110.91 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 361' ' ' ARG . . . . . . . . . . . . . 47.2 mtt180 -122.47 160.35 25.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.887 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 362' ' ' PHE . . . . . 0.509 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 6.1 m-85 -147.31 155.77 42.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.883 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 46.7 t -83.9 -29.48 27.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.884 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 31.7 mtp180 -113.21 165.38 12.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.904 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 1.2 m -70.23 -62.43 1.39 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.819 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -45.38 -38.33 5.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.862 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -60.22 -37.51 80.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.903 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.671 HD22 ' HB3' ' A' ' 351' ' ' PHE . 10.1 tp -80.79 -44.8 17.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.907 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 74.6 m -56.5 -48.02 78.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.887 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 370' ' ' ARG . . . . . 0.456 ' HG3' ' N ' ' A' ' 371' ' ' HIS . 6.8 ptm180 -56.38 -30.29 62.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.911 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 371' ' ' HIS . . . . . 0.456 ' N ' ' HG3' ' A' ' 370' ' ' ARG . 23.8 t60 -74.23 -45.91 45.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.843 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 42.3 mmm-85 -43.28 -29.26 0.39 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 60.6 mtt180 -49.64 -47.45 49.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.892 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 56.0 p -45.17 -38.79 5.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.833 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 375' ' ' HIS . . . . . 0.578 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 45.2 m-70 -92.29 155.83 17.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.898 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 6.0 m -84.56 102.98 13.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.861 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -107.68 114.36 4.21 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.481 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 86.1 t -50.64 134.5 10.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.909 0.385 . . . . 0.0 111.144 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 379' ' ' LYS . . . . . . . . . . . . . 20.0 mtpp -104.32 160.43 26.07 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.614 0.721 . . . . 0.0 110.895 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -32.15 18.96 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.68 2.253 . . . . 0.0 112.318 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 77.0 p -55.56 155.91 5.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.875 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -111.99 177.12 18.55 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.48 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 383' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 112.08 2.98 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.682 2.255 . . . . 0.0 112.324 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 6.6 t -59.38 -44.4 92.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.81 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 5.6 t 68.07 42.09 1.88 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.828 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.513 179.955 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 339' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.507 -0.237 . . . . 0.0 112.507 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 5.6 m -54.27 111.92 0.87 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.849 0.356 . . . . 0.0 110.824 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 14.9 t -165.89 148.36 7.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . -119.02 120.49 4.68 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.494 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . 0.43 ' O ' ' C ' ' A' ' 344' ' ' SER . 59.9 p -109.03 112.81 25.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.928 0.394 . . . . 0.0 110.815 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 344' ' ' SER . . . . . 0.43 ' C ' ' O ' ' A' ' 343' ' ' SER . 51.8 p -36.27 -53.39 0.82 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.911 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -170.76 141.19 6.37 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.505 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 14.6 t -67.64 144.17 55.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.837 0.351 . . . . 0.0 111.116 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -123.64 121.66 4.6 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.488 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -64.3 162.66 14.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.884 0.373 . . . . 0.0 110.892 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 349' ' ' LYS . . . . . 0.424 ' HA ' ' HD2' ' A' ' 350' ' ' PRO . 46.0 mttp -104.8 93.4 6.16 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.619 0.723 . . . . 0.0 110.919 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 349' ' ' LYS . 53.5 Cg_endo -69.76 -28.25 25.49 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.7 2.267 . . . . 0.0 112.308 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 351' ' ' PHE . . . . . 0.808 ' HB3' HD22 ' A' ' 368' ' ' LEU . 80.8 m-85 -74.39 102.04 4.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.864 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -109.58 131.75 54.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.097 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 51.1 t -48.63 147.4 2.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.905 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 88.7 m -92.06 -34.6 14.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.181 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.574 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 58.0 t-105 -44.29 139.99 3.1 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.542 0.687 . . . . 0.0 110.941 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . 0.516 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 54.0 Cg_endo -69.72 138.18 37.33 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.693 2.262 . . . . 0.0 112.381 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 84.28 -41.58 3.01 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.471 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 42.4 t -60.23 152.08 25.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.863 0.364 . . . . 0.0 110.903 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -140.51 45.96 0.95 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.446 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 25.0 m95 -98.03 129.81 44.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.786 0.327 . . . . 0.0 110.913 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 361' ' ' ARG . . . . . 0.49 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 72.3 mtt180 -121.0 167.46 12.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.868 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 362' ' ' PHE . . . . . 0.518 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 7.4 m-85 -153.13 147.77 26.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.854 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 68.1 m -73.16 -33.48 65.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.899 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -110.45 171.13 7.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.88 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 37.4 t -75.68 -55.09 5.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.858 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -49.87 -48.08 51.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.877 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -52.42 -32.8 40.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.875 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.808 HD22 ' HB3' ' A' ' 351' ' ' PHE . 10.9 tp -84.13 -43.29 15.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.92 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 12.2 t -58.28 -45.06 88.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.853 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 370' ' ' ARG . . . . . 0.476 ' CZ ' ' HB2' ' A' ' 370' ' ' ARG . 3.8 ptm85 -58.81 -31.34 68.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.861 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 371' ' ' HIS . . . . . 0.415 ' CB ' ' CZ ' ' A' ' 362' ' ' PHE . 11.0 t60 -73.34 -47.44 42.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.838 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 24.8 mmm-85 -43.55 -28.24 0.36 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.867 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 81.2 mtt180 -51.87 -44.75 63.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.897 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 4.9 t -48.58 -32.16 7.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.836 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 375' ' ' HIS . . . . . 0.574 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 57.7 m-70 -95.75 144.51 26.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.844 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 1.9 m -70.25 -57.73 4.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.858 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 128.33 66.2 0.13 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.489 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 2.8 t 56.54 50.86 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.889 0.376 . . . . 0.0 111.145 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 379' ' ' LYS . . . . . . . . . . . . . 25.6 mmtp -140.43 143.96 35.07 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.594 0.711 . . . . 0.0 110.887 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . 0.414 ' O ' ' C ' ' A' ' 381' ' ' SER . 53.8 Cg_endo -69.81 -5.64 16.73 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.631 2.221 . . . . 0.0 112.347 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . 0.414 ' C ' ' O ' ' A' ' 380' ' ' PRO . 3.8 t -37.62 -61.35 0.62 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.86 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 65.07 -179.07 8.81 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.737 -0.745 . . . . 0.0 112.466 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 383' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 87.4 0.55 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.692 2.262 . . . . 0.0 112.338 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 13.5 t -41.05 -62.85 0.76 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.8 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 41.7 p -51.97 -53.66 38.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.839 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.474 -179.979 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 339' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 95.8 p 41.54 42.18 1.88 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.89 0.376 . . . . 0.0 110.893 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 3.6 m -77.98 97.0 5.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.883 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . -94.82 -151.81 28.71 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.453 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 91.3 p -125.57 104.77 8.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.851 0.358 . . . . 0.0 110.873 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 5.4 m -58.36 -44.29 88.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.89 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -172.53 -122.6 0.67 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.436 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 55.5 p -104.33 129.16 52.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.831 0.348 . . . . 0.0 111.155 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 147.38 99.06 0.22 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.507 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -128.8 166.04 19.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.913 0.387 . . . . 0.0 110.888 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 349' ' ' LYS . . . . . 0.462 ' HB3' ' N ' ' A' ' 362' ' ' PHE . 46.2 mttm -107.35 93.39 9.61 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.538 0.685 . . . . 0.0 110.912 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 349' ' ' LYS . 53.7 Cg_endo -69.76 -31.69 20.04 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.696 2.264 . . . . 0.0 112.344 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 351' ' ' PHE . . . . . 0.544 ' HB3' HD22 ' A' ' 368' ' ' LEU . 93.6 m-85 -72.96 94.04 1.81 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.897 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -101.46 147.0 26.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.096 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 53.2 t -66.24 145.02 56.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 46.2 p -90.63 -27.38 19.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.126 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.575 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 61.7 t-105 -47.86 139.64 9.08 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.58 0.705 . . . . 0.0 110.886 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . 0.527 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 54.0 Cg_endo -69.77 136.97 34.33 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.703 2.269 . . . . 0.0 112.319 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 84.16 -36.13 2.92 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.493 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 48.3 t -65.93 156.64 32.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.87 0.366 . . . . 0.0 110.879 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -147.04 44.79 0.8 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.481 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 39.8 m95 -96.74 129.99 44.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.813 0.34 . . . . 0.0 110.884 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 361' ' ' ARG . . . . . 0.449 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 51.1 mtm-85 -121.71 163.67 18.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.853 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 362' ' ' PHE . . . . . 0.47 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 7.3 m-85 -149.35 151.83 34.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.865 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 29.6 t -75.02 -36.66 61.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.846 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 40.9 mtp85 -109.38 162.91 13.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 90.1 p -68.11 -57.47 6.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.847 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -47.65 -38.15 14.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.91 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -61.66 -32.25 72.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.856 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.544 HD22 ' HB3' ' A' ' 351' ' ' PHE . 7.8 tp -84.53 -46.99 11.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.952 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 46.9 t -54.37 -44.33 72.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.822 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -59.18 -36.3 75.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.815 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 371' ' ' HIS . . . . . 0.413 ' CB ' ' CZ ' ' A' ' 362' ' ' PHE . 18.8 t60 -70.0 -43.46 71.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.877 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 9.3 mmt85 -45.29 -28.21 0.78 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.879 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 47.6 mtp180 -53.04 -43.72 66.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.891 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 49.1 m -47.67 -33.65 7.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.856 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 375' ' ' HIS . . . . . 0.575 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 70.6 m-70 -93.93 169.9 9.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.859 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 88.8 p -89.14 48.79 1.67 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.871 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -57.49 -76.04 0.23 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.513 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 33.7 m -116.47 145.44 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.855 0.36 . . . . 0.0 111.113 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 379' ' ' LYS . . . . . . . . . . . . . 17.2 pttp -77.51 143.79 68.84 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.556 0.693 . . . . 0.0 110.915 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 99.8 0.78 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.66 2.24 . . . . 0.0 112.34 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 80.4 p -101.72 81.17 2.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.878 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 151.29 146.04 4.25 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.478 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 383' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 114.99 3.88 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.681 2.254 . . . . 0.0 112.349 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 91.0 p -171.2 169.69 6.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.9 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 4.2 t -148.19 142.94 26.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.905 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.47 -179.967 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 339' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 19.3 t -48.21 133.02 15.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.873 0.368 . . . . 0.0 110.851 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 85.0 p -126.19 -44.42 1.74 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.822 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 99.7 -95.05 1.45 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.476 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 97.2 p -59.51 96.06 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.889 0.376 . . . . 0.0 110.889 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 59.6 p -56.59 -46.55 80.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.878 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 66.03 42.47 94.62 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.444 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 57.5 p -47.71 133.17 13.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.882 0.373 . . . . 0.0 111.136 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 125.28 165.66 12.15 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.475 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -89.55 152.51 21.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.886 0.374 . . . . 0.0 110.881 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 349' ' ' LYS . . . . . 0.405 ' HB3' ' C ' ' A' ' 362' ' ' PHE . 65.8 mttt -125.96 93.7 43.33 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.598 0.714 . . . . 0.0 110.874 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -33.61 16.34 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.653 2.235 . . . . 0.0 112.357 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 351' ' ' PHE . . . . . 0.729 ' HB3' HD22 ' A' ' 368' ' ' LEU . 90.6 m-85 -69.03 104.81 2.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.869 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -109.53 145.44 36.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.114 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 40.4 t -62.84 150.4 41.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.858 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 71.6 p -94.34 -31.94 13.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.193 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.573 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 58.4 t-105 -46.87 140.03 6.39 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.536 0.684 . . . . 0.0 110.876 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . 0.523 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 53.5 Cg_endo -69.82 138.57 37.94 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.662 2.241 . . . . 0.0 112.317 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 83.94 -38.64 2.83 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.483 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 45.3 t -64.04 157.08 26.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.894 0.378 . . . . 0.0 110.87 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -146.36 42.34 0.95 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.476 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 35.8 m95 -92.53 128.45 38.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.761 0.315 . . . . 0.0 110.925 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 361' ' ' ARG . . . . . 0.527 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 50.2 mtm180 -119.88 167.48 12.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.934 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 362' ' ' PHE . . . . . 0.527 ' CD1' ' C ' ' A' ' 361' ' ' ARG . 13.9 m-85 -154.19 149.32 26.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.925 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 72.7 m -77.44 -26.53 51.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.849 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 70.8 mtt180 -116.85 162.16 18.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.854 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 93.8 p -69.42 -57.96 4.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.891 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -48.29 -40.96 26.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.877 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -60.68 -32.91 72.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.908 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.729 HD22 ' HB3' ' A' ' 351' ' ' PHE . 7.1 tp -83.17 -44.78 14.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.929 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 42.7 m -58.09 -45.53 87.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -58.75 -29.03 66.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.87 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 12.0 t60 -75.21 -46.91 30.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.88 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 41.6 mmm-85 -42.4 -29.31 0.26 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.866 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 43.4 mtp180 -49.63 -47.36 49.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.888 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 9.4 t -44.77 -38.93 4.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.85 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 375' ' ' HIS . . . . . 0.573 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 56.2 m-70 -88.91 141.58 28.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.88 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 3.3 m -70.99 -58.72 3.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.9 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 85.29 -112.61 3.69 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.526 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 34.9 m -112.71 145.41 18.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.883 0.373 . . . . 0.0 111.129 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 379' ' ' LYS . . . . . 0.401 ' HZ2' ' H ' ' A' ' 384' ' ' SER . 17.0 ptmt -55.82 141.81 65.29 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.597 0.713 . . . . 0.0 110.885 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -51.07 0.41 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.636 2.224 . . . . 0.0 112.374 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 76.4 p -175.27 161.72 2.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.834 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 80.5 159.05 19.62 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.481 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 383' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 87.49 0.55 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.718 2.278 . . . . 0.0 112.356 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . 0.401 ' H ' ' HZ2' ' A' ' 379' ' ' LYS . 4.8 t 43.44 43.45 4.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.852 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 31.8 t -98.04 136.48 38.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.873 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.511 -179.985 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 339' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 341' ' ' SER . 48.2 t -108.21 140.65 41.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.911 0.386 . . . . 0.0 110.867 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 340' ' ' SER . 59.5 p -37.83 149.76 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.848 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . -129.64 68.55 0.54 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.473 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 36.6 m -88.97 103.32 15.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.847 0.356 . . . . 0.0 110.845 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 1.8 t -63.27 125.16 23.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.865 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 154.08 -172.74 32.72 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.455 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 35.4 p -103.79 163.49 12.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.815 0.34 . . . . 0.0 111.118 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 122.47 58.54 0.21 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.485 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -59.71 153.6 19.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.909 0.385 . . . . 0.0 110.888 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 349' ' ' LYS . . . . . 0.413 ' HA ' ' HD2' ' A' ' 350' ' ' PRO . 76.6 mttt -104.31 93.21 5.45 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.566 0.698 . . . . 0.0 110.916 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 349' ' ' LYS . 54.6 Cg_endo -69.69 -31.32 21.06 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.648 2.232 . . . . 0.0 112.357 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 351' ' ' PHE . . . . . 0.683 ' HB3' HD22 ' A' ' 368' ' ' LEU . 96.1 m-85 -72.69 103.76 3.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.889 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -111.57 139.65 46.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.097 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 39.9 t -59.18 148.29 32.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.934 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 34.2 m -92.9 -31.39 14.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.12 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.572 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 56.3 t-105 -46.97 140.16 6.45 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.54 0.686 . . . . 0.0 110.938 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . 0.522 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 53.7 Cg_endo -69.72 141.85 46.54 Favored 'Trans proline' 0 C--N 1.34 0.13 0 C-N-CA 122.69 2.26 . . . . 0.0 112.341 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 81.4 -36.57 2.41 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.465 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 42.8 t -67.4 153.63 43.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.924 0.392 . . . . 0.0 110.86 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -144.36 42.06 1.06 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.5 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 33.4 m95 -93.17 128.54 39.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.781 0.324 . . . . 0.0 110.921 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 361' ' ' ARG . . . . . 0.465 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 40.9 mtm180 -120.71 166.05 14.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.888 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 362' ' ' PHE . . . . . 0.494 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 7.2 m-85 -151.94 151.59 31.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.927 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 24.1 m -80.6 -23.24 39.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.86 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 5.4 mtp-105 -120.0 154.11 35.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.857 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . 0.401 ' O ' ' N ' ' A' ' 368' ' ' LEU . 89.8 p -62.41 -63.43 1.23 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.867 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -41.65 -42.01 2.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.872 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -59.26 -39.73 83.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.869 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.683 HD22 ' HB3' ' A' ' 351' ' ' PHE . 8.0 tp -77.14 -42.43 37.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.933 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 24.5 t -58.84 -47.22 85.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.824 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -58.71 -28.31 65.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.916 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 24.7 t60 -75.36 -46.38 33.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 44.2 mmm-85 -43.12 -29.44 0.37 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.853 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 68.8 mtm180 -52.2 -44.31 64.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.889 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 58.8 m -46.36 -38.14 8.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.876 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 375' ' ' HIS . . . . . 0.572 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 55.0 m-70 -92.82 166.21 12.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.852 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 2.0 m -101.07 160.28 14.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.896 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -82.1 -125.78 0.87 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.468 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . 0.427 ' H ' HG22 ' A' ' 378' ' ' VAL . 0.1 OUTLIER -52.76 137.21 13.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.94 0.4 . . . . 0.0 111.11 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 379' ' ' LYS . . . . . 0.472 ' CG ' ' HD2' ' A' ' 380' ' ' PRO . 32.5 tttm -97.51 140.52 22.05 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.539 0.685 . . . . 0.0 110.907 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . 0.472 ' HD2' ' CG ' ' A' ' 379' ' ' LYS . 54.1 Cg_endo -69.74 -10.4 28.47 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.704 2.269 . . . . 0.0 112.321 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . 0.449 ' C ' ' O ' ' A' ' 380' ' ' PRO . 2.1 m -34.6 137.18 0.13 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.879 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . 0.463 ' N ' ' HD2' ' A' ' 383' ' ' PRO . . . -64.85 -60.48 6.85 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.522 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 383' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 382' ' ' GLY . 54.1 Cg_endo -69.77 2.6 3.39 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.649 2.233 . . . . 0.0 112.367 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 43.1 t -45.79 93.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.851 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 385' ' ' SER . . . . . 0.434 ' N ' ' O ' ' A' ' 383' ' ' PRO . 28.5 t -80.16 -56.52 4.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.868 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.499 -179.992 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 339' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 40.3 t -107.58 156.97 18.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.899 0.381 . . . . 0.0 110.841 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 4.0 t -110.25 -49.3 3.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.875 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . -58.19 -66.6 2.7 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.497 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 1.9 m -63.8 81.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.808 0.337 . . . . 0.0 110.879 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 1.8 m -115.07 147.79 39.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.835 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -130.52 -177.93 15.16 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.49 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . 0.466 HG23 ' N ' ' A' ' 347' ' ' GLY . 8.9 t -66.56 -43.59 84.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.816 0.341 . . . . 0.0 111.111 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . 0.466 ' N ' HG23 ' A' ' 346' ' ' THR . . . 122.93 107.75 1.89 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.471 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -64.18 148.08 50.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.898 0.38 . . . . 0.0 110.889 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 349' ' ' LYS . . . . . 0.411 ' HA ' ' HD2' ' A' ' 350' ' ' PRO . 30.5 mttm -120.83 93.25 48.65 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.546 0.689 . . . . 0.0 110.923 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 349' ' ' LYS . 53.6 Cg_endo -69.78 -28.69 24.85 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.719 2.28 . . . . 0.0 112.321 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 351' ' ' PHE . . . . . 0.677 ' HB3' HD22 ' A' ' 368' ' ' LEU . 94.6 m-85 -75.61 98.65 4.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.844 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -106.51 145.55 31.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.117 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 35.8 t -62.08 148.2 44.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.917 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 41.8 m -92.89 -31.87 14.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.131 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.577 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 55.7 t-105 -49.54 140.23 14.22 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.574 0.702 . . . . 0.0 110.951 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . 0.517 ' HD2' ' CG ' ' A' ' 355' ' ' TRP . 53.9 Cg_endo -69.78 140.71 43.28 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.676 2.25 . . . . 0.0 112.349 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 84.03 -41.53 2.99 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.474 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 44.9 t -63.28 150.9 42.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.888 0.375 . . . . 0.0 110.92 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -140.19 44.03 1.09 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.476 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 39.3 m95 -93.91 129.56 40.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.728 0.299 . . . . 0.0 110.946 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 361' ' ' ARG . . . . . 0.426 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 56.7 mtm180 -122.73 164.61 17.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.902 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 362' ' ' PHE . . . . . 0.469 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 11.3 m-85 -151.37 151.01 31.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.857 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 50.4 m -78.15 -25.8 47.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.871 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 78.1 mtt-85 -115.36 163.27 15.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.915 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 88.2 p -72.39 -53.47 12.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.851 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -50.23 -44.61 53.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.87 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -57.24 -34.4 68.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.864 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.677 HD22 ' HB3' ' A' ' 351' ' ' PHE . 6.5 tp -80.49 -44.38 19.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.915 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 14.9 m -57.87 -45.12 86.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.851 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -60.67 -28.27 68.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.839 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 16.8 t60 -76.7 -44.84 31.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.875 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 45.7 mmm-85 -45.43 -28.14 0.83 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.864 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -52.66 -44.57 66.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.878 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 39.2 m -46.69 -38.12 9.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.883 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 375' ' ' HIS . . . . . 0.577 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 38.3 m-70 -93.71 158.47 15.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.878 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 6.1 m -94.08 106.11 18.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.845 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -119.72 -136.17 5.2 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.461 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 14.9 p -133.76 141.54 43.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.873 0.368 . . . . 0.0 111.13 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 379' ' ' LYS . . . . . 0.473 ' CG ' ' HD2' ' A' ' 380' ' ' PRO . 6.0 ttpm? -143.98 139.44 16.01 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.584 0.707 . . . . 0.0 110.902 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . 0.473 ' HD2' ' CG ' ' A' ' 379' ' ' LYS . 53.6 Cg_endo -69.81 -171.14 0.45 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.671 2.247 . . . . 0.0 112.285 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 51.1 m -63.64 -56.71 13.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.844 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 122.93 -78.73 0.35 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.452 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 383' ' ' PRO . . . . . 0.407 ' O ' ' C ' ' A' ' 384' ' ' SER . 53.8 Cg_endo -69.71 -6.77 19.38 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.71 2.273 . . . . 0.0 112.357 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . 0.407 ' C ' ' O ' ' A' ' 383' ' ' PRO . 88.7 p 37.41 42.08 0.3 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.869 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 29.9 t -44.68 -47.31 10.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.843 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.483 -179.975 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 339' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 16.4 m -105.33 105.05 14.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.889 0.376 . . . . 0.0 110.871 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 1.7 t -95.64 120.48 35.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.882 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 162.77 -159.63 32.01 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.468 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 13.0 t -145.04 157.0 44.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.902 0.382 . . . . 0.0 110.847 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 2.8 t -103.9 96.66 6.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.86 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 114.15 100.26 2.36 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.459 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 7.3 t -142.64 135.88 28.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.875 0.369 . . . . 0.0 111.14 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 139.4 -94.87 0.2 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.502 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -164.2 158.54 19.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.929 0.395 . . . . 0.0 110.877 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 349' ' ' LYS . . . . . 0.43 ' HA ' ' HD2' ' A' ' 350' ' ' PRO . 64.1 mttt -125.79 93.44 44.25 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.592 0.711 . . . . 0.0 110.871 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 349' ' ' LYS . 53.4 Cg_endo -69.76 -31.57 20.27 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.685 2.256 . . . . 0.0 112.317 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 351' ' ' PHE . . . . . 0.687 ' HB3' HD22 ' A' ' 368' ' ' LEU . 97.0 m-85 -71.74 100.48 2.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.872 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -108.47 132.92 53.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.121 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 353' ' ' CYS . . . . . 0.553 ' HA ' HD11 ' A' ' 368' ' ' LEU . 35.9 t -49.55 153.95 1.05 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.902 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 30.6 m -94.92 -34.55 12.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.191 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.555 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 46.9 t-105 -44.59 140.66 3.1 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.555 0.693 . . . . 0.0 110.932 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . 0.521 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 53.7 Cg_endo -69.72 140.07 41.91 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.671 2.247 . . . . 0.0 112.372 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 83.65 -41.97 3.0 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.463 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 34.9 t -58.81 149.69 25.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.936 0.398 . . . . 0.0 110.908 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -139.21 42.53 1.24 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.456 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 37.0 m95 -94.8 128.61 41.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.771 0.319 . . . . 0.0 110.874 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 361' ' ' ARG . . . . . 0.408 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 37.7 mtt180 -121.74 159.15 27.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.923 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 362' ' ' PHE . . . . . 0.434 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 4.8 m-85 -144.64 152.47 40.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.874 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 36.2 t -74.39 -34.57 63.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.874 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 36.3 mtt-85 -110.63 169.7 8.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.872 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 68.2 p -74.76 -57.4 3.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.893 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -47.34 -44.93 24.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.859 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -55.97 -32.67 64.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.906 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.687 HD22 ' HB3' ' A' ' 351' ' ' PHE . 12.5 tp -83.78 -42.72 16.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.913 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 14.8 t -58.66 -46.88 86.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.836 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 48.6 ptt85 -58.01 -29.29 65.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.849 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -74.34 -45.62 46.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.843 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . 0.416 ' HB3' ' NH1' ' A' ' 372' ' ' ARG . 4.6 mmm180 -42.98 -29.46 0.34 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.853 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 77.4 mtt180 -50.85 -45.5 59.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.846 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 3.2 m -44.56 -39.48 4.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.879 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 375' ' ' HIS . . . . . 0.555 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 48.2 m-70 -89.86 151.14 21.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.848 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 4.2 t -88.64 56.43 3.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.852 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 56.68 163.78 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.478 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 2.3 t -98.06 52.57 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.935 0.397 . . . . 0.0 111.166 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 379' ' ' LYS . . . . . . . . . . . . . 7.1 ptmm? -158.51 143.98 12.14 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.576 0.703 . . . . 0.0 110.912 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -46.76 1.1 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.687 2.258 . . . . 0.0 112.345 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 29.2 t -78.31 161.71 27.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.851 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 179.53 70.54 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.48 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 383' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 153.53 68.61 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.704 2.27 . . . . 0.0 112.309 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 10.4 m -84.25 99.43 10.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.858 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 32.6 m -158.59 159.35 35.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.882 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.501 179.991 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 339' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 N-CA-C 112.454 -0.259 . . . . 0.0 112.454 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 1.8 m 52.82 42.02 31.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.856 0.36 . . . . 0.0 110.831 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 11.9 m -46.54 130.28 11.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.848 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . -132.41 -79.72 0.17 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.47 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 33.4 t -81.21 135.42 35.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.86 0.362 . . . . 0.0 110.901 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 3.2 m -124.43 41.86 3.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.869 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -166.57 -79.31 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.516 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 44.2 p -126.63 104.94 8.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.796 0.331 . . . . 0.0 111.167 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -174.56 83.99 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.489 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 348' ' ' GLU . . . . . 0.42 ' CG ' ' N ' ' A' ' 349' ' ' LYS . 27.3 tt0 -160.64 163.3 32.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.941 0.4 . . . . 0.0 110.878 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 349' ' ' LYS . . . . . 0.42 ' N ' ' CG ' ' A' ' 348' ' ' GLU . 47.7 mttm -113.04 93.46 25.32 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.555 0.693 . . . . 0.0 110.877 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 349' ' ' LYS . 53.7 Cg_endo -69.73 -26.29 27.88 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.705 2.27 . . . . 0.0 112.366 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 351' ' ' PHE . . . . . 0.651 ' HB3' HD22 ' A' ' 368' ' ' LEU . 89.4 m-85 -79.95 97.78 6.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.906 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . 0.457 ' CB ' ' HG2' ' A' ' 361' ' ' ARG . . . -110.17 144.0 39.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.12 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 43.5 t -60.13 144.68 49.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.881 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 62.3 p -93.94 -26.14 16.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.178 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.569 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 60.3 t-105 -49.87 139.82 16.4 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.571 0.7 . . . . 0.0 110.927 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . 0.525 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 54.1 Cg_endo -69.77 137.93 36.59 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.709 2.273 . . . . 0.0 112.321 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 84.53 -33.83 3.19 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.478 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 49.9 t -72.97 153.77 40.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.904 0.383 . . . . 0.0 110.881 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -143.71 48.55 0.74 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.456 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 39.2 m95 -97.93 128.66 44.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.8 0.333 . . . . 0.0 110.875 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 361' ' ' ARG . . . . . 0.507 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 58.1 mtm180 -121.72 164.21 17.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.905 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 362' ' ' PHE . . . . . 0.507 ' CD1' ' C ' ' A' ' 361' ' ' ARG . 4.5 m-85 -151.23 151.13 31.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.896 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 52.6 m -80.06 -19.43 47.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.896 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 5.5 mpt_? -122.94 162.14 22.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.851 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 9.8 t -70.17 -62.74 1.27 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.874 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -43.66 -41.21 4.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.851 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . 0.414 ' O ' ' CG ' ' A' ' 370' ' ' ARG . 24.2 mm-40 -59.29 -40.11 85.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.888 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.651 HD22 ' HB3' ' A' ' 351' ' ' PHE . 12.5 tp -77.06 -44.96 28.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.895 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 30.4 t -55.73 -44.67 77.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.846 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 370' ' ' ARG . . . . . 0.442 ' HG3' ' N ' ' A' ' 371' ' ' HIS . 9.6 ptt180 -59.32 -33.86 71.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.899 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 371' ' ' HIS . . . . . 0.442 ' N ' ' HG3' ' A' ' 370' ' ' ARG . 17.3 t60 -71.31 -46.69 60.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.9 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . 0.41 ' HB3' ' NH1' ' A' ' 372' ' ' ARG . 4.9 mmm180 -41.42 -30.13 0.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.838 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -49.67 -44.36 47.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.864 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 1.4 t -46.51 -33.44 4.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.881 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 375' ' ' HIS . . . . . 0.569 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 53.2 m-70 -99.23 166.47 11.2 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.884 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 2.2 m -110.82 166.59 10.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.814 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 155.61 -40.11 0.6 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.494 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . 0.479 HG13 ' O ' ' A' ' 378' ' ' VAL . 9.2 p -160.32 125.18 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.851 0.357 . . . . 0.0 111.146 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 379' ' ' LYS . . . . . . . . . . . . . 18.4 pttp -96.47 143.82 26.77 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.603 0.716 . . . . 0.0 110.892 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -176.36 1.47 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.637 2.225 . . . . 0.0 112.308 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 29.3 p -121.86 93.36 3.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.824 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 154.09 83.57 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.434 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 383' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 107.53 1.88 Allowed 'Trans proline' 0 N--CA 1.465 -0.149 0 C-N-CA 122.707 2.271 . . . . 0.0 112.371 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 1.1 t -54.17 -60.22 3.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.847 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 54.6 p -156.65 164.49 38.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.875 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.477 -179.966 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 339' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 19.8 m 60.98 42.21 13.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.846 0.355 . . . . 0.0 110.827 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 5.1 t -68.05 127.5 33.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.84 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 166.24 55.36 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.469 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 19.6 m -159.71 117.46 2.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.912 0.387 . . . . 0.0 110.845 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 3.8 m -112.31 135.14 53.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.811 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 125.86 74.96 0.23 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.425 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 74.3 p -67.59 150.33 48.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.803 0.335 . . . . 0.0 111.173 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 133.08 107.73 1.04 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.44 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -83.19 157.81 22.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.96 0.41 . . . . 0.0 110.842 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 349' ' ' LYS . . . . . 0.477 ' HB3' ' N ' ' A' ' 362' ' ' PHE . 36.9 mttp -104.41 93.41 5.79 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.574 0.702 . . . . 0.0 110.915 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 349' ' ' LYS . 54.0 Cg_endo -69.77 -32.2 18.99 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.696 2.264 . . . . 0.0 112.319 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 351' ' ' PHE . . . . . 0.636 ' HB3' HD22 ' A' ' 368' ' ' LEU . 98.3 m-85 -72.16 99.2 2.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.847 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -106.72 141.68 37.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.059 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 39.6 t -58.8 149.18 27.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.881 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 27.0 m -90.75 -33.19 15.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.138 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.573 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 56.2 t-105 -45.21 140.16 3.91 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.587 0.708 . . . . 0.0 110.865 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . 0.514 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 53.9 Cg_endo -69.74 142.37 47.84 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.713 2.275 . . . . 0.0 112.329 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 80.95 -37.99 2.36 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.491 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 49.7 t -63.12 154.52 30.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.827 0.346 . . . . 0.0 110.88 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -143.8 39.04 1.3 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.5 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 48.0 m95 -92.61 128.03 38.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.72 0.295 . . . . 0.0 110.899 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 361' ' ' ARG . . . . . 0.515 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 43.7 mtm180 -121.2 169.47 10.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.818 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 362' ' ' PHE . . . . . 0.515 ' CD1' ' C ' ' A' ' 361' ' ' ARG . 9.4 m-85 -154.48 153.51 31.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.876 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 27.2 t -75.83 -35.43 59.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.884 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -108.16 167.6 9.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.891 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 54.6 p -73.83 -55.51 6.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.836 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -48.58 -45.46 37.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.869 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -55.25 -33.72 63.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.884 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.636 HD22 ' HB3' ' A' ' 351' ' ' PHE . 6.8 tp -81.98 -45.41 15.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 27.0 t -56.35 -45.99 80.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.854 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 370' ' ' ARG . . . . . 0.44 ' HG3' ' N ' ' A' ' 371' ' ' HIS . 20.4 ptt180 -59.19 -31.96 69.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.88 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 371' ' ' HIS . . . . . 0.44 ' N ' ' HG3' ' A' ' 370' ' ' ARG . 17.7 t60 -73.75 -38.25 64.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.876 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 19.9 mmm-85 -52.0 -24.96 7.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.885 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 37.5 mtt85 -55.56 -43.35 75.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.902 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 32.7 t -48.51 -36.02 14.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.89 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 375' ' ' HIS . . . . . 0.573 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 58.6 m-70 -93.68 144.15 25.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.871 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 3.2 m -88.19 165.63 14.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.816 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -119.14 -132.81 4.53 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.505 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 96.6 t -59.31 119.08 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.884 0.373 . . . . 0.0 111.102 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 379' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -47.84 134.83 11.1 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.601 0.715 . . . . 0.0 110.874 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -51.04 0.41 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.624 2.216 . . . . 0.0 112.367 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 1.8 m -175.11 176.83 2.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.855 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 64.82 146.25 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.492 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 383' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -50.53 0.45 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.697 2.264 . . . . 0.0 112.316 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 3.6 m 41.56 38.54 0.91 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.854 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 3.7 t 44.14 47.06 7.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.848 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.373 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.498 -179.976 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 339' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.501 -0.239 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 13.9 t -84.32 145.99 27.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.902 0.382 . . . . 0.0 110.877 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 2.1 t -130.13 127.76 40.44 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.863 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 150.81 -57.68 0.45 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.534 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 7.8 t -49.21 -47.08 46.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.924 0.393 . . . . 0.0 110.903 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 51.1 m -143.56 150.06 38.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.876 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 158.98 -153.48 24.59 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.507 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 9.3 t -75.29 -18.65 60.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.853 0.359 . . . . 0.0 111.138 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 348' ' ' GLU . . . -80.54 -35.86 24.72 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.513 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 348' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 347' ' ' GLY . 22.1 tt0 -35.17 146.5 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.881 0.372 . . . . 0.0 110.951 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 349' ' ' LYS . . . . . 0.46 ' HB3' ' N ' ' A' ' 362' ' ' PHE . 46.2 mttm -133.93 93.35 20.51 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.564 0.697 . . . . 0.0 110.895 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 349' ' ' LYS . 53.4 Cg_endo -69.79 -30.57 21.91 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.659 2.239 . . . . 0.0 112.298 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 351' ' ' PHE . . . . . 0.745 ' HB3' HD22 ' A' ' 368' ' ' LEU . 95.0 m-85 -74.25 95.68 2.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.883 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . 0.522 ' HB2' ' HD3' ' A' ' 361' ' ' ARG . . . -103.97 135.58 45.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.089 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 43.5 t -51.77 150.88 3.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.92 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 70.2 p -95.55 -30.69 13.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.147 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.566 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 55.0 t-105 -46.08 140.21 5.14 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.574 0.702 . . . . 0.0 110.895 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . 0.513 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 53.9 Cg_endo -69.73 133.8 26.51 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.681 2.254 . . . . 0.0 112.345 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 88.88 -37.75 3.28 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.528 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 46.8 t -64.78 151.86 44.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.917 0.389 . . . . 0.0 110.846 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -141.5 43.1 1.11 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.482 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 37.9 m95 -95.92 129.16 43.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.778 0.323 . . . . 0.0 110.917 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 361' ' ' ARG . . . . . 0.522 ' HD3' ' HB2' ' A' ' 352' ' ' ALA . 25.7 mtt180 -121.51 161.01 23.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.828 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 362' ' ' PHE . . . . . 0.49 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 10.2 m-85 -145.91 153.18 40.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.845 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 45.2 t -78.3 -29.84 48.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.819 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.14 165.78 11.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.848 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 36.1 t -73.89 -47.61 36.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.852 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -56.36 -46.89 79.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.876 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -54.26 -31.43 53.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.844 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.745 HD22 ' HB3' ' A' ' 351' ' ' PHE . 8.4 tp -83.8 -44.03 14.79 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.948 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 5.5 t -57.7 -47.04 83.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.836 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 25.8 ptt180 -57.93 -33.12 68.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.877 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 22.3 t60 -72.32 -43.92 63.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.875 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . 0.412 ' HB3' ' NH1' ' A' ' 372' ' ' ARG . 4.9 mmm180 -44.68 -28.54 0.63 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.906 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 373' ' ' ARG . . . . . 0.432 ' NH1' ' HB3' ' A' ' 373' ' ' ARG . 10.3 mtp-105 -55.39 -42.79 74.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 58.4 m -47.28 -31.43 3.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.863 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 375' ' ' HIS . . . . . 0.566 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 61.8 m-70 -99.03 165.98 11.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.866 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 2.8 m -97.72 133.69 41.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.83 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 156.42 63.55 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.483 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 10.8 p -171.47 149.05 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.879 0.371 . . . . 0.0 111.085 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 379' ' ' LYS . . . . . . . . . . . . . 21.3 mtmt -45.13 144.11 2.22 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.573 0.701 . . . . 0.0 110.893 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 154.19 67.86 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.643 2.229 . . . . 0.0 112.323 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 58.7 m -114.74 102.53 10.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.816 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 67.81 -158.15 51.74 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.53 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 383' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 150.84 68.95 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.714 2.276 . . . . 0.0 112.316 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 4.1 m -86.97 112.98 22.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.915 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 1.1 t -99.21 142.53 30.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.848 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.521 -179.987 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 339' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.494 -0.243 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 4.4 m -78.55 151.51 32.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.878 0.371 . . . . 0.0 110.874 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 3.2 t -75.19 133.4 41.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.853 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . -102.45 -151.89 23.93 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.484 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 2.7 t -69.03 113.34 6.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.855 0.36 . . . . 0.0 110.853 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 33.2 m -90.69 41.27 1.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.881 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -146.86 64.93 0.43 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.457 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 12.8 t -95.48 145.1 25.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.785 0.326 . . . . 0.0 111.185 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -128.69 -74.3 0.17 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.479 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -142.95 112.37 6.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.874 0.368 . . . . 0.0 110.883 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 349' ' ' LYS . . . . . 0.432 ' NZ ' ' HB2' ' A' ' 361' ' ' ARG . 7.6 mtmp? -134.49 93.04 19.3 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.584 0.706 . . . . 0.0 110.899 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -28.18 25.6 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.705 2.27 . . . . 0.0 112.316 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 351' ' ' PHE . . . . . 0.601 ' HB3' HD22 ' A' ' 368' ' ' LEU . 84.1 m-85 -76.52 102.26 5.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.871 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -115.8 137.59 51.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.088 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 43.2 t -55.59 146.5 20.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.85 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 93.5 m -93.14 -29.05 15.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.154 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.552 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 59.0 t-105 -47.79 139.91 8.71 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.566 0.698 . . . . 0.0 110.932 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . 0.523 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 53.8 Cg_endo -69.8 140.97 43.81 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.707 2.271 . . . . 0.0 112.283 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 81.94 -36.87 2.51 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.503 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 47.2 t -68.29 151.51 46.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.853 0.358 . . . . 0.0 110.922 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -140.61 45.33 0.99 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.513 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 39.3 m95 -94.24 128.65 40.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.794 0.33 . . . . 0.0 110.913 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 361' ' ' ARG . . . . . 0.455 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 18.2 mtt85 -122.61 165.33 16.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.843 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 362' ' ' PHE . . . . . 0.534 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 11.3 m-85 -152.72 151.2 30.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 49.9 m -77.04 -33.41 57.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.855 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -104.67 171.65 7.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.833 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . 0.57 ' HA ' ' CD1' ' A' ' 351' ' ' PHE . 80.7 p -81.13 -55.64 4.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.865 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.62 -34.59 59.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.853 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -62.75 -34.58 77.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.881 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.601 HD22 ' HB3' ' A' ' 351' ' ' PHE . 9.4 tp -81.01 -45.58 16.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.943 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 58.7 m -56.02 -43.7 78.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.877 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -60.17 -28.9 68.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.855 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -76.44 -43.55 39.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.852 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 22.0 mmm-85 -45.97 -27.14 0.84 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.895 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 25.8 mtp85 -51.13 -46.01 61.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.847 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 58.3 m -46.42 -35.29 5.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.841 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 375' ' ' HIS . . . . . 0.552 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 66.3 m-70 -92.41 159.72 15.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.861 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 24.8 p -108.28 174.67 5.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.836 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -103.97 -107.7 3.21 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.477 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 12.6 p -68.1 143.74 15.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.886 0.374 . . . . 0.0 111.146 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 379' ' ' LYS . . . . . . . . . . . . . 24.7 pttt -52.05 144.22 21.57 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.612 0.72 . . . . 0.0 110.878 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 144.86 55.07 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.63 2.22 . . . . 0.0 112.355 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 382' ' ' GLY . 1.2 t -123.59 -62.01 1.34 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.85 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 381' ' ' SER . . . 35.92 82.86 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.46 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 383' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -39.85 6.05 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.671 2.247 . . . . 0.0 112.339 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 65.9 p -70.45 -48.04 57.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 2.3 m -125.66 113.63 17.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.884 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.467 -179.992 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 339' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 112.476 -0.25 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 2.7 m -132.52 141.31 48.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.872 0.368 . . . . 0.0 110.885 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 41.2 t -116.64 153.11 32.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.898 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 169.41 -82.94 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.514 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 30.4 t -123.08 136.59 54.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.863 0.363 . . . . 0.0 110.867 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 17.2 m -50.72 116.62 2.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.822 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -60.54 147.71 45.39 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.454 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 66.7 p -118.15 86.41 2.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.832 0.349 . . . . 0.0 111.138 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 131.54 127.79 2.89 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.475 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 348' ' ' GLU . . . . . 0.404 ' O ' ' HD3' ' A' ' 350' ' ' PRO . 0.2 OUTLIER -54.66 166.23 0.49 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.959 0.409 . . . . 0.0 110.847 -179.871 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 349' ' ' LYS . . . . . 0.421 ' HA ' ' HD2' ' A' ' 350' ' ' PRO . 56.6 mttt -104.31 92.93 5.15 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.559 0.695 . . . . 0.0 110.892 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 349' ' ' LYS . 54.3 Cg_endo -69.82 -29.4 23.64 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.721 2.28 . . . . 0.0 112.342 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 351' ' ' PHE . . . . . 0.732 ' HB3' HD22 ' A' ' 368' ' ' LEU . 94.4 m-85 -74.98 100.45 4.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.878 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -107.33 150.49 26.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.067 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 41.0 t -68.06 144.12 55.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.891 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 89.4 m -89.09 -28.69 19.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.139 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.578 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 57.8 t-105 -49.87 140.03 16.12 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.51 0.672 . . . . 0.0 110.931 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . 0.524 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 53.8 Cg_endo -69.72 138.64 38.41 Favored 'Trans proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.716 2.278 . . . . 0.0 112.358 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 84.34 -39.87 2.92 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.527 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 44.8 t -63.9 155.18 31.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.868 0.366 . . . . 0.0 110.896 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -145.3 45.21 0.84 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.494 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 32.7 m95 -96.13 128.69 43.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.745 0.307 . . . . 0.0 110.957 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 361' ' ' ARG . . . . . 0.519 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 56.6 mtm-85 -120.77 167.14 12.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.848 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 362' ' ' PHE . . . . . 0.519 ' CD1' ' C ' ' A' ' 361' ' ' ARG . 8.2 m-85 -153.2 146.94 25.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.876 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 29.0 t -70.96 -34.01 71.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.868 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 364' ' ' ARG . . . . . 0.456 ' HD2' ' N ' ' A' ' 364' ' ' ARG . 0.0 OUTLIER -109.66 174.0 6.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.855 -179.913 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 7.1 m -79.6 -57.95 3.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -46.59 -39.44 11.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.859 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 -62.43 -31.64 72.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.864 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.732 HD22 ' HB3' ' A' ' 351' ' ' PHE . 9.1 tp -84.92 -45.91 11.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.898 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 37.1 t -56.43 -46.66 80.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.858 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -58.56 -31.91 68.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.867 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 13.4 t60 -70.87 -46.35 62.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.855 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 54.6 mmm-85 -44.09 -29.08 0.56 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.851 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 62.3 mtt-85 -48.74 -45.92 40.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 36.8 t -47.65 -35.78 9.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.875 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 375' ' ' HIS . . . . . 0.578 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 46.4 m-70 -94.98 170.96 9.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.869 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 45.6 t -75.37 -59.21 2.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.853 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 76.31 -75.81 1.54 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.478 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 7.7 p -119.05 144.74 26.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.863 0.363 . . . . 0.0 111.172 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 379' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -124.37 144.13 44.97 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.601 0.715 . . . . 0.0 110.915 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -174.95 1.01 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.686 2.257 . . . . 0.0 112.3 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 3.6 m -133.35 72.52 1.48 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.856 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 128.73 -91.8 0.33 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.539 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 383' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 172.13 13.21 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.666 2.244 . . . . 0.0 112.366 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 36.7 t -128.62 108.63 10.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.889 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 67.9 m -99.11 84.48 3.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.876 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.272 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.463 -179.956 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 339' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 72.5 m -39.65 121.05 1.18 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.859 0.362 . . . . 0.0 110.817 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 71.7 m -106.91 83.05 1.78 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.848 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . -140.03 167.91 25.25 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.473 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 35.3 p -108.87 93.27 4.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.905 0.383 . . . . 0.0 110.872 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 49.4 m -96.6 40.54 1.13 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.837 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 114.57 -40.57 2.43 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.513 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 6.6 t -94.37 163.04 13.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.896 0.379 . . . . 0.0 111.136 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 159.34 -42.95 0.46 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.482 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -51.72 170.13 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.94 0.4 . . . . 0.0 110.895 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 349' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -106.24 93.38 7.97 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.597 0.713 . . . . 0.0 110.904 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -29.82 23.1 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.683 2.255 . . . . 0.0 112.334 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 351' ' ' PHE . . . . . 0.564 ' CD1' ' HA ' ' A' ' 365' ' ' SER . 94.8 m-85 -74.43 95.5 2.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -109.58 139.65 44.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.11 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 53.3 t -58.85 145.07 42.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.865 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 49.9 m -93.11 -27.94 16.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.138 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.526 ' CD2' ' HD2' ' A' ' 356' ' ' PRO . 61.3 t-105 -47.93 139.69 9.22 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.521 0.677 . . . . 0.0 110.918 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . 0.526 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 54.0 Cg_endo -69.76 137.62 35.87 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.69 2.26 . . . . 0.0 112.325 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 84.49 -39.94 2.94 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.476 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 41.8 t -62.77 154.64 29.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.884 0.373 . . . . 0.0 110.843 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -142.57 47.71 0.81 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.513 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 31.6 m95 -97.68 132.81 42.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.754 0.311 . . . . 0.0 110.919 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 361' ' ' ARG . . . . . 0.485 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 30.1 mtt180 -128.51 163.23 25.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.875 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 362' ' ' PHE . . . . . 0.551 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 5.6 m-85 -151.94 152.77 32.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 50.7 m -79.06 -27.36 43.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.866 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 364' ' ' ARG . . . . . 0.501 ' C ' ' CD2' ' A' ' 351' ' ' PHE . 66.6 mtt180 -113.27 168.44 9.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.822 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . 0.564 ' HA ' ' CD1' ' A' ' 351' ' ' PHE . 31.2 t -74.65 -62.85 1.39 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.865 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -44.38 -38.59 4.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.911 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -58.97 -41.79 88.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.885 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.551 ' HA ' ' CD1' ' A' ' 362' ' ' PHE . 6.5 tp -76.0 -45.19 35.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 27.4 t -55.86 -49.45 73.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.868 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 25.8 ptt85 -56.05 -28.24 56.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.887 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 20.0 t60 -79.11 -41.85 27.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.852 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 22.0 mmm-85 -48.99 -24.7 1.61 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.849 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 -55.9 -44.16 77.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.936 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 39.5 t -46.64 -34.75 5.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.855 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 375' ' ' HIS . . . . . 0.479 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 48.5 m-70 -94.11 156.85 16.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.852 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 55.5 p -84.09 51.67 2.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -93.29 -123.23 3.46 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.463 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 87.8 t -62.07 131.55 27.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.902 0.382 . . . . 0.0 111.16 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 379' ' ' LYS . . . . . 0.474 ' CG ' ' HD2' ' A' ' 380' ' ' PRO . 21.2 ttmt -132.06 140.24 37.5 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.568 0.699 . . . . 0.0 110.9 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . 0.474 ' HD2' ' CG ' ' A' ' 379' ' ' LYS . 54.1 Cg_endo -69.74 -31.98 19.53 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.665 2.243 . . . . 0.0 112.345 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 74.1 m 51.12 40.96 27.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.876 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -88.82 152.1 22.78 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.514 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 383' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 105.67 1.53 Allowed 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.726 2.284 . . . . 0.0 112.303 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 5.5 m -110.67 154.28 24.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.863 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 7.5 t -129.18 160.88 31.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.89 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.482 -179.994 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 339' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.464 -0.254 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 2.0 m -98.97 168.13 10.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.853 0.359 . . . . 0.0 110.886 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 90.2 p -106.74 145.04 32.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.884 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . -80.01 -138.29 1.86 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.467 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 24.8 p -79.87 129.35 34.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.872 0.368 . . . . 0.0 110.865 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 4.7 m -85.13 163.35 18.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.849 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 92.19 -88.79 1.35 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.465 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 72.1 p -129.32 133.6 47.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.81 0.338 . . . . 0.0 111.154 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 128.77 56.19 0.11 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.483 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -114.4 157.28 23.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.974 0.416 . . . . 0.0 110.842 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 349' ' ' LYS . . . . . 0.468 ' HB3' ' N ' ' A' ' 362' ' ' PHE . 74.4 mttt -104.2 93.95 6.21 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.548 0.69 . . . . 0.0 110.873 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -36.61 10.62 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.677 2.251 . . . . 0.0 112.408 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 351' ' ' PHE . . . . . 0.622 ' HB3' HD22 ' A' ' 368' ' ' LEU . 86.2 m-85 -67.57 98.28 0.67 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.907 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -107.45 138.83 42.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.07 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 353' ' ' CYS . . . . . . . . . . . . . 45.3 t -55.35 132.65 48.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.885 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 28.0 m -79.93 -18.86 49.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.125 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.56 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 58.7 t-105 -55.8 139.9 68.92 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.588 0.709 . . . . 0.0 110.949 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . 0.525 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 54.1 Cg_endo -69.7 137.73 36.33 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.711 2.274 . . . . 0.0 112.367 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 83.77 -37.29 2.81 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.498 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 47.0 t -65.13 153.81 39.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.859 0.362 . . . . 0.0 110.923 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -142.45 44.73 0.96 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.485 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 43.3 m95 -97.98 130.67 44.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.791 0.329 . . . . 0.0 110.926 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 361' ' ' ARG . . . . . . . . . . . . . 30.7 mtt180 -122.23 163.34 19.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.861 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 362' ' ' PHE . . . . . 0.529 ' CD1' ' HA ' ' A' ' 368' ' ' LEU . 23.5 m-85 -148.81 148.93 30.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.896 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 34.4 p -72.13 -35.48 69.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.841 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 64.3 mtt180 -112.9 165.58 12.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.886 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . 0.446 ' HB2' ' CE2' ' A' ' 351' ' ' PHE . 26.3 t -71.54 -52.7 16.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.909 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -51.02 -31.37 18.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.894 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -71.25 -29.2 64.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.874 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.622 HD22 ' HB3' ' A' ' 351' ' ' PHE . 10.4 tp -86.71 -47.16 9.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.924 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 22.1 t -54.43 -43.5 71.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.836 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -59.69 -35.42 74.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.87 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 22.8 t60 -70.84 -41.77 71.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.883 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -45.96 -27.64 0.95 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.881 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 373' ' ' ARG . . . . . 0.428 ' NH1' ' HB3' ' A' ' 373' ' ' ARG . 10.1 mtp-105 -53.45 -43.86 68.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.892 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 28.5 t -49.91 -33.47 17.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.863 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 375' ' ' HIS . . . . . 0.56 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 78.3 m-70 -95.77 172.39 8.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.87 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 3.3 m -76.99 -65.03 1.0 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.895 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 135.53 -77.99 0.35 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.493 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . . . . . . . . . 31.5 m -113.35 129.19 69.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.94 0.4 . . . . 0.0 111.17 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 379' ' ' LYS . . . . . 0.475 ' CG ' ' HD2' ' A' ' 380' ' ' PRO . 25.3 ttpt -51.45 139.37 27.77 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.59 0.71 . . . . 0.0 110.872 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . 0.475 ' HD2' ' CG ' ' A' ' 379' ' ' LYS . 53.7 Cg_endo -69.78 150.09 67.65 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.705 2.27 . . . . 0.0 112.328 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 27.7 t -167.74 120.28 0.9 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.843 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 177.6 138.46 3.04 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.479 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 383' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -15.92 37.52 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.662 2.241 . . . . 0.0 112.345 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 8.4 t -60.12 -62.68 1.69 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.882 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 79.2 p -84.48 136.11 33.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.86 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.512 179.994 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 339' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 28.4 t -84.73 -44.22 13.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.843 0.354 . . . . 0.0 110.834 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 50.1 p -149.26 171.79 15.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.855 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . -76.65 175.23 53.51 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.497 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 24.0 t -40.95 -54.64 2.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.883 0.373 . . . . 0.0 110.859 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 344' ' ' SER . . . . . . . . . . . . . 68.4 m -64.02 -59.11 4.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.872 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . 70.64 104.18 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.542 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 28.7 p 38.36 40.64 0.37 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.805 0.336 . . . . 0.0 111.153 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -80.69 -135.1 1.53 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.534 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 348' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -161.29 130.99 4.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.919 0.39 . . . . 0.0 110.872 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 349' ' ' LYS . . . . . 0.41 ' HA ' ' HD2' ' A' ' 350' ' ' PRO . 53.0 mttp -134.59 93.34 18.6 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.565 0.697 . . . . 0.0 110.903 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 349' ' ' LYS . 53.4 Cg_endo -69.74 -25.17 28.97 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.66 2.24 . . . . 0.0 112.335 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 351' ' ' PHE . . . . . 0.558 ' HB3' HD22 ' A' ' 368' ' ' LEU . 84.5 m-85 -80.35 92.88 5.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.912 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -104.09 139.09 39.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.104 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 353' ' ' CYS . . . . . 0.44 ' HA ' HD11 ' A' ' 368' ' ' LEU . 50.2 t -53.28 148.68 8.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.836 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 82.6 p -94.83 -26.55 16.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.111 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.566 ' CE3' ' HB3' ' A' ' 375' ' ' HIS . 49.8 t-105 -52.47 140.58 35.73 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.62 0.724 . . . . 0.0 110.924 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 356' ' ' PRO . . . . . 0.512 ' HD2' ' CD2' ' A' ' 355' ' ' TRP . 53.3 Cg_endo -69.78 138.94 38.95 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.652 2.235 . . . . 0.0 112.341 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 357' ' ' GLY . . . . . . . . . . . . . . . 84.22 -37.82 2.87 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.52 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 358' ' ' CYS . . . . . . . . . . . . . 49.1 t -63.49 155.64 28.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.927 0.394 . . . . 0.0 110.862 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . -142.58 37.91 1.49 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.519 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 360' ' ' TRP . . . . . . . . . . . . . 42.7 m95 -92.19 128.97 38.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.758 0.313 . . . . 0.0 110.899 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 361' ' ' ARG . . . . . 0.487 ' C ' ' CD1' ' A' ' 362' ' ' PHE . 56.6 mtt180 -124.34 165.01 18.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.926 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 362' ' ' PHE . . . . . 0.487 ' CD1' ' C ' ' A' ' 361' ' ' ARG . 7.6 m-85 -149.98 152.11 34.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.86 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 363' ' ' SER . . . . . . . . . . . . . 49.9 m -77.9 -22.85 49.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.867 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 364' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -118.72 165.99 13.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.832 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . 0.492 ' HA ' ' CD1' ' A' ' 351' ' ' PHE . 1.3 t -74.17 -55.76 5.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.836 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -49.36 -45.97 46.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.868 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -54.58 -35.91 63.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.861 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.558 HD22 ' HB3' ' A' ' 351' ' ' PHE . 14.3 tp -79.64 -42.55 24.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 44.7 t -57.8 -49.16 77.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.848 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -56.15 -31.61 63.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.868 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 371' ' ' HIS . . . . . . . . . . . . . 20.1 t60 -73.15 -46.29 51.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.862 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 372' ' ' ARG . . . . . 0.421 ' HB3' ' NH1' ' A' ' 372' ' ' ARG . 5.6 mmm180 -41.34 -29.98 0.16 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.905 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 373' ' ' ARG . . . . . . . . . . . . . 84.5 mtt180 -51.08 -46.66 61.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.878 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 374' ' ' SER . . . . . . . . . . . . . 85.3 p -43.56 -38.18 2.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 375' ' ' HIS . . . . . 0.566 ' HB3' ' CE3' ' A' ' 355' ' ' TRP . 39.0 m-70 -94.8 172.84 7.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.858 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 3.0 m -106.36 158.15 17.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.832 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -167.56 122.81 1.07 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.452 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 378' ' ' VAL . . . . . 0.415 ' O ' HG23 ' A' ' 378' ' ' VAL . 33.0 m -108.63 126.68 65.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.879 0.371 . . . . 0.0 111.092 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 379' ' ' LYS . . . . . 0.478 ' CD ' ' HD2' ' A' ' 380' ' ' PRO . 33.2 tptt -82.14 137.74 45.99 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.589 0.709 . . . . 0.0 110.894 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . 0.478 ' HD2' ' CD ' ' A' ' 379' ' ' LYS . 53.4 Cg_endo -69.75 165.95 29.23 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.664 2.242 . . . . 0.0 112.348 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 2.2 m 63.53 38.28 9.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.871 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 122.25 146.12 7.19 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.478 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 383' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 170.88 15.47 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.723 2.282 . . . . 0.0 112.33 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . . . . . . . . . 83.8 p -127.24 168.83 14.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.851 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 385' ' ' SER . . . . . . . . . . . . . 14.8 t -60.42 128.25 35.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.868 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.501 -179.996 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_